<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microbiology (Reading)</journal-id><journal-id journal-id-type="iso-abbrev">Microbiology (Reading)</journal-id><journal-id journal-id-type="hwp">micro</journal-id><journal-id journal-id-type="publisher-id">micro</journal-id><journal-title-group><journal-title>Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1350-0872</issn><issn pub-type="epub">1465-2080</issn><publisher><publisher-name>Microbiology Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40402078</article-id><article-id pub-id-type="pmc">PMC12098983</article-id>
<article-id pub-id-type="publisher-id">001563</article-id><article-id pub-id-type="doi">10.1099/mic.0.001563</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Anti-staphylococcal fatty acids: mode of action, bacterial resistance and implications for therapeutic application</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Douglas</surname><given-names>Edward J.A.</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">*</xref><email>e.douglas24@imperial.ac.uk</email></contrib><contrib contrib-type="author"><name><surname>Palk</surname><given-names>Nathanael</given-names></name><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Rudolph</surname><given-names>Emily R.</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Laabei</surname><given-names>Maisem</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="cor2" ref-type="corresp">*</xref><email>maisem.laabei@bristol.ac.uk</email></contrib><aff id="aff1"><label>1</label><institution content-type="department">Centre for Bacterial Resistance Biology</institution>, <institution>Imperial College London</institution>, <addr-line content-type="city">London W2 1NY</addr-line>, <country>UK</country></aff><aff id="aff2"><label>2</label><institution content-type="department">School of Cellular and Molecular Medicine</institution>, <institution>University of Bristol</institution>, <addr-line content-type="city">Bristol BS8 1TD</addr-line>, <country>UK</country></aff><aff id="aff3"><label>3</label><institution content-type="department">Department of Life Sciences</institution>, <institution>University of Bath</institution>, <addr-line content-type="city">Bath BA2 7AY</addr-line>, <country>UK</country></aff></contrib-group><author-notes><fn fn-type="COI-statement"><p>The authors declare that there are no conflicts of interest.</p></fn><corresp id="cor1">Edward J.A. Douglas, <email xlink:href="e.douglas24@imperial.ac.uk">e.douglas24@imperial.ac.uk</email></corresp><corresp id="cor2">Maisem Laabei, <email xlink:href="maisem.laabei@bristol.ac.uk">maisem.laabei@bristol.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>5</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>171</volume><issue>5</issue><elocation-id>001563</elocation-id><history><date date-type="received"><day>03</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>29</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author&#x02019;s institution.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="mic-171-5-01563.pdf"/><abstract><title>Abstract</title><p>Novel strategies to counter multidrug-resistant pathogens such as methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> are urgently required. The antimicrobial properties of fatty acids (FAs) have long been recognized and offer significant promise as viable alternatives to, or potentiators of, conventional antibiotics. In this review, we examine the interplay between FAs and <italic toggle="yes">S. aureus</italic>, specifically detailing the underlying molecular mechanisms responsible for FA-mediated inhibition and the counteracting staphylococcal systems evolved to withstand FA onslaught. Finally, we present an update on the recent therapeutic FA applications to combat <italic toggle="yes">S. aureus</italic> infection, either as a monotherapy or in combination with antibiotics or host-derived antimicrobial peptides. Given the frequency of interaction between FAs and <italic toggle="yes">S. aureus</italic> during host colonization and infection, understanding FA mode of action and deciphering <italic toggle="yes">S. aureus</italic> FA resistance strategies are central in rationally designing future anti-staphylococcal FAs and FA-combination therapies.</p></abstract><kwd-group><kwd>fatty acids</kwd><kwd>mode of action</kwd><kwd>resistance mechanisms</kwd><kwd><italic toggle="yes">Staphylococcus aureus</italic></kwd><kwd>therapeutics</kwd></kwd-group><funding-group><award-group><funding-source>
<institution-wrap><institution-id>http://dx.doi.org/10.13039/501100000691</institution-id></institution-wrap>
<institution>Academy of Medical Sciences</institution>
</funding-source><award-id>SBF006\1023</award-id><principal-award-recipient>
<name><surname>Laabei</surname><given-names>Maisem</given-names></name>
</principal-award-recipient></award-group><award-group><funding-source>
<institution-wrap><institution-id>http://dx.doi.org/10.13039/501100000266</institution-id></institution-wrap>
<institution>Engineering and Physical Sciences Research Council</institution>
</funding-source><award-id>EP/X022935/1</award-id><principal-award-recipient>
<name><surname>Laabei</surname><given-names>Maisem</given-names></name>
</principal-award-recipient></award-group></funding-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Fatty acids (FAs) are comprised of a hydrophilic carboxyl head group and a hydrophobic carbon tail. They can be grouped based on the hydrocarbon chain&#x02019;s length or degree of saturation. Based on their length, FAs are organized as short-chain FAs (SCFAs) (less than 6 carbons), medium-chain FAs (between 6 and 11 carbons) and long-chain FAs (LCFAs) (more than 11 carbons). According to their degree of saturation (or the number of double bonds), FAs can be classified as saturated (containing only single bonds), monounsaturated or polyunsaturated (PUFA) FAs, the latter two containing one or more double bonds, respectively [<xref rid="R1" ref-type="bibr">1</xref>]. FAs are employed as innate immune defence agents by diverse eukaryotic organisms including plants, algae and mammals [<xref rid="R2" ref-type="bibr">2</xref>]. FAs are found scattered throughout the human body and can be isolated from most tissues; however, hot spots, with the highest FA biosynthesis, occur in the liver and adipocytes [<xref rid="R3" ref-type="bibr">3</xref>]. Host-specific FAs such as sapienic acid (<italic toggle="yes">cis</italic>-6-hexadecenoic acid), exclusively produced by humans [<xref rid="R4" ref-type="bibr">4</xref>], are important colonization barriers that can restrict or eliminate several bacterial pathogens, including the opportunistic, multidrug-resistant (MDR) human pathogen, <italic toggle="yes">Staphylococcus aureus</italic>. Humans [<xref rid="R5" ref-type="bibr">5</xref>] and mice [<xref rid="R6" ref-type="bibr">6</xref>] deficient in the production of sapienic acid are more susceptible to <italic toggle="yes">S. aureus</italic> skin infections. Moreover, patients suffering from atopic dermatitis (AD), a chronic skin disease frequently exacerbated by <italic toggle="yes">S. aureus</italic>, display decreased levels of both sapienic acid and oleic acid, suggesting that deficiency in FAs contributes to staphylococcal skin pathophysiology [<xref rid="R7" ref-type="bibr">7</xref>].</p><p><italic toggle="yes">S. aureus</italic> is a major human pathogen that can cause a myriad of illnesses ranging from superficial skin diseases to life-threatening systemic infections and toxinoses [<xref rid="R8" ref-type="bibr">8</xref>].</p><p>Treatment of <italic toggle="yes">S. aureus</italic> infections has become complicated by the global emergence of multiple lineages that have gained resistance to clinically relevant antibiotics [<xref rid="R9" ref-type="bibr">9</xref>]. Recent predictive statistical models estimate that methicillin-resistant <italic toggle="yes">S. aureus</italic> caused more than 100,000 deaths worldwide in 2019 [<xref rid="R10" ref-type="bibr">10</xref>]. Furthermore, studies investigating global antimicrobial resistance burden across the 1990&#x02013;2021 timespan have concluded that deaths associated with and attributable to methicillin-resistant <italic toggle="yes">S. aureus</italic> (MRSA) have increased the most from a panel of 22 pathogens and 84 pathogen-drug combinations [<xref rid="R11" ref-type="bibr">11</xref>]. Accordingly, the WHO recognizes <italic toggle="yes">S. aureus</italic> as a priority pathogen where there is a critical need for the development of new antibiotics and immunotherapeutics to combat <italic toggle="yes">S. aureus</italic> diseases [<xref rid="R12" ref-type="bibr">12</xref>].</p><p>A suite of FAs has been observed to possess anti-staphylococcal activity (<xref rid="T1" ref-type="table">Table 1</xref>); for simplicity, we refer to FAs by both their &#x02018;organism identifier&#x02019; and the delta system nomenclature. Renewed interest in exploring the use of FAs or FA-associated therapies to combat <italic toggle="yes">S. aureus</italic> infection has grown in recent years, motivated by the rise of antimicrobial-resistant <italic toggle="yes">S. aureus</italic> and the accompanying increase in morbidity and mortality associated with <italic toggle="yes">S. aureus</italic> disease globally [<xref rid="R13" ref-type="bibr">13</xref>].</p><table-wrap position="float" id="T1"><label>Table 1.</label><caption><title>FAs with reported toxicity to <italic toggle="yes">S. aureus</italic></title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" rowspan="1" colspan="1">Name</th><th align="center" valign="top" rowspan="1" colspan="1">Delta naming system</th><th align="center" valign="top" rowspan="1" colspan="1">Anti-staphylococcal activity</th></tr></thead><tbody><tr><td colspan="3" valign="top" align="left" rowspan="1">
<italic toggle="yes">
<bold>Saturated FAs</bold>
</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Caprylic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C8:0</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R195" ref-type="bibr">195</xref><xref rid="R196" ref-type="bibr">196</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Capric acid</td><td align="center" valign="top" rowspan="1" colspan="1">C10:0</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R56" ref-type="bibr">56</xref><xref rid="R196" ref-type="bibr">196</xref><xref rid="R197" ref-type="bibr"> 197</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Undecanoic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C11:0</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R56" ref-type="bibr">56</xref><xref rid="R193" ref-type="bibr">193</xref><xref rid="R198" ref-type="bibr"> 198</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lauric acid</td><td align="center" valign="top" rowspan="1" colspan="1">C12:0</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R4" ref-type="bibr">4</xref><xref rid="R65" ref-type="bibr">65</xref><xref rid="R193" ref-type="bibr"> 193</xref><xref rid="R196" ref-type="bibr"> 196</xref><xref rid="R197" ref-type="bibr"> 197</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Myristic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C14:0</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R65" ref-type="bibr">65</xref><xref rid="R196" ref-type="bibr">196</xref><xref rid="R197" ref-type="bibr"> 197</xref><xref rid="R199" ref-type="bibr"> 199</xref>]</td></tr><tr><td colspan="3" valign="top" align="left" rowspan="1">
<bold>
<italic toggle="yes">Unsaturated FAs</italic>
</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Myristoleic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C14:1&#x00394;9</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R56" ref-type="bibr">56</xref><xref rid="R193" ref-type="bibr">193</xref><xref rid="R197" ref-type="bibr"> 197</xref><xref rid="R200" ref-type="bibr"> 200</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sapienic (<italic toggle="yes">cis</italic>-6-hexadecenoic acid) acid</td><td align="center" valign="top" rowspan="1" colspan="1">C16:1&#x00394;6</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R4" ref-type="bibr">4</xref><xref rid="R21" ref-type="bibr">21</xref><xref rid="R22" ref-type="bibr"> 22</xref><xref rid="R65" ref-type="bibr"> 65</xref><xref rid="R145" ref-type="bibr"> 145</xref><xref rid="R196" ref-type="bibr"> 196</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Palmitoleic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C16:1&#x00394;9</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R4" ref-type="bibr">4</xref><xref rid="R65" ref-type="bibr">65</xref><xref rid="R121" ref-type="bibr"> 121</xref><xref rid="R197" ref-type="bibr"> 197</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vaccenic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C18:1&#x00394;7</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R56" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oleic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C18:1&#x00394;9</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R56" ref-type="bibr">56</xref><xref rid="R67" ref-type="bibr">67</xref><xref rid="R168" ref-type="bibr"> 168</xref><xref rid="R169" ref-type="bibr"> 169</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Petroselinic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C18:1&#x00394;12</td><td align="center" valign="top" rowspan="1" colspan="1">[(<xref rid="R56" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Linoleic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C18:2&#x00394;9, &#x00394;12</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R60" ref-type="bibr">60</xref><xref rid="R65" ref-type="bibr">65</xref><xref rid="R66" ref-type="bibr"> 66</xref><xref rid="R201" ref-type="bibr"> 201</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">&#x003b1;</italic>-Linolenic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C18:3&#x00394;9,12,15</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="R65" ref-type="bibr">65</xref><xref rid="R201" ref-type="bibr">201</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">&#x003b3;</italic>-Linolenic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C18:3&#x00394;6,9,12</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R65" ref-type="bibr">65</xref><xref rid="R202" ref-type="bibr">202</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Arachidonic acid</td><td align="center" valign="top" rowspan="1" colspan="1">C20:4&#x00394;5,8,11,14</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R56" ref-type="bibr">56</xref><xref rid="R61" ref-type="bibr">61</xref><xref rid="R65" ref-type="bibr"> 65</xref><xref rid="R95" ref-type="bibr"> 95</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Eicosapentaenoic acid (EPA)</td><td align="center" valign="top" rowspan="1" colspan="1">C20:5&#x00394;5,8,11,14,17</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R55" ref-type="bibr">55</xref><xref rid="R203" ref-type="bibr">203</xref><xref rid="R204" ref-type="bibr"> 204</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Docosahexaenoic acid (DHA)</td><td align="center" valign="top" rowspan="1" colspan="1">C22:6&#x00394;4,7,10,13,16</td><td align="center" valign="top" rowspan="1" colspan="1">[<xref rid="R55" ref-type="bibr">55</xref><xref rid="R203" ref-type="bibr">203</xref>]</td></tr></tbody></table></table-wrap><p>Accordingly, understanding how FAs function to eradicate bacteria and conversely how bacteria withstand FA onslaught is paramount for the successful use of FAs in combatting bacterial infection, either alone or in conjunction with other therapeutics. This review documents the role of FAs in the context of <italic toggle="yes">S. aureus</italic> colonization and infection and discusses mechanisms of activity of key anti-staphylococcal FAs and the resistance strategies <italic toggle="yes">S. aureus</italic> has evolved to prevent FA-mediated eradication and lastly presents an overview of recent therapeutic applications of FAs to treat <italic toggle="yes">S. aureus</italic> disease.</p></sec><sec id="s2"><title>Interactions between FAs and <italic toggle="yes">S. aureus</italic></title><sec id="s2-1"><title>Skin</title><p><italic toggle="yes">S. aureus</italic> colonizes ~20&#x02013;30% of the population in sites such as the nasal mucosa, intestine, groin and axillae [<xref rid="R14" ref-type="bibr">14</xref>]. Colonization is harmless but also a recognized risk factor for subsequent disease with up to 80% of <italic toggle="yes">S. aureus</italic> infections originating from the colonizing strain [<xref rid="R15" ref-type="bibr">15</xref><xref rid="R16" ref-type="bibr">16</xref>].</p><p>Numerous FAs are found in the nasal mucosa and on the skin (<xref rid="T1" ref-type="table">Table 1</xref>). On the skin, they are present in high quantities in human sebum, produced from sebaceous glands [<xref rid="R4" ref-type="bibr">4</xref><xref rid="R17" ref-type="bibr">17</xref>]. In combination with a low pH and the presence of antimicrobial peptides (AMPs), FAs protect the skin from colonization of pathogenic bacterial species [<xref rid="R18" ref-type="bibr">18</xref>]. Skin microbiota studies have indicated that <italic toggle="yes">S. aureus</italic> colonization is reduced in areas where FAs are found in high amounts [<xref rid="R19" ref-type="bibr">19</xref><xref rid="R20" ref-type="bibr">20</xref>]. A potent anti-staphylococcal FA, sapienic acid, displays rapid bactericidal activity <italic toggle="yes">in vitro</italic> [<xref rid="R4" ref-type="bibr">4</xref><xref rid="R21" ref-type="bibr">21</xref>], and short-term topical application of sapienic acid was associated with a reduction in <italic toggle="yes">S. aureus</italic> recovery from 6/8 AD patients [<xref rid="R5" ref-type="bibr">5</xref>].</p><p>Skin FAs also play a role as effective anti-virulence agents and potentiators of innate immune responses. Glycerol monolaurate (GML) and lauric acid block the expression of <italic toggle="yes">&#x003b1;</italic>-haemolysin, protein A and toxic shock syndrome toxin, whereas sapienic acid exposure inhibits the transcription of protein A and <italic toggle="yes">&#x003b1;</italic>-haemolysin [<xref rid="R22" ref-type="bibr">22</xref><xref rid="R23" ref-type="bibr">23</xref>]. Unsaturated FAs (uFAs) such as palmitoleic and oleic acid can become incorporated into the lipid moiety of staphylococcal lipoproteins and potentiate the activation of various immune cells in a TLR2-dependent manner [<xref rid="R24" ref-type="bibr">24</xref>]. Incubation of human sebocytes with lauric acid, palmitic acid or oleic acid increases the expression of hBD-2, a highly active anti-staphylococcal AMP [<xref rid="R25" ref-type="bibr">25</xref>].</p><p>Despite the presence of FAs on the skin and in sebaceous glands, <italic toggle="yes">S. aureus</italic> characteristically infects the skin in the form of a carbuncle or furuncle [<xref rid="R26" ref-type="bibr">26</xref>]. These infections typically start in a hair follicle [<xref rid="R26" ref-type="bibr">26</xref>]. Sebaceous glands are located almost exclusively within or next to hair follicles and together form a pilosebaceous unit [<xref rid="R27" ref-type="bibr">27</xref>]. Therefore, <italic toggle="yes">S. aureus</italic> skin infections become established within a niche, which has high concentrations of FAs [<xref rid="R4" ref-type="bibr">4</xref>]. This suggests a remarkably high adaptive response to FAs present on the skin. In support of this, a study investigating the virulence gene response of <italic toggle="yes">S. aureus</italic> in a cutaneous infection model using human skin explants found several genes important for FA resistance to be upregulated [<xref rid="R28" ref-type="bibr">28</xref>]. In the early stages of infection (2&#x02009;h), <italic toggle="yes">essA</italic> and <italic toggle="yes">esaA</italic> were upregulated ~2-fold [<xref rid="R28" ref-type="bibr">28</xref>]. These genes produce effectors of the type 7 secretion system (T7SS), an apparatus that has been implicated in FA resistance (discussed below). Twenty-four hours after the establishment of infection, the lipase <italic toggle="yes">geh</italic> as well as the surface protein <italic toggle="yes">isdA</italic> was also upregulated [<xref rid="R28" ref-type="bibr">28</xref>]. Finally, between 24 and 72&#x02009;h, the surface protein <italic toggle="yes">sasF</italic>, as well as secreted components of the T7SS<italic toggle="yes">,</italic> was upregulated between 3- and 6-fold [<xref rid="R28" ref-type="bibr">28</xref>]. Another study has shown that the production of Geh lipases plays an important role in the promotion of skin inflammation and damage [<xref rid="R29" ref-type="bibr">29</xref>]. Furthermore, the authors showed, using a &#x00394;lipase strain, that lipases are integral for the ability of <italic toggle="yes">S. aureus</italic> to penetrate the lipid-rich infundibulum of the hair follicle [<xref rid="R29" ref-type="bibr">29</xref>]. Taken together, these studies suggest that overcoming the antimicrobial activity of FAs is key to the establishment of infection.</p></sec><sec id="s2-2"><title>Bloodstream</title><p>Bacteraemia is among the most severe infections caused by <italic toggle="yes">S. aureus</italic> with a high mortality rate of 20&#x02013;30% [<xref rid="R30" ref-type="bibr">30</xref><xref rid="R31" ref-type="bibr">31</xref>]. Human serum contains several FAs with anti-staphylococcal activity (<xref rid="T1" ref-type="table">Table 1</xref>), with arachidonic acid being the most abundant [<xref rid="R32" ref-type="bibr">32</xref><xref rid="R33" ref-type="bibr">33</xref>]. In addition, FAs are stored in an esterified form within the host membrane of macrophages [<xref rid="R34" ref-type="bibr">34</xref>]. Upon phagocytosis of a pathogen, phospholipase A2 enzymes release free FAs which promote local antimicrobial activity or where they can be oxidized into biologically active lipid mediators, known as eicosanoids [<xref rid="R35" ref-type="bibr">35</xref>]. In general, omega-6 FAs, such as arachidonic acid, are oxidized into pro-inflammatory eicosanoids, such as prostaglandins, leukotrienes and thromboxanes, by cyclooxygenase (COX), lipoxygenase and cytochrome P450 enzymes, or via free radical oxidation [<xref rid="R36" ref-type="bibr">36</xref><xref rid="R37" ref-type="bibr">37</xref>]. Accordingly, serum levels of prostaglandins, such as PGE2 and PGD2, are significantly increased in patients with bacterial sepsis compared with healthy controls, and these patients also exhibit increased PLA2 and COX-2 activity [<xref rid="R37" ref-type="bibr">37</xref>]. In contrast, omega-3 FAs, such as eicosapentaenoic and docosahexaenoic, are mostly metabolized into anti-inflammatory molecules, such as resolvins, protectins and maresins [<xref rid="R38" ref-type="bibr">38</xref>].</p><p>Levels of omega-6 and omega-3 FAs and their metabolites are important factors in the outcome of <italic toggle="yes">S. aureus</italic> bacteraemia infections. For example, a decreased level of arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid and linolenic acid in serum was identified as a significant risk factor for poor outcome in a study of 200 sepsis patients [<xref rid="R39" ref-type="bibr">39</xref>]. Furthermore, Svahn <italic toggle="yes">et al</italic>. demonstrated that mice fed a polyunsaturated high-fat diet (HFD-P) have a decreased bacterial load and increased survival from an <italic toggle="yes">S. aureus</italic> bacteraemia infection compared with mice fed a saturated high-fat diet (HFD-S) [<xref rid="R40" ref-type="bibr">40</xref>]. Interestingly, mice fed HFD-P had a higher frequency of neutrophils in the bone marrow and blood and exhibited higher neutrophil recruitment. A follow-up study demonstrated that specifically dietary omega-3 FAs are responsible for increased survival from <italic toggle="yes">S. aureus</italic> bacteraemia and treatment of mice fed HFD-S with resolvins, a metabolite of omega-3 FAs, decreased bacterial loads in the kidney and improved survival up to 8&#x02009;days after treatment [<xref rid="R41" ref-type="bibr">41</xref>].</p></sec><sec id="s2-3"><title>Intracellular environment</title><p><italic toggle="yes">S. aureus</italic> is capable of invading and surviving inside many cell types, including epithelial and endothelial cells, keratinocytes, fibroblasts and osteoblasts [<xref rid="R42" ref-type="bibr">42</xref><xref rid="R43" ref-type="bibr">43</xref>]. Moreover, <italic toggle="yes">S. aureus</italic> can survive and replicate within professional phagocytes [<xref rid="R44" ref-type="bibr">44</xref><xref rid="R45" ref-type="bibr">45</xref>]. The intracellular environment can provide protection from the host immune system and antibiotics, which are unable to penetrate the host cell membrane. Furthermore, intracellular <italic toggle="yes">S. aureus</italic> acts as a reservoir facilitating persistence and dissemination to new sites of infection [<xref rid="R43" ref-type="bibr">43,45</xref><xref rid="R50" ref-type="bibr">50</xref>]. Using untargeted MS-MS, Yan <italic toggle="yes">et al</italic>. found that linoleic acid metabolism was upregulated in macrophage cells infected with <italic toggle="yes">S. aureus</italic> [<xref rid="R51" ref-type="bibr">51</xref>]. Furthermore, treatment of <italic toggle="yes">S. aureus</italic>-infected macrophages with linoleic or arachidonic acid significantly reduced intracellular bacterial numbers. Using fluorescent probes, the authors confirmed that linoleic acid induced the production of superoxide and reactive oxygen species (ROS) intracellularly, resulting in bacterial elimination. Finally, the authors demonstrated that multiple treatments of linoleic could decrease bacterial loads in the lung, liver and spleen during an <italic toggle="yes">S. aureus</italic> bacteraemia mouse model [<xref rid="R51" ref-type="bibr">51</xref>]. Collectively, the results indicate that FAs are important in the eradication of intracellular bacteria and may have promise as a new therapeutic approach to tackle persistent <italic toggle="yes">S. aureus</italic> infections.</p></sec><sec id="s2-4"><title>Biofilm</title><p>Biofilms are organized populations of bacteria that are embedded in a matrix of extracellular polymeric substances (EPSs) such as polysaccharides, nucleic acids and proteins [<xref rid="R52" ref-type="bibr">52</xref>]. Biofilm production serves as a physical barrier, protecting the population from adverse environmental conditions such as those posed by the immune system and antibiotic administration [<xref rid="R53" ref-type="bibr">53</xref>].</p><p>Several uFAs have been shown to prevent the formation of <italic toggle="yes">S. aureus</italic> biofilm. Oleic acid has been observed to inhibit primary adhesion during the production of biofilm [<xref rid="R54" ref-type="bibr">54</xref>]. At a concentration of 5&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>, roughly 10-fold lower than their MIC, the omega-6 FAs <italic toggle="yes">cis</italic>-4,7,10,13,16,19-docosahexaenoic acid, <italic toggle="yes">cis</italic>-5,8,11,14,17-eicosapentaenoic acid, erucic acid (<italic toggle="yes">cis</italic>-13-docosenoic acid) and gondoic acid (<italic toggle="yes">cis</italic>-11-eicosenoic acid) weakened the virulence of <italic toggle="yes">S. aureus</italic> in a biofilm and <italic toggle="yes">&#x003b1;</italic>-haemolysin-dependent manner [<xref rid="R55" ref-type="bibr">55</xref>]. A recent comparison of 27 FAs and their biofilm activity found that 3 C18 uFAs, oleic, petroselinic and vaccenic acids, inhibited biofilm formation at sub-MIC concentrations (100&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup>) against <italic toggle="yes">S. aureus</italic> [<xref rid="R56" ref-type="bibr">56</xref>]. Additionally, petroselinic acid was shown to inhibit the production of the virulence factors lipase, staphyloxanthin (STX) and <italic toggle="yes">&#x003b1;</italic>-haemolysin. Further transcriptional analysis found that petroselinic acid repressed the expression of <italic toggle="yes">agrA</italic> [<xref rid="R56" ref-type="bibr">56</xref>].</p><p>Evidence of FA-mediated biofilm dispersion has been observed in diverse bacterial species. For example, <italic toggle="yes">cis</italic>-11-methyl-2-dodecenoic acid produced by <italic toggle="yes">Xanthomonas campestris</italic>, a member of the diffusible signal factor (DSF) family of quorum sensing molecules, promotes biofilm self-dispersion through the activation of endoglucanase, which degrades EPS [<xref rid="R57" ref-type="bibr">57</xref><xref rid="R58" ref-type="bibr">58</xref>]. Similarly, decanoic acid, another DSF member, produced by <italic toggle="yes">Pseudomonas aeruginosa</italic> can induce the dispersal of pre-formed biofilm of several bacterial species including <italic toggle="yes">S. aureus</italic> [<xref rid="R59" ref-type="bibr">59</xref>], suggesting that uFAs may act as potent intra- and inter-species biofilm modulatory signalling molecules.</p></sec></sec><sec id="s3"><title>Mechanism of action of anti-staphylococcal FAs</title><sec id="s3-1"><title>Membrane fluidity</title><p>In general, membrane fluidity refers to the viscosity of lipids in membrane bilayers and describes the ease of movement of molecules within this membrane environment. The structure of FAs correlates with their antimicrobial activity against <italic toggle="yes">S. aureus</italic>, with numerous investigators reporting that uFAs with <italic toggle="yes">cis</italic>-double bonds are active, whereas saturated and uFAs with <italic toggle="yes">trans</italic>-double bonds have reduced antimicrobial activity [<xref rid="R60" ref-type="bibr">60</xref><xref rid="R61" ref-type="bibr">61</xref>]. uFAs with <italic toggle="yes">cis</italic>-double bonds contain a &#x02018;kink&#x02019; in the hydrocarbon tail, which separates adjacent phospholipids and increases fluidity [<xref rid="R62" ref-type="bibr">62</xref>]. In contrast, saturated FAs (sFAs) (no double bonds) and uFAs with <italic toggle="yes">trans</italic>-double bonds have a straight hydrocarbon chain, which can pack together tightly in the membrane, decreasing fluidity [<xref rid="R63" ref-type="bibr">63</xref>]. For example, <italic toggle="yes">S. aureus</italic> strains with higher levels of saturated membrane lipids have increased membrane rigidity compared with strains with elevated levels of polyunsaturated lipids [<xref rid="R64" ref-type="bibr">64</xref>]. Moreover, there is a direct correlation between the degree of unsaturation (i.e. number of <italic toggle="yes">cis</italic>-double bonds) and the potency of uFAs [<xref rid="R61" ref-type="bibr">61</xref><xref rid="R65" ref-type="bibr">65</xref>].</p><p>An increase in fluidity can interfere with ATP synthesis as increased movement of electron carriers and proton pumps can impact the ability to generate proton motive force (PMF) [<xref rid="R21" ref-type="bibr">21</xref>]. Additionally, leakage of small molecules and ions from the intracellular space can occur, leading to growth inhibition [<xref rid="R65" ref-type="bibr">65</xref>]. Cartron <italic toggle="yes">et al</italic>. utilized the fluorescent hydrocarbon 1,6-diphenyl-1,3,5-hexatriene to demonstrate that sapienic acid decreased the polarization index in <italic toggle="yes">S. aureus</italic> cells at sub-lytic and lytic concentrations, indicating a decrease in lipid packing and an increase in membrane fluidity [<xref rid="R21" ref-type="bibr">21</xref>].</p><p>Additional evidence for uFAs increasing fluidity of bacterial membranes can be inferred from the survival response of <italic toggle="yes">S. aureus</italic> to linoleic acid exposure where genes involved in the synthesis of STX, a carotenoid pigment that reduces membrane fluidity, were significantly upregulated [<xref rid="R66" ref-type="bibr">66</xref>]. Interestingly, numerous studies have also shown a direct correlation between the degree of pigmentation and sensitivity of <italic toggle="yes">S. aureus</italic> to uFAs [<xref rid="R67" ref-type="bibr">67</xref><xref rid="R68" ref-type="bibr">68</xref>]. However, the growth in either linoleic or oleic acid has the opposite effect of decreasing membrane fluidity [<xref rid="R69" ref-type="bibr">69</xref><xref rid="R70" ref-type="bibr">70</xref>]. Therefore, initial exposure to uFAs increases fluidity, but long-term exposure to lower concentrations may involve an adaptive response that decreases membrane fluidity.</p></sec><sec id="s3-2"><title>Membrane destabilization</title><p>If the accumulation of uFAs becomes excessive, the barrier function of the membrane can become compromised. The accumulation of uFAs in the bilayer can cause the formation of transient pores from curvature stress or stable toroidal pores from the bending of the membrane [<xref rid="R71" ref-type="bibr">71</xref><xref rid="R72" ref-type="bibr">72</xref>]. At high concentrations, uFAs can solubilize large fractions of the membrane in a detergent-like fashion where lipids are micellized away from the lipid bilayer [<xref rid="R71" ref-type="bibr">71</xref><xref rid="R72" ref-type="bibr">72</xref>]. Parsons <italic toggle="yes">et al</italic>. used TO-PRO-3 iodide, a membrane-impermeable dye which emits fluorescence upon binding to DNA, to demonstrate that palmitoleic acid treatment disrupted the barrier function of the <italic toggle="yes">S. aureus</italic> membrane. Moreover, the authors identified the release of ATP and low-molecular-weight proteins (&#x0003c;20&#x02009;kDa) into the supernatant [<xref rid="R65" ref-type="bibr">65</xref>]. Rapid release of DNA and ATP was also observed with <italic toggle="yes">S. aureus</italic> cells treated with sapienic acid, and transmission electron microscopy revealed severe morphological defects, including multiple and aberrant positioning of the septa, an effect consistent with the disintegration of the membrane [<xref rid="R21" ref-type="bibr">21</xref>].</p></sec><sec id="s3-3"><title>Disruption of the electron transport chain</title><p>The electron transport chain (ETC) is a series of protein complexes which transfer electrons to generate an electrochemical gradient of protons (PMF) which is utilized by the membrane protein complex, ATP synthase, to generate ATP from ADP and inorganic phosphate (P<sub>i</sub>) [<xref rid="R73" ref-type="bibr">73</xref><xref rid="R74" ref-type="bibr">74</xref>]. The functioning of the ETC is reliant on a stable cell membrane. Therefore, the ability of uFAs to interfere with the ETC relates to their ability to increase membrane fluidity and disrupt the integrity of the lipid bilayer. The disruption of the ETC starves bacteria of ATP, resulting in growth inhibition and eventual cell death [<xref rid="R1" ref-type="bibr">1</xref><xref rid="R62" ref-type="bibr">62</xref>]. Using tetrazolium-based dyes, which are actively reduced by components of the ETC, DeMars <italic toggle="yes">et al</italic>. confirmed that oleic acid treatment resulted in impaired ETC activity in <italic toggle="yes">S. aureus</italic> [<xref rid="R70" ref-type="bibr">70</xref>].</p></sec><sec id="s3-4"><title>Uncoupling of oxidative phosphorylation</title><p>Oxidative phosphorylation refers specifically to the final step of respiration, in which the ATP synthase uses the energy from transporting protons back inside the cell to synthesize ATP [<xref rid="R73" ref-type="bibr">73</xref><xref rid="R74" ref-type="bibr">74</xref>]. &#x02018;Uncoupling&#x02019; of oxidative phosphorylation can occur when an external factor facilitates the transport of protons back inside the cell independently of the ATP synthase. This external factor, known as a protonophore, dissipates both membrane potential (&#x00394;&#x003a8;) and the proton gradient (&#x00394;pH). FAs are proposed to act as protonophores as they can exist in deprotonated forms, where the carboxyl group is ionized (COO&#x02212;), and in a protonated form (COOH). In the extracellular space, the ionized FA can be protonated and freely diffuse across the lipid bilayer where it is deprotonated, releasing the H+ ion into the intracellular space. The FA can then flip back across the membrane to transport another proton. This activity provides an alternative route for protons to re-enter the cell, uncoupling the activity of the ETC from ATP synthesis [<xref rid="R75" ref-type="bibr">75</xref><xref rid="R76" ref-type="bibr">76</xref>]. The lipophilic cation tetraphenylphosphonium ion (TPP+) can be used as a marker of &#x00394;&#x003a8;. TPP+ accumulates inside the cell under normal conditions as the intracellular space is negatively charged. If a cell becomes depolarized and intracellular space becomes less negatively charged, TPP+ will move into the extracellular space until it reaches an equilibrium [<xref rid="R77" ref-type="bibr">77</xref><xref rid="R78" ref-type="bibr">78</xref>]. Studies using TPP+ have shown that sub-lethal concentrations of sapienic acid lead to the depolarization of <italic toggle="yes">S. aureus</italic> and a reduction in intracellular pH, suggesting that sapienic acid carries protons inside the cell, despite the presence of an intact membrane, and that &#x00394;&#x003a8; and &#x00394;pH are disrupted by this activity [<xref rid="R21" ref-type="bibr">21</xref>].</p></sec><sec id="s3-5"><title>Interference with FA biosynthesis</title><p>Bacterial FA biosynthesis is an essential process required to produce phospholipids and is executed by a set of individual enzymes known collectively as the FASII pathway [<xref rid="R79" ref-type="bibr">79</xref>]. The final step of FASII that catalyses the rate-limiting chain elongation process is mediated by the enoyl-ACP reductase, FabI. Given the essential nature of this enzyme and the lack of sequence homologue in humans, FabI represents a promising target for anti-staphylococcal therapeutics, with candidates in late-stage clinical trials [<xref rid="R80" ref-type="bibr">80</xref><xref rid="R82" ref-type="bibr">82</xref>]. Intrigued by the antimicrobial properties of unsaturated LCFAs, Zheng <italic toggle="yes">et al</italic>. showed that linoleic acid, palmitoleic acid, oleic acid, linolenic acid and arachidonic acid inhibited FabI, whereas saturated oleic acid (stearic acid) or the methyl ester of linoleic acid lacked FabI inhibition or anti-staphylococcal activity [<xref rid="R83" ref-type="bibr">83</xref>]. The authors found that linoleic acid directly bound to FabI, preventing interaction with NADH or NADPH, and also bound to the FabI-NADPH complex, restricting the binding of the substrate. Furthermore, the incorporation of [1-<sup>14</sup>C] acetate into the membrane of <italic toggle="yes">S. aureus</italic> was blocked by linoleic acid, confirming that uFAs can inhibit <italic toggle="yes">de novo</italic> FA biosynthesis in live bacterial cells [<xref rid="R83" ref-type="bibr">83</xref>].</p><p>Importantly, <italic toggle="yes">S. aureus</italic> has evolved several strategies to resist FabI-targeting antibiotics such as triclosan and AFN-1252. Mutations in FabI which increase resistance to triclosan and AFN-1252 have been identified [<xref rid="R84" ref-type="bibr">84</xref><xref rid="R85" ref-type="bibr">85</xref>], and a significant portion of triclosan-resistant clinical isolates contains mutations in the FabI promoter which result in elevated expression [<xref rid="R86" ref-type="bibr">86</xref>]. Furthermore, mutations in <italic toggle="yes">accC</italic> and <italic toggle="yes">accD</italic>, genes involved in FASII initiation, increase resistance to FASII inhibitors via FA auxotrophy, although these mutants require FA supplementation for growth and have decreased virulence in infection models [<xref rid="R87" ref-type="bibr">87</xref><xref rid="R89" ref-type="bibr">89</xref>]. Interestingly, the growth of <italic toggle="yes">S. aureus</italic> in the presence of triclosan and FAs abundant in the human host leads to high-frequency mutations in <italic toggle="yes">fabD</italic> which increase triclosan resistance. Less efficient FabD activity, which uses ACP and malonyl-CoA to synthesize malonyl-ACP, leaves more ACP available for PlsX which can then incorporate exogenous FAs (exoFAs) into phospholipids when FASII is inhibited (FASII bypass) [<xref rid="R90" ref-type="bibr">90</xref>]. Similarly, the growth of <italic toggle="yes">S. aureus</italic> with FAs and human serum also increases resistance to FASII inhibitors via FASII bypass, but this occurs independently of mutations. Instead, it was identified that serum protects <italic toggle="yes">S. aureus</italic> from FA-mediated stress, leading to greater retention of ACP for phospholipid biosynthesis from exoFAs [<xref rid="R91" ref-type="bibr">91</xref>]. This suggests that the use of FabI inhibitors may be limited against <italic toggle="yes">S. aureus</italic> in certain host environments.</p></sec><sec id="s3-6"><title>Lipid peroxidation and auto-oxidation</title><p>Lipid peroxidation is the oxidative degradation of FAs where ROS and free radicals can attack uFAs by abstracting a hydrogen atom, adjacent to the double bond, forming a lipid radical. Lipid radicals can react with molecular oxygen to form a lipid peroxyl radical that can also abstract hydrogens from other uFAs, resulting in a chain reaction which continues until it is terminated by antioxidants [<xref rid="R92" ref-type="bibr">92</xref>]. Auto-oxidation occurs when PUFAs are exposed to molecular oxygen, which results in the formation of a lipid peroxyl radical without the need for initiation by free radicals [<xref rid="R93" ref-type="bibr">93</xref>]. Arachidonic acid is particularly susceptible to these processes as it contains four double bonds and thus more sites for initiation of peroxidation [<xref rid="R94" ref-type="bibr">94</xref>]. At each stage of lipid peroxidation and auto-oxidation, numerous antimicrobial components are produced including lipid hydroperoxides, reactive aldehydes (such as malondialdehyde and 4-hydroxynonenal), isoprostanes and <italic toggle="yes">&#x003b1;</italic>,<italic toggle="yes">&#x003b2;</italic>-unsaturated carbonyls. These molecules are highly reactive and, therefore, can have detrimental effects on macromolecules, such as proteins and DNA. Furthermore, they can contribute to the instability of the cell membrane [<xref rid="R92" ref-type="bibr">92</xref>]. Lipid peroxidation was initially proposed by Knapp and Melly, as a key antibacterial mechanism of FAs as the addition of catalase, which decomposes hydrogen peroxide and prevents lipid peroxidation initiation, reduced arachidonic acid toxicity towards <italic toggle="yes">S. aureus</italic> [<xref rid="R61" ref-type="bibr">61</xref>]. More recently, Beavers <italic toggle="yes">et al</italic>. found that paraquat, which generates ROS to initiate lipid peroxidation, increased arachidonic acid killing of <italic toggle="yes">S. aureus,</italic> whereas manganese, an antioxidant, reduced killing. Further, these authors demonstrated that the lipid peroxidation reaction occurs intracellularly as a membrane-permeable scavenger of the peroxidation product, isolevuglandin, could alleviate arachidonic acid toxicity, whereas an impermeable scavenger had no impact [<xref rid="R95" ref-type="bibr">95</xref>]. Overall, these studies indicate that lipid peroxidation of arachidonic acid contributes to anti-staphylococcal activity.</p></sec><sec id="s3-7"><title>Cell wall biosynthesis</title><p>The exposure of <italic toggle="yes">S. aureus</italic> to uFAs has a significant effect on the transcription of genes involved in cell wall biosynthesis. For example, Kenny <italic toggle="yes">et al</italic>. observed that linoleic acid upregulates the <italic toggle="yes">mraY</italic>, <italic toggle="yes">murD</italic>, <italic toggle="yes">murG</italic> and <italic toggle="yes">murA1</italic> enzymes, involved in the synthesis of peptidoglycan (PGN) precursors, Lipid I and Lipid II. Enzymes which increase the pool of <sc>aa</sc> required for PGN biosynthesis, such as <sc>l</sc>-lysine and <sc>d</sc>-alanine, and several genes involved in wall teichoic acid (WTA) biosynthesis (<italic toggle="yes">tarA</italic>, <italic toggle="yes">tarG</italic> and <italic toggle="yes">tarB</italic>) were also upregulated [<xref rid="R66" ref-type="bibr">66</xref>]. Neumann <italic toggle="yes">et al</italic>. observed that sapienic acid treatment upregulates the transcription of <italic toggle="yes">pbp2</italic> and downregulates <italic toggle="yes">pbp4</italic>, enzymes involved in incorporating new PGN precursors into the cell wall and crosslinking the PGN layer, respectively. The transcription of the <italic toggle="yes">dltABCD</italic> operon, which coordinates the addition of a <sc>d</sc>-alanine residue to WTA and <italic toggle="yes">mprF</italic>, the synthase and flippase of the phospholipid lysyl-phosphatidylglycerol, was also downregulated, suggesting that sapienic acid exposure may decrease cell surface charge [<xref rid="R96" ref-type="bibr">96</xref>]. This transcriptional response may be evidence that the integrity of the cell wall is perturbed by FAs. Equally, it could be part of a generalized stress response where altering cell wall properties might prevent FAs from reaching the cell membrane. Recently, our work has demonstrated that the exposure of <italic toggle="yes">S. aureus</italic> to arachidonic acid upregulates the expression of <italic toggle="yes">tcaA</italic>, a key indicator of cell wall stress response via VraRS activation [<xref rid="R97" ref-type="bibr">97</xref>]. Interestingly, other studies have observed that linoleic acid upregulates the expression of the major autolysin, <italic toggle="yes">atl</italic>, and downregulates the expression of <italic toggle="yes">cstR</italic>, which inhibits autolysis [<xref rid="R98" ref-type="bibr">98</xref><xref rid="R99" ref-type="bibr">99</xref>]. Correspondingly, <italic toggle="yes">S. aureus</italic> cells grown in the presence of linoleic acid exhibit higher rates of autolysis in a Triton X-100 autolysis assay [<xref rid="R66" ref-type="bibr">66</xref>]. Further investigation is needed to determine the effect of uFA membrane insertion on cell wall biosynthesis and the localization of proteins involved in PGN biosynthesis.</p></sec><sec id="s3-8"><title>DNA replication</title><p>Quinolone antibiotics inhibit bacterial DNA replication by targeting both DNA gyrase, an enzyme that introduces supercoils in DNA ahead of the replication fork to mediate the separation of daughter chromosomes, and topoisomerase IV, an enzyme which removes interlinking between the daughter chromosomes. 2-Hexadecenoic acid (2-HDA) is a synthetic alkynoic FAs which has potent anti-staphylococcal activity and was found to inhibit the supercoiling function of DNA gyrase in a similar fashion to the fluoroquinolone antibiotic, ciprofloxacin [<xref rid="R100" ref-type="bibr">100</xref>]. Sanabria-Rios <italic toggle="yes">et al</italic>. hypothesized that this compound binds to the ATPase region of GyrB to inhibit its activity; however, further studies are required for confirmation [<xref rid="R100" ref-type="bibr">100</xref>]. It is not known whether natural uFAs can negatively impact DNA replication, but genes involved in DNA replication and repair are upregulated when <italic toggle="yes">S. aureus</italic> is exposed to sapienic acid, which may indicate the occurrence of DNA damage [<xref rid="R66" ref-type="bibr">66</xref><xref rid="R96" ref-type="bibr">96</xref>].</p><p>A schematic of the multiple mechanisms of action of anti-staphylococcal FAs is highlighted in <xref rid="F1" ref-type="fig">Fig. 1</xref>.</p><fig position="float" id="F1" fig-type="figure"><label>Fig. 1.</label><caption><title>Mechanism of action of anti-staphylococcal FAs.</title></caption><graphic xlink:href="mic-171-01563-g001" position="float"/></fig></sec></sec><sec id="s4"><title>FA resistance mechanisms employed by <italic toggle="yes">S. aureus</italic></title><sec id="s4-1"><title>Hydrophilic surface factors</title><p>FAs are highly hydrophobic molecules by virtue of their long hydrocarbon tail. Unsurprisingly, a major defence strategy to thwart FAs is the expression of hydrophilic surface factors, including capsule, WTA and the cell wall anchored iron-regulated surface determinant protein A (IsdA), which reduces the penetration of FAs across the cell envelope.</p><sec id="s4-1-1"><title>Capsule</title><p>The hydrophilic staphylococcal polysaccharide capsule is the outermost component of the cell envelope and is a diverse macromolecular structure with 11 serotypes described in <italic toggle="yes">S. aureus</italic> to date, but with most isolates expressing capsular polysaccharides type 5 (CP5) or type 8 (CP8) [<xref rid="R101" ref-type="bibr">101</xref>]. Initial studies focusing on FA resistance mechanisms in <italic toggle="yes">S. aureus</italic> concentrated on capsular expression; Mortensen and Kapral compared the survival of capsulated and non-capsulated <italic toggle="yes">S. aureus</italic> strains in response to FA challenge where a marked decrease in susceptibility was noted for most capsulated strains [<xref rid="R102" ref-type="bibr">102</xref>]. However, certain strains were shown to be highly resistant to FAs despite being non-capsulated, which suggested the presence of alternative resistance mechanisms. Whilst genes responsible for capsule biosynthesis are frequently elevated in response to FA challenge [<xref rid="R66" ref-type="bibr">66</xref><xref rid="R96" ref-type="bibr">96</xref>], certain globally successful clones of <italic toggle="yes">S. aureus</italic>, most notably clonal complex (CC) 1 and CC8, are acapsular, due to the presence of mutations (<italic toggle="yes">capE</italic>) or truncations (<italic toggle="yes">capD</italic>) in capsular biosynthetic genes or mutations in the <italic toggle="yes">cap</italic> promoter region [<xref rid="R103" ref-type="bibr">103</xref>].</p></sec><sec id="s4-1-2"><title>Wall teichoic acid</title><p>WTA are glycopolymer structures that decorate the cell wall and are comprised of up to 40 ribitol-phosphate subunits that are modified with <sc>d</sc>-alanine and <italic toggle="yes">N</italic>-acetylglucosamine residues [<xref rid="R104" ref-type="bibr">104</xref>]. WTAs play central physiological roles most notably in cell division, protection against host antimicrobial components and as an aid in host colonization [<xref rid="R105" ref-type="bibr">105</xref>]. The deletion of <italic toggle="yes">tarO</italic> (<italic toggle="yes">tagO</italic>) which encodes an <italic toggle="yes">N</italic>-acetylglucosamine-phosphate transferase that catalyses the first step of WTA synthesis abolishes WTA production [<xref rid="R106" ref-type="bibr">106</xref>]. WTA-deficient mutants display decreased hydrophilicity and enhanced susceptibility to sFAs and uFAs. Loss of WTA resulted in enhanced FA penetration through the cell envelope where they bind more efficiently to the cell membrane [<xref rid="R107" ref-type="bibr">107</xref>].</p><p>Beavers <italic toggle="yes">et al</italic>. conducted an <italic toggle="yes">in vitro</italic> serial passage experiment to select for arachidonic acid-resistant <italic toggle="yes">S. aureus</italic>, identifying a strain harbouring a K253* mutation in the <italic toggle="yes">lcpA</italic> gene which resulted in a quarter of the catalytic domain being deleted [<xref rid="R95" ref-type="bibr">95</xref>]. LcpA is a member of the LytR-CpsA-Psr (LCP) family of proteins, which ligate newly synthesized WTA polymers to PGN [<xref rid="R108" ref-type="bibr">108</xref><xref rid="R109" ref-type="bibr">109</xref>]. Accordingly, mutants lacking the LCP family of enzymes have reduced WTA in the cell wall, which is instead released into the extracellular milieu [<xref rid="R110" ref-type="bibr">110</xref>]. It has been shown that the deletion of the entire <italic toggle="yes">lcpA</italic> gene increased resistance to arachidonic acid and demonstrated that treatment of the <italic toggle="yes">lcpA</italic> mutant with subinhibitory tunicamycin, which inhibits TarO, could eliminate the resistant phenotype, highlighting that WTA was required for arachidonic acid resistance. Finally, the authors hypothesized that resistance was dependent on the levels of intracellular ROS, as arachidonic acid kills <italic toggle="yes">S. aureus</italic> through a lipid peroxidation mechanism. Accordingly, they found that the <italic toggle="yes">lcpA</italic> mutant produced less ROS, whilst a <italic toggle="yes">tarO</italic> mutant produced more ROS, correlating with the arachidonic acid sensitivity of these strains [<xref rid="R95" ref-type="bibr">95</xref>].</p><p>Subsequently, our study identified that mutation of <italic toggle="yes">tcaA</italic>, a gene associated with glycopeptide resistance in <italic toggle="yes">S. aureus</italic>, also increased resistance to arachidonic acid [<xref rid="R97" ref-type="bibr">97</xref>]. Moreover, we found that a <italic toggle="yes">tcaA</italic> mutant displayed a similar phenotype to a <italic toggle="yes">lcpA</italic> mutant, where WTA is reduced in the cell wall and released into the supernatant. In this study, we hypothesized that extracellular WTA could sequester or inactivate arachidonic acid in the environment to prevent it from reaching the bacterial cell surface. Accordingly, we demonstrated that the bacterial supernatant of either a <italic toggle="yes">tcaA</italic> or <italic toggle="yes">lcpA</italic> mutant could protect a WT strain from arachidonic acid toxicity. In contrast, the supernatant from a <italic toggle="yes">tarO</italic> mutant had no protective effect. Moreover, the addition of purified WTA extract from a WT strain could also protect from arachidonic acid killing. Together, this data suggests that extracellular WTA in the environment can prevent arachidonic acid from killing <italic toggle="yes">S. aureus</italic>.</p></sec><sec id="s4-1-3"><title>Iron-regulated surface determinant protein A</title><p>Under iron-limiting conditions, IsdA is the most abundant protein expressed on the staphylococcal surface [<xref rid="R111" ref-type="bibr">111</xref>]. IsdA is a cell wall-anchored protein that plays key roles in nasal colonization [<xref rid="R112" ref-type="bibr">112</xref><xref rid="R113" ref-type="bibr">113</xref>] and iron acquisition from haem [<xref rid="R114" ref-type="bibr">114</xref>]. Clarke <italic toggle="yes">et al</italic>. further investigated the effect of IsdA expression on cell surface physiochemical properties and noted that the growth of several lab strains of <italic toggle="yes">S. aureus</italic> under iron-limited conditions displayed enhanced surface hydrophilicity compared with growth in the presence of iron. The authors confirmed the role of IsdA and specifically the C domain of this protein, to function in mediating the switch in hydrophilic profile and resistance to sFAs and uFAs when grown under iron depletion [<xref rid="R22" ref-type="bibr">22</xref>]. Furthermore, by employing a live human skin model, the authors showed that IsdA was required for survival on human skin, suggesting the importance of this protein in mediating resistance to a suite of FAs.</p></sec><sec id="s4-1-4"><title>SasF</title><p>SasF is an <italic toggle="yes">S. aureus</italic> surface protein that is believed to be involved in adhesion and, by virtue of this, colonization. In agreement with this, <italic toggle="yes">sasF</italic> has been shown to be upregulated along with additional members of this family, <italic toggle="yes">sasC</italic> and <italic toggle="yes">sasD</italic>, when <italic toggle="yes">S. aureus</italic> encounters human skin [<xref rid="R28" ref-type="bibr">28</xref>]. Prior to this work, Kwiecinski <italic toggle="yes">et al</italic>. established a role for SasF in virulence in a mouse skin model of abscess formation [<xref rid="R115" ref-type="bibr">115</xref>]. Furthermore, in the presence of linoleic acid, <italic toggle="yes">sasF</italic> expression was upregulated 32-fold, and a <italic toggle="yes">sasF</italic> mutant was observed to exhibit substantially lower survival rates in linoleic acid-killing assays [<xref rid="R66" ref-type="bibr">66</xref>]. A similar result has been shown in <italic toggle="yes">Staphylococcus saprophyticus,</italic> where a <italic toggle="yes">sasF</italic> mutant was shown to be more susceptible to linoleic acid [<xref rid="R116" ref-type="bibr">116</xref>]. It was reasoned that SasF may contribute towards FA resistance through altering cell surface hydrophobicity [<xref rid="R66" ref-type="bibr">66</xref>], reminiscent of IsdA discussed above. However, a <italic toggle="yes">sasF</italic> mutant generated in the SH1000 background did not display altered hydrophobicity in a hexadecane partitioning assay [<xref rid="R66" ref-type="bibr">66</xref>], and thus, SasF may help resist FA toxicity in a manner independent of modifications to surface hydrophobicity.</p></sec></sec><sec id="s4-2"><title>Membrane vesicles</title><p>Previous studies observed that <italic toggle="yes">S. aureus</italic> grown in the presence of sub-lethal concentrations of FAs survived secondary exposure to a lethal concentration [<xref rid="R96" ref-type="bibr">96</xref><xref rid="R117" ref-type="bibr">117</xref>]. The authors recognized that this adaptation may be the result of an inducible FA stress response system. A subsequent study by Kengmo Tchoupa and Peschel used a linoleic acid analogue to reveal that <italic toggle="yes">S. aureus</italic> prevented FA binding via secretion of a novel factor present in bacterial culture supernatants. The authors discovered that <italic toggle="yes">S. aureus</italic> responded to FA challenge by enhancing the release of membrane vesicles (MVs). MVs were shown to be a general feature released by genetically diverse <italic toggle="yes">S. aureus</italic> strains and showed activity against a broad range of FAs. Although the secretion of MVs increases survival following FA exposure, MVs were shown to contain high levels of lipoproteins, which induce a stronger TLR2-mediated immune response which functions to combat infection [<xref rid="R118" ref-type="bibr">118</xref>].</p></sec><sec id="s4-3"><title>Detoxification systems</title><p><italic toggle="yes">S. aureus</italic> secretes two enzymes that detoxify FAs into molecules lacking activity: the previously described FA-modifying enzyme (FAME) or Lip2 and more recently discovered oleate hydratase (OhyA).</p><sec id="s4-3-1"><title>Lip2</title><p>Abscess homogenates were shown to possess bactericidal factors that were active against <italic toggle="yes">S. aureus</italic> [<xref rid="R119" ref-type="bibr">119</xref>]; however, another unidentified enzyme eliminated this antimicrobial activity, which was subsequently named as FAME [<xref rid="R120" ref-type="bibr">120</xref>]. FAME was shown to use a variety of alcohols as a substrate but favoured cholesterol to drive the esterification reaction to form esterified FAs with significantly decreased bactericidal activity [<xref rid="R120" ref-type="bibr">120</xref>]. The gene responsible for FAME activity has recently been characterized. Proteomic analysis of <italic toggle="yes">S. aureus</italic> culture supernatant following exposure to subinhibitory concentrations of FAs identified lipases as major determinants of MVs that were previously shown to deactivate FAs. Subsequent genetic mutational analysis confirmed that <italic toggle="yes">lip2</italic> (also referred to as <italic toggle="yes">geh</italic> or <italic toggle="yes">sal2</italic>) was required for protection against FA, with detoxification of FAs requiring the presence of cholesterol [<xref rid="R121" ref-type="bibr">121</xref>]. Moreover, an engineered, catalytically inactive <italic toggle="yes">lip2</italic> which showed no lipase activity was also unable to mediate cholesterol-dependent FA resistance. Genomic analysis indicated that <italic toggle="yes">lip2</italic> appeared to be highly conserved across major <italic toggle="yes">S. aureus</italic> lineages; however, the <italic toggle="yes">lip2</italic> sequence displays a conserved integration site for prophages. Interestingly, prophage-mediated disruption of <italic toggle="yes">lip2</italic> was rare in <italic toggle="yes">S. aureus</italic> isolated from the nose, skin and blood, suggesting a role for <italic toggle="yes">lip2</italic>-mediated FA detoxification during colonization and/or infection. Moreover, results from an <italic toggle="yes">in vivo</italic> mouse skin colonization model indicate that <italic toggle="yes">S. aureus</italic> was protected from sapienic acid challenge in a lipase- and cholesterol-dependent manner [<xref rid="R121" ref-type="bibr">121</xref>].</p></sec><sec id="s4-3-2"><title>Oleate hydratases</title><p>OhyAs are a large family of enzymes that catalyse the hydration or isomerization of double bonds in uFAs, first isolated from soluble enzyme preparations of <italic toggle="yes">Pseudomonas</italic> spp. [<xref rid="R122" ref-type="bibr">122</xref>]. Subramanian <italic toggle="yes">et al</italic>. predicted that the <italic toggle="yes">S. aureus</italic> SA0102 gene encoded an OhyA and subsequently showed using a recombinant version of the protein that it possessed hydratase activity, hydrating only uFAs containing <italic toggle="yes">cis-</italic>9-double bonds, but not FAs containing <italic toggle="yes">trans</italic>-9-double bonds or <italic toggle="yes">cis</italic>-double bonds at positions other than carbon-9 [<xref rid="R123" ref-type="bibr">123</xref>]. In this study, palmitoleic acid (C16:1&#x00394;9) was shown to be a substrate for OhyA, and the resulting hydrated product had no antimicrobial activity. Palmitoleic acid completely inhibited the growth of <italic toggle="yes">S. aureus;</italic> however, the growth was subsequently recovered following a 2-h lag period, presumably the duration required for sufficient levels of OhyA to accumulate or the duration needed for OhyA-mediated detoxification of palmitoleic acid. Importantly, the growth of an &#x00394;<italic toggle="yes">ohyA</italic> mutant could not be recovered following the palmitoleic acid challenge. Interestingly, OhyA does portray a degree of substrate specificity as this enzyme could not protect <italic toggle="yes">S. aureus</italic> from sapienic acid (C16:1&#x00394;6) challenge [<xref rid="R123" ref-type="bibr">123</xref>]. Importantly, MVs released upon linoleic acid exposure contained high levels of OhyA as well as Lip2 [<xref rid="R118" ref-type="bibr">118</xref>], indicating that <italic toggle="yes">S. aureus</italic> coordinates resources to detoxify major antimicrobial FAs.</p></sec></sec><sec id="s4-4"><title>Membrane stabilizers</title><p>FAs impart membrane perturbation which strongly influences the fluidity and permeability of the bacterial membrane, resulting in growth inhibition [<xref rid="R1" ref-type="bibr">1</xref><xref rid="R72" ref-type="bibr">72</xref><xref rid="R95" ref-type="bibr"> 95</xref>]. To counteract FA-induced membrane damage, <italic toggle="yes">S. aureus</italic> has evolved several membrane-stabilizing strategies outlined below.</p><sec id="s4-4-1"><title>Type 7 secretion system</title><p>The T7SS, also referred to as the ESAT-6 secretion system, is a membrane-embedded secretory system for several important virulence factors [<xref rid="R124" ref-type="bibr">124</xref>]. The <italic toggle="yes">S. aureus</italic> T7SS consists of four integral membrane proteins (EsaA, EssA, EssB and EssC) and two cytosolic proteins (EsaB and EsaG) which together orchestrate the secretion of five virulence effectors: EsxA, EsxB, EsxC, EsxD and EsaD [<xref rid="R124" ref-type="bibr">124</xref>].</p><p><italic toggle="yes">S. aureus</italic> strains lacking a functional T7SS have been shown to be less virulent in numerous mouse models of infection [<xref rid="R69" ref-type="bibr">69</xref><xref rid="R125" ref-type="bibr">125</xref><xref rid="R126" ref-type="bibr"> 126</xref>]. Intriguingly, FAs have been observed to induce T7SS, a mechanism that is reliant on the incorporation of FAs into the bacterial membrane mediated by the FA scavenging system FakAB [<xref rid="R66" ref-type="bibr">66</xref><xref rid="R69" ref-type="bibr">69</xref><xref rid="R126" ref-type="bibr"> 126</xref>]. Furthermore, recent studies have shown that <italic toggle="yes">S. aureus esxC</italic>, <italic toggle="yes">esxA</italic>, <italic toggle="yes">esxB</italic> and <italic toggle="yes">essC</italic> mutants were more sensitive to linoleic acid and arachidonic acid [<xref rid="R127" ref-type="bibr">127</xref>]. Mechanistic dissection of T7SS-mediated FA protection focused on investigations of <italic toggle="yes">S. aureus</italic> lacking EsxC (a representative effector of T7SS) and EssC (the main transporter of T7SS). No significant difference in FA binding was observed between WT and mutant strains, indicating that T7SS components did not participate in the binding or sequestering of FAs [<xref rid="R127" ref-type="bibr">127</xref>]. Using the membrane-impermeable fluorescent dye propidium iodide, the authors indicated that mutant strains displayed increased staining compared with the WT, suggesting that an intact T7SS helps to maintain membrane integrity following challenge with FAs. Whole-cell proteomics revealed that T7SS mutants were less able to respond to FA challenge by upregulating proteins associated with hydrolase or oxidoreductase activities. Staining of WT or T7SS mutants with dichlorofluorescin, which reports on the presence of ROS, following treatment with FAs indicated significantly enhanced ROS generation in mutants compared with WT, indicating that T7SS plays a role in mitigating against FA-induced damage [<xref rid="R127" ref-type="bibr">127</xref>].</p></sec><sec id="s4-4-2"><title>Staphyloxanthin</title><p>STX is a carotenoid pigment that possesses a long carbon chain skeleton with two terminal rings, located in the cell membrane of <italic toggle="yes">S. aureus</italic> [<xref rid="R128" ref-type="bibr">128</xref>]. STX also contains numerous conjugated double bonds that confer antioxidant activity; STX mutants display hypersensitivity to ROS typically found in the phagosome of neutrophils [<xref rid="R129" ref-type="bibr">129</xref>]. STX also plays a role in reducing membrane fluidity and functions to stabilize the cell membrane structure, which explains the additional hypersensitivity of STX mutants to antimicrobial FAs [<xref rid="R66" ref-type="bibr">66</xref>]. In addition, the incorporation of FAs can alter membrane fluidity, resulting in enhanced expression of STX via activation of the <italic toggle="yes">&#x003c3;</italic><sup>B</sup> stress response [<xref rid="R66" ref-type="bibr">66</xref><xref rid="R130" ref-type="bibr">130</xref>]. Currently, multiple STX inhibitors are being developed [<xref rid="R131" ref-type="bibr">131</xref><xref rid="R132" ref-type="bibr">132</xref>] which may synergize with antimicrobial FAs as a novel combinatorial anti-staphylococcal treatment.</p></sec><sec id="s4-4-3"><title>Membrane-stabilizing protein A</title><p>Membrane-stabilizing protein A (MspA) was discovered through a genome-wide association study that focused on identifying alterations in genetic loci associated with toxin production in <italic toggle="yes">S. aureus</italic> [<xref rid="R133" ref-type="bibr">133</xref>]. MspA is a small membrane-bound protein with four membrane-spanning domains. Subsequent studies observed that <italic toggle="yes">mspA</italic> mutants displayed hypersensitivity to innate immune defence molecules, surviving poorly when challenged with oleic acid and human neutrophil peptide-1, and were severely attenuated in superficial and systemic mouse models of infection [<xref rid="R134" ref-type="bibr">134</xref>]. Moreover, <italic toggle="yes">mspA</italic> inactivation resulted in significantly lower levels of STX and was more sensitive to membrane-damaging detergents and displayed enhanced membrane permeability [<xref rid="R134" ref-type="bibr">134</xref>].</p><p>Further work on this protein sought to characterize the function of MspA within the membrane. Through a series of elegant experiments, it was shown that the inactivation of <italic toggle="yes">mspA</italic> triggered over-accumulation of lipoteichoic acid (LTA), which altered autolysin activity and cell separation, causing the cells to inflate in size. Bacterial two-hybrid and three-hybrid assays found that MspA interacted directly with the LTA biosynthesis enzymes UgtP, LtaA and LtaS. Furthermore, MspA was shown to disrupt the interaction between LtaA and LtaS. It was concluded that MspA may act as a &#x02018;dimmer&#x02019; switch and helps to maintain the correct physiological levels of LTA within the cell envelope [<xref rid="R135" ref-type="bibr">135</xref>]. Taken together, the disruption in the architecture and integrity of the cell envelope of the MspA mutant may render the cell membrane more susceptible to various stresses and explain the increased susceptibility to FAs.</p></sec></sec><sec id="s4-5"><title>Efflux pumps and transporters</title><p>Synthetic and natural FAs have been shown to inhibit DNA/RNA replication, disturb cell wall and FA biosynthesis, inhibit protein synthesis and disrupt metabolic pathways [<xref rid="R136" ref-type="bibr">136</xref>]. As such, numerous efflux pumps that reduce the intracellular accumulation of FAs have been shown to contribute to FA resistance.</p><sec id="s4-5-1"><title>Tet38</title><p>Tet38 is part of the major facilitator superfamily of efflux pumps and has been observed to play a role in antibiotic extrusion [<xref rid="R137" ref-type="bibr">137</xref><xref rid="R138" ref-type="bibr">138</xref>] and to promote internalization and phagolysosome escape of epithelial cells [<xref rid="R139" ref-type="bibr">139</xref>]. Expression levels of <italic toggle="yes">tet38</italic> have been shown to be elevated in models of subcutaneous abscess [<xref rid="R140" ref-type="bibr">140</xref>] and following exposure to linoleic acid [<xref rid="R66" ref-type="bibr">66</xref>]. Moreover, Tet38 as well as the NorB and NorD efflux pumps have been shown to be crucial for the survival of <italic toggle="yes">S. aureus</italic> within abscesses [<xref rid="R141" ref-type="bibr">141</xref><xref rid="R142" ref-type="bibr">142</xref>]. In a subsequent experiment, Truong-Bolduc <italic toggle="yes">et al</italic>. showed that Tet38-expressing strains displayed between a 5- and 8-fold increase in resistance to palmitoleic and undecanoic acid, whilst exposure of <italic toggle="yes">S. aureus</italic> to these FAs was shown to selectively induce the expression of <italic toggle="yes">tet38</italic> transcripts 4-fold [<xref rid="R143" ref-type="bibr">143</xref>]. The involvement of Tet38 in FA resistance corresponded well with colonization potential, as a &#x00394;<italic toggle="yes">tet38</italic> mutant exhibited a 5-fold decrease in colonizing potential in a murine skin infection model [<xref rid="R143" ref-type="bibr">143</xref>].</p></sec><sec id="s4-5-2"><title>FarE</title><p>FarE was first implicated in <italic toggle="yes">S. aureus</italic> FA resistance by Kenny <italic toggle="yes">et al</italic>., following observations that a putative MMPL efflux pump (SAR2632) was upregulated 2-fold following linoleic acid challenge, and a <italic toggle="yes">SAR2632</italic> mutant displayed decreased survival following linoleic challenge [<xref rid="R66" ref-type="bibr">66</xref>]. FarE was later characterized as an efflux pump by the work of Alnaseri <italic toggle="yes">et al</italic>. following a screen to determine the genetic factors involved in <italic toggle="yes">S. aureus</italic> adaptation to growth in the presence of linoleic acid identified a SNP, H121Y, within SAUSA300_2490. Further analysis revealed this gene to encode a TetR family DNA-binding protein designated <italic toggle="yes">farR</italic>, which was accompanied by a divergently transcribed effector gene, SAUSA300_2489, classified as a resistance-nodulation-cell division (RND) efflux transporter, designated <italic toggle="yes">farE</italic> [<xref rid="R117" ref-type="bibr">117</xref>].</p><p>The <italic toggle="yes">farR</italic> H121Y mutant was found to be a hyperproducer of FarE, and FarR was found to directly regulate the expression of FarE. Additionally, FarR and FarE were demonstrated to be strongly induced in response to linoleic acid, arachidonic acid, sapienic acid, linolenic acid and palmitoleic acid. Mutational analysis revealed a &#x00394;<italic toggle="yes">farE</italic> mutant to be hyper-susceptible to linoleic and arachidonic acids, but not palmitoleic acid. Consistent with an efflux-dependent mechanism of resistance, the inactivation of <italic toggle="yes">farE</italic> resulted in an increased cellular accumulation of radiolabelled [<sup>14</sup>C]-linoleic acid [<xref rid="R117" ref-type="bibr">117</xref>]. A follow-up study provided an in-depth characterization of FarR-regulated FarE function. Complementation of a &#x00394;<italic toggle="yes">farER</italic> mutant with either <italic toggle="yes">farE</italic> or <italic toggle="yes">farR</italic> did not restore linoleic acid resistance; however, resistance was restored through complementation of <italic toggle="yes">farER</italic> expressed from their native promoters or ectopic expression of <italic toggle="yes">farE</italic>. The authors also showed that FarR was needed for the expression of <italic toggle="yes">farE</italic> whilst also auto-repressing its own expression. Their experiments also revealed that FarR activates <italic toggle="yes">farE</italic> expression in a manner dependent on a FakA-associated product derived from exoFA metabolism. The authors proposed that this would be to ensure that the efflux of FAs only occurs when the capacity for FA incorporation is exceeded [<xref rid="R144" ref-type="bibr">144</xref>].</p></sec><sec id="s4-5-3"><title>Mnh</title><p>A comparative transcriptomic study of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">Staphylococcus epidermidis</italic> in response to sapienic acid challenge has shown that the <italic toggle="yes">mnhABCDEFG</italic> operon was considerably upregulated [<xref rid="R145" ref-type="bibr">145</xref>]. <italic toggle="yes">S. aureus</italic> harbours two multi-subunit Na<sup>+</sup>/H<sup>+</sup> (Mnh) antiporters which function to maintain cytoplasmic membrane pH, enabling survival under environmental stress [<xref rid="R146" ref-type="bibr">146</xref>]. Further analysis confirmed that an in-frame <italic toggle="yes">mnhF</italic> mutant was more susceptible to sapienic acid than WT <italic toggle="yes">S. aureus</italic> [<xref rid="R145" ref-type="bibr">145</xref>]. Other studies have reported that a <italic toggle="yes">mnhD</italic> mutant was more sensitive to thrombin-induced platelet microbicidal protein 1 (tPMP-1) [<xref rid="R147" ref-type="bibr">147</xref>] and that this operon is also involved in mediating resistance to bile salts and expelling cholic acid [<xref rid="R148" ref-type="bibr">148</xref>]. In addition to the <italic toggle="yes">mnh</italic> operon, multiple other cationic transporter systems (CopA, CzrB, OpuD2 and OpuBA) were found to be upregulated in response to sapienic challenge. Perhaps collective upregulation of these transporter systems protects <italic toggle="yes">S. aureus</italic> from the effect of solute leakage, induced through sapienic acid-mediated membrane depolarization [<xref rid="R65" ref-type="bibr">65</xref><xref rid="R145" ref-type="bibr">145</xref><xref rid="R149" ref-type="bibr"> 149</xref>]. Membrane proteins such as FloA and MspA (discussed above) have been shown to provide stability to membrane architecture [<xref rid="R150" ref-type="bibr">150</xref>]. Therefore, an alternative hypothesis is that Mnh may provide some mechanical stability/strengthening to the bacterial membrane, thus protecting it from the membrane-damaging effects of FAs.</p></sec></sec><sec id="s4-6"><title>FA metabolism</title><p><italic toggle="yes">S. aureus</italic> can produce sFAs through the action of the resident FASII system. However, it can also scavenge exoFAs from the host environment through the action of the FA kinase (FAK) system [<xref rid="R151" ref-type="bibr">151</xref><xref rid="R152" ref-type="bibr">152</xref>]. The FAK system is comprised of the FAK FakA which works in conjunction with the FA-binding proteins FakB1 and FakB2 [<xref rid="R152" ref-type="bibr">152</xref>]. In <italic toggle="yes">S. aureus</italic>, FakB1 is used to remove saturated exoFAs, and FakB2 is used to remove unsaturated exoFAs from the bacterial membrane [<xref rid="R153" ref-type="bibr">153</xref>]. Once removed, FakA proceeds to phosphorylate the carboxyl head of the exoFA to create an acyl phosphate which can then be fed into the phospholipid pathway [<xref rid="R152" ref-type="bibr">152</xref>]. Non-<italic toggle="yes">S. aureus</italic> FAs can be incorporated into the bacterial membrane impacting lipid packaging and composition, leading to an alteration in the fluidity of the membrane [<xref rid="R70" ref-type="bibr">70</xref>].</p><p>It stands to reason that <italic toggle="yes">S. aureus</italic> utilizes the FAK system to ensure the passive accumulation of FAs into the membrane does not result in a catastrophic loss of membrane barrier function. However, proving this experimentally is challenging. In support of the FAK system, being an FA resistance determinant is the observation that other key FA resistance strategies are intrinsically linked to FAK metabolites. For example, we have discussed above how exoFA breakdown products interact with FarR to ensure that <italic toggle="yes">farE</italic> expression only occurs once the metabolic capacity for exoFA incorporation is exceeded [<xref rid="R144" ref-type="bibr">144</xref>]. Similarly, it has been observed that the T7SS is induced in response to FA scavenging by FAK [<xref rid="R144" ref-type="bibr">144</xref>]. Paradoxically, the deletion of <italic toggle="yes">fakA</italic> or a dual deletion of <italic toggle="yes">fakB1</italic> and <italic toggle="yes">fakB2</italic> leads to enhanced resistance to FAs [<xref rid="R154" ref-type="bibr">154</xref>]. Specifically, &#x00394;<italic toggle="yes">fakA</italic> mutants were found to be more resistant to linoleic and oleic acid, which was phenocopied by the &#x00394;<italic toggle="yes">fakB1/B2</italic> double mutant [<xref rid="R154" ref-type="bibr">154</xref>]. Enhanced resistance in the absence of FakA has been attributed to elevated basal levels of <italic toggle="yes">farE</italic> expression [<xref rid="R144" ref-type="bibr">144</xref>], as well as pleiotropic effects on <italic toggle="yes">S. aureus</italic> transcriptional signalling. Specifically, USA300 &#x00394;<italic toggle="yes">fakA</italic> is associated with reduced transcription of the SaeRS two-component system which contributes to defective Hla production [<xref rid="R155" ref-type="bibr">155</xref>]. The expression of <italic toggle="yes">sigB</italic> was also increased roughly 8-fold in the &#x00394;<italic toggle="yes">fakA</italic> mutant, and its resistance profile could be reduced to an intermediary phenotype when <italic toggle="yes">&#x003c3;</italic><sup>B</sup> was deleted [<xref rid="R154" ref-type="bibr">154</xref>]. <italic toggle="yes">&#x003c3;</italic><sup>B</sup> has previously been implicated in FA resistance, where a &#x00394;<italic toggle="yes">sigB</italic> mutant was more sensitive to linoleic acid challenge compared with the WT strain [<xref rid="R66" ref-type="bibr">66</xref>].</p><p>This contradiction is further exemplified when looking at mouse models of infection using WT and <italic toggle="yes">fakA</italic> mutants. Whilst the inactivation of <italic toggle="yes">fakA</italic> does not affect <italic toggle="yes">S. aureus</italic> proliferation [<xref rid="R156" ref-type="bibr">156</xref>], <italic toggle="yes">fakA</italic> mutants are outcompeted [<xref rid="R157" ref-type="bibr">157</xref>] or found in lower abundance [<xref rid="R69" ref-type="bibr">69</xref>], compared with the WT in systemic mouse infections. However, <italic toggle="yes">fakA</italic> mutants provoke larger lesions and contribute to increased dermonecrosis than the WT during murine skin infection [<xref rid="R158" ref-type="bibr">158</xref>]. Therefore, whether exoFA incorporation by <italic toggle="yes">S. aureus</italic> functions as an antimicrobial FA resistance mechanism remains unclear.</p><p><italic toggle="yes">S. aureus</italic> is also capable of metabolizing FAs through <italic toggle="yes">&#x003b2;</italic>-oxidation. In this pathway, FadD activates LCFAs through conversion into acyl-CoA. FadE then generates a trans-enoyl acyl-CoA intermediate, and FabB sequentially converts this into hydroxy acyl-CoA and then <italic toggle="yes">&#x003b2;</italic>-keto acyl-CoA. Finally, FadA cleaves <italic toggle="yes">&#x003b2;</italic>-keto acyl-CoA to release acetyl-CoA, and the shortened carbon chain is combined with CoA-SH to allow for additional cycles of <italic toggle="yes">&#x003b2;</italic>-oxidation to occur [<xref rid="R159" ref-type="bibr">159</xref><xref rid="R160" ref-type="bibr">160</xref>]. The genes for this pathway are in a single locus in <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">fadXDEBA</italic>, where <italic toggle="yes">fadX</italic> is an alternative acyl-CoA transferase to <italic toggle="yes">fadD</italic> which can activate SCFAs. The deletion of the entire <italic toggle="yes">fadXDEBA</italic> operon (USA300&#x02206;<italic toggle="yes">fad</italic>) decreases viability in the presence of palmitic acid [<xref rid="R160" ref-type="bibr">160</xref>]. Whilst sFAs are non-toxic towards <italic toggle="yes">S. aureus</italic>, C16 acyl-phosphate formed from palmitic acid is a poor substrate for phospholipid biosynthesis. These chains are instead elongated by FabF for efficient utilization by the PlsY acyltransferase [<xref rid="R161" ref-type="bibr">161</xref>]. Interestingly, USA300&#x02206;<italic toggle="yes">fad</italic> has increased incorporation of C16 into phosphatidylglycerol upon exposure to palmitic acid and concurrently does not produce palmitoyl-CoA, the first metabolite in <italic toggle="yes">&#x003b2;</italic>-oxidation [<xref rid="R160" ref-type="bibr">160</xref>]. Combined, these data suggest that <italic toggle="yes">fadXDEBA</italic> protects <italic toggle="yes">S. aureus</italic> from a metabolic bottleneck caused by palmitic acid incorporation into PGN by drawing it away from phospholipid biosynthesis.</p><p>An illustration of the FA resistance strategies utilized by <italic toggle="yes">S. aureus</italic> is provided in <xref rid="F2" ref-type="fig">Fig. 2</xref>.</p><fig position="float" id="F2" fig-type="figure"><label>Fig. 2.</label><caption><title>Strategies employed by <italic toggle="yes">S. aureus</italic> to resist FAs antimicrobial activity.</title></caption><graphic xlink:href="mic-171-01563-g002" position="float"/></fig></sec></sec><sec id="s5"><title>Therapeutic application</title><p>FAs are attracting attention due to their clinical potential for the treatment of <italic toggle="yes">S. aureus</italic> infections. In addition to being extremely potent, they are also broad-spectrum and have activity against MDR <italic toggle="yes">S. aureus</italic>, and their chemical structures are amenable to modifications aimed at enhancing activity. Furthermore, they are generally considered non-toxic and harbour additional anti-inflammatory properties that could contribute to infection resolution [<xref rid="R2" ref-type="bibr">2</xref><xref rid="R162" ref-type="bibr">162</xref>].</p><sec id="s5-1"><title>FAs for decolonization and treatment of skin infections</title><p>Whilst some studies have suggested the use of FAs to treat systemic infections [<xref rid="R22" ref-type="bibr">22</xref><xref rid="R163" ref-type="bibr">163</xref>], the most likely prospect for exploiting FAs therapeutically is as a topical agent. Currently, topical treatment of superficial <italic toggle="yes">S. aureus</italic> infections and nasal decolonization prior to hospital admission relies on the use of fusidic acid, mupirocin, clindamycin or retapamulin ointments [<xref rid="R8" ref-type="bibr">8</xref>]. However, declining clinical efficacy due to the increasing prevalence of MDR <italic toggle="yes">S. aureus</italic> strains highlights the need for alternative therapies [<xref rid="R164" ref-type="bibr">164</xref><xref rid="R165" ref-type="bibr">165</xref>].</p><p>Multiple studies have observed success using FAs as therapeutic <italic toggle="yes">S. aureus</italic> decolonization agents. Lacy and Lord performed <italic toggle="yes">S. aureus</italic> survival assays on human skin with and without the addition of neat linoleic acid. In the untreated patient group, a high percentage of the initial inoculum was recovered after 6&#x02009;h. Conversely, for the linoleic acid-treated group, &#x0003c;0.01% of the starting inoculum was recovered in the same time period [<xref rid="R166" ref-type="bibr">166</xref>]. Other studies investigated the use of lauric acid monoester (LAM), observing <italic toggle="yes">in vitro</italic> effectiveness against methicillin-susceptible <italic toggle="yes">S. aureus</italic> (MSSA) and MRSA isolates and MIC<sub>90</sub> values of &#x0003c;4&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> versus 0.25&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> for mupirocin. An <italic toggle="yes">in vivo</italic> murine model of MRSA nasopharyngeal colonization indicated that LAM formulations were more effective than mupirocin in eradicating <italic toggle="yes">S. aureus</italic> carriage following 3&#x02009;days of treatment [<xref rid="R167" ref-type="bibr">167</xref>].</p><p>FA and FA formulations have shown effectiveness in the treatment of murine skin infections. Packaging of oleic acid into liposomes (LipoOA) as a novel delivery system displayed bactericidal activity at concentrations of 12.5&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> against MRSA252, 12-fold more effective than free oleic acid [<xref rid="R168" ref-type="bibr">168</xref>]. The increased potency was suggested to be the result of the increased fusion of oleic acid into the bacterial membrane. The therapeutic efficacy of LipoOA was further evaluated in a mouse skin infection model; MRSA252 (1&#x000d7;10<sup>7</sup>&#x02009;c.f.u.) was injected into the skin alongside either control, FA-free liposomes or LipoOA. Following 24&#x02009;h, skin lesions formed in the control liposome group but not the LipoOA. Further homogenization of skin tissues showed that the amount of MRSA252 remaining was 500-fold less in the LipoOA compared with the bare liposome treatment group [<xref rid="R168" ref-type="bibr">168</xref>]. Future studies evaluating the therapeutic effect once skin lesions are formed are required. The ability of oleic acid to resolve mouse skin infections has further been demonstrated by Chen <italic toggle="yes">et al.</italic> when directly administered in the same location as the subcutaneous injection of <italic toggle="yes">S. aureus</italic>. Oleic acid treatment significantly attenuated skin lesion formation and alleviated the skin damage caused by the infecting <italic toggle="yes">S. aureus</italic> strain [<xref rid="R169" ref-type="bibr">169</xref>].</p><p>Sapienic acid has also shown promise in the treatment of MSSA disease in both a murine model of systemic infection and AD where either injection or topical application of sapienic acid 2&#x02013;4&#x02009;h after infection resulted in a significant reduction in the <italic toggle="yes">S. aureus</italic> burden [<xref rid="R22" ref-type="bibr">22</xref>].</p></sec><sec id="s5-2"><title>Synthetic FAs</title><sec id="s5-2-1"><title>Furan FAs</title><p>Recently, there has been a focus on understanding and manipulating the chemical structures of FAs such to improve their potency and/or spectrum of activity. Furan FAs, characterized by a furan ring and an unbranched 9, 11 or 13 carbon chain FA, are important human biologics displaying antioxidant, antithrombotic, anti-inflammatory and cardioprotective properties [<xref rid="R170" ref-type="bibr">170</xref>]. Using a microbial biotransformation approach, Ellamar <italic toggle="yes">et al.</italic> synthesized a novel, biologically active furan FA [7,10-epoxyoctadeca-7,9-dienoic acid (7,10-EODA)] [<xref rid="R170" ref-type="bibr">170</xref>]. 7,10-EODA exhibited an MIC range of 125&#x02013;250&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> against a cohort of MSSA and MRSA strains and prevented the production of haemolysins, autolysins and proteases at subinhibitory concentrations [<xref rid="R171" ref-type="bibr">171</xref>]. Furthermore, 7,10-EODA synergized with <italic toggle="yes">&#x003b2;</italic>-lactams, facilitating increased antibiotic binding, resulting in fractional inhibitory concentration indexes below the 0.5 threshold against clinical MRSA isolates [<xref rid="R172" ref-type="bibr">172</xref>].</p></sec><sec id="s5-2-2"><title>Acetylenic acids</title><p>Acetylenic FAs are typically found in plants and used as a component of their natural defences against micro-organisms. This class of FAs contains a highly peculiar C&#x02261;C and has been of interest to medicinal chemists due to their antimicrobial activity towards nosocomial pathogens. Synthetic 2-alkynoic FAs, such as 2-HDA, have received attention for their impressive antimicrobial activity. Structure&#x02013;activity relationship studies of 2-HDA demonstrated that the C&#x02261;C bond at position 2 in hexadecenoic acid is pivotal to its antimicrobial potency [<xref rid="R173" ref-type="bibr">173</xref>] and that the antibacterial activity of hexadecenoic acid decreases as the triple bond is moved further away from the terminal carboxyl group [<xref rid="R100" ref-type="bibr">100</xref>]. 2-HDA exhibits activity against a range of problematic bacterial species including <italic toggle="yes">S. aureus</italic> with MIC values of 15.6&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> [<xref rid="R173" ref-type="bibr">173</xref>]. 2-HDA retained activity against MRSA isolates resistant to ciprofloxacin, which the authors linked to its capacity to inhibit DNA gyrase [<xref rid="R100" ref-type="bibr">100</xref>].</p></sec><sec id="s5-2-3"><title><italic toggle="yes">&#x003b1;</italic>-Methoxylated FAs</title><p>The <italic toggle="yes">&#x003b1;</italic>-methoxylated FAs are unusual 14&#x02013;28 carbon FAs that possess a methoxy branch and are recovered from a number of different Caribbean sponge species [<xref rid="R174" ref-type="bibr">174</xref>]. Carballeira <italic toggle="yes">et al.</italic> reported the complete synthesis of (&#x000b1;)-2-methoxy-6-hexadecenoic acid which displayed higher potency than the naturally derived 6-hexadecenoic (sapienic acid) [<xref rid="R175" ref-type="bibr">175</xref>]. The authors also synthesized the synthetic acetylenic acid derivatives of both (&#x000b1;)-2-methoxy-6-hexadecenoic acid and (6<italic toggle="yes">Z</italic>)-(&#x000b1;)-2-methoxy-6-octadecenoic acid (2M,6-ODA); the addition of a C&#x02261;C bond in (&#x000b1;)-2-methoxy-6-hexadecenoic acid did not enhance potency. However, the acetylenic derivative of 2M,6-ODA was the most potent methoxylated FA tested with an MIC range of 31&#x02013;125&#x02009;&#x000b5;g&#x02009;ml<sup>&#x02212;1</sup> against <italic toggle="yes">S. aureus</italic>.</p></sec></sec><sec id="s5-3"><title>FA-AMP conjugates</title><p>AMPs are generally short (10&#x02013;50 <sc>aa</sc>) with a net positive charge (+2&#x02009;to +9) and a high proportion of hydrophobic residues (&#x0003e;30%) that exhibit broad antimicrobial activity [<xref rid="R176" ref-type="bibr">176</xref><xref rid="R177" ref-type="bibr">177</xref>]. Upon contact with target membranes, AMPs adopt an amphipathic structure, and the hydrophobic residues insert in the bilayer to form transient pores. In addition, the peptide can aggregate on the surface to induce a detergent-like disintegration. Both mechanisms disrupt essential membrane processes and lead to leakage of intracellular contents [<xref rid="R176" ref-type="bibr">176</xref><xref rid="R178" ref-type="bibr">178</xref>].</p><p>AMPs are of significant interest for future therapeutic development; however, challenges related to insufficient potency and lack of activity and stability under physiological conditions are important limitations. Lipidation, the chemical covalent attachment of FA chains to AMPs, shows promise in circumventing obstacles related to the therapeutic use of AMPs. Lipidation has been shown to enhance bioactivity; for example, conjugation of C-12 FAs to a short peptide sequence derived from human cathepsin G (N-terminal sequence 117&#x02013;136) increased antimicrobial activity 16&#x02013;32-fold compared with non-lipidated AMPs against a panel of <italic toggle="yes">S. aureus</italic> isolates [<xref rid="R179" ref-type="bibr">179</xref>]. To investigate the importance of FA acyl chain length on the antimicrobial activity of FA-AMP conjugates, Mak <italic toggle="yes">et al.</italic> used the human cathepsin G N-terminal sequence 117&#x02013;136 and modified this sequence with FAs ranging from C-2 to C-18 hydrocarbons. The authors observed an increase in <italic toggle="yes">&#x003b1;</italic>-helical formation of the peptides up to a chain length of C-12, but no change in structure was observed in peptides containing C-14 to C-18. This data correlated with the ability of FA-AMP conjugates to lyse large unilamellar membranes and display antimicrobial activity against MRSA and vancomycin-intermediate isolates of <italic toggle="yes">S. aureus</italic> [<xref rid="R179" ref-type="bibr">179</xref>]. Chu-Kung <italic toggle="yes">et al.</italic> conjugated FAs ranging from C-12 to C-20 in length to a synthetic leucine-lysine AMP and measured the critical micelle concentration of the peptides using pyrene solubilization and tensiometry [<xref rid="R180" ref-type="bibr">180</xref><xref rid="R181" ref-type="bibr">181</xref>]. The authors identified higher aggregation of the peptides into micelles as hydrocarbon chain length increased. Importantly, if the peptides aggregated at a concentration below the minimum bactericidal concentration, no antimicrobial activity was observed, highlighting that self-assembly at high hydrophobicity inhibits AMP activity.</p><p>Lipidation can also improve the antimicrobial activity of AMPs when tested under conditions aiming to mimic physiological conditions. Human serum albumin can sequester AMPs, diminishing activity due to its negative charge; Grimsey <italic toggle="yes">et al.</italic> observed that the addition of C-12 and C-14 FAs to synthetic AMP domains increased the activity against MRSA in the presence of 25% human serum between 4- and 8-fold compared with the parent peptide [<xref rid="R182" ref-type="bibr">182</xref>].</p><p>Physiological salt concentrations can also be inhibitory for AMP activity as they interfere with electrostatic interactions between the peptide and the bacterial membrane. Zhong <italic toggle="yes">et al.</italic> conjugated C-10 and C-12 FAs to the N-terminus of anoplin-D4,7 and found that antimicrobial activity was much higher against <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">S. aureus</italic> in the presence of physiological concentrations of NaCl, KCl, MgCl<sub>2</sub>, ZnCl<sub>2</sub> and FeCl<sub>3</sub>, compared with the parent peptide [<xref rid="R183" ref-type="bibr">183</xref>]. In support of these observations, Krishnakumari and Nagaraj demonstrated that N-terminal palmitoylation of the C-terminal segment of bovine-<italic toggle="yes">&#x003b2;</italic>-defensin-2 allowed the peptide to maintain activity against <italic toggle="yes">E. coli</italic> and <italic toggle="yes">S. aureus</italic> in the presence of 150&#x02009;mM NaCl. In contrast, the parent peptide has no activity under these conditions. The authors proposed that the FA chain acts as an anchor to solidify electrostatic contact between the AMP and bacterial membrane and allow for pore formation in the presence of physiological salt concentrations [<xref rid="R184" ref-type="bibr">184</xref>].</p></sec><sec id="s5-4"><title>Antibiotic potentiation</title><p>Lipophilic side chain modification of the glycopeptide antibiotic, vancomycin, can improve potency as the modified antibiotic can anchor to the membrane and induce secondary membrane-damaging effects [<xref rid="R185" ref-type="bibr">185</xref>]. This antibiotic potentiation served as the rationale for the work of Sidders <italic toggle="yes">et al.</italic>, who proposed that partnering vancomycin with cell membrane-active agents like FAs could improve activity [<xref rid="R186" ref-type="bibr">186</xref>]. Palmitoleic acid, linoleic acid and rhamnolipids (RLs) (glycolipids consisting of <sc>l</sc>-rhamnose and <italic toggle="yes">&#x003b2;</italic>-hydroxy FA moieties) were observed to potentiate vancomycin killing but not other cell wall targeting antibiotics such as <italic toggle="yes">&#x003b2;</italic>-lactams and fosfomycin. Further molecular dissection focussing on vancomycin/palmitoleic acid found that the synergistic activity was due to the accumulation of membrane-bound cell wall precursors. This accumulation led to the generation of large fluid patches within the membrane which caused protein delocalization and a loss of membrane integrity [<xref rid="R186" ref-type="bibr">186</xref>]. FA-vancomycin synergy has similarly been noted with omega-3 FAs and has proved to be an effective combination in alleviating osteomyelitis caused by <italic toggle="yes">S. aureus</italic> in rats [<xref rid="R187" ref-type="bibr">187</xref>].</p><p>Aminoglycosides are intracellularly active antibiotics that rely on PMF to enter the bacterial cell [<xref rid="R188" ref-type="bibr">188</xref>]. As a facultative anaerobe, <italic toggle="yes">S. aureus</italic> can effectively switch off PMF and reduce aminoglycoside entry by switching between the energy-yielding metabolic pathways of respiration and fermentation [<xref rid="R189" ref-type="bibr">189</xref><xref rid="R190" ref-type="bibr">190</xref>]. Consequently, higher concentrations of aminoglycosides that can cause significant adverse reactions to the host are required to eradicate fermentative <italic toggle="yes">S. aureus</italic> [<xref rid="R191" ref-type="bibr">191</xref>]. Recently, Radlinski <italic toggle="yes">et al.</italic> demonstrated that GML and RLs acted as potent tobramycin adjuvants and could restore tobramycin susceptibility to highly antibiotic-resistant <italic toggle="yes">S. aureus</italic> persister cells [<xref rid="R189" ref-type="bibr">189</xref>]. Interestingly, the RL challenge but not GML resulted in enhanced aminoglycoside uptake due to RL-mediated modifications of cell surface charge, membrane fluidity and small molecule permeability. Moreover, treatment with RL resulted in perturbation of membrane-associated cell-division machinery, whereas GML caused membrane clumping suggestive of significant membrane destabilization [<xref rid="R189" ref-type="bibr">189</xref>].</p><p>Similar antibiotic potentiation observations have been noted with arachidonic acid partnered with gentamicin, resulting in a substantial reduction in <italic toggle="yes">S. aureus</italic> viability compared with individual gentamicin treatment. This was suggested to be due to arachidonic acid increasing membrane fluidity as palmitic acid, which is fully saturated and does not increase membrane fluidity, did not synergize with gentamicin [<xref rid="R192" ref-type="bibr">192</xref>]. A screen of 15 sFAs and 15 uFAs for synergy with tobramycin found myristoleic acid-tobramycin to reduce bacterial viability by &#x0003e;4&#x02009;log compared with tobramycin treatment alone against MSSA and MRSA isolates. The aminoglycoside potentiation effect of myristoleic acid was also demonstrated with tobramycin, kanamycin, gentamicin and streptomycin [<xref rid="R193" ref-type="bibr">193</xref>].</p></sec></sec><sec sec-type="conclusions" id="s6"><title>Conclusions</title><p>FA and FA-combinational therapies represent promising anti-staphylococcal treatment options, whilst FA monotherapy displays additional anti-infective activity by blocking the expression of key <italic toggle="yes">S. aureus</italic> virulence factors central to disease.</p><p>The site of action of FAs is primarily the bacterial membrane. Studies have shown that FA exposure results in severe damage to membrane physiology, altering membrane fluidity, increasing membrane permeability and disrupting the ETC. Further dissection of FA mode of action identified FabI, a core enzyme of staphylococcal FA biosynthesis as a target. Moreover, lipid peroxidation of specific FAs such as arachidonic acid was demonstrated to be a key feature of antimicrobial activity. <italic toggle="yes">S. aureus</italic> transcriptomic analysis following exposure to FAs revealed significant alteration in genes involved in cell wall biosynthesis, hinting at a potential role of FAs in disrupting cell wall synthesis. Resistance to FAs exists in the form of structural barriers, surface determinants that repel the hydrophobic FAs, secreted MVs and detoxification enzymes that inactivate FAs. In addition, integral membrane stabilizers defend against FA membrane insertion and disruption, whilst increasing evidence indicates that efflux pumps play a key role in staphylococcal FA resistance.</p><p>Whilst the use of FAs as therapeutic agents is attractive, there are several significant gaps in the literature that impede future development. Given the high concentrations of FAs required to eliminate bacterial pathogens including <italic toggle="yes">S. aureus</italic>, further research on FA toxicity to human cells and organ systems is essential. The activity of FAs and FA combinations in clinically relevant environments, for example, in the presence of human serum or under physiological salt conditions, is relatively unknown but does represent significant limitations for the clinical implementation of host-derived AMP-based therapeutics [<xref rid="R194" ref-type="bibr">194</xref>]. Experimental evidence informing on the types of infection that are best suited for FA-based therapies is lacking; most animal infection studies focus on topical FA infection control applications and provide no data on the critical pharmacokinetic and pharmacodynamic properties of FAs. Lastly, little information is available on the frequency of resistance to FAs and whether resistance determinants can be mobilized and rapidly exchanged.</p><p>Research in developing more potent FAs through profiling molecular-level membrane interactions may help predict potency and synergistic potential, promoting the rational design of future therapeutics. FA-AMP conjugates and improved FA delivery systems have the potential to improve potency and stability and decrease cytotoxicity. Continued development in antibiotic and FA mode of action discoveries has the potential to identify future FA-based antibiotic adjuvants that will help preserve and improve current therapies aimed at combating MDR <italic toggle="yes">S. aureus</italic> infections.</p></sec></body><back><ack><title>Acknowledgements</title><p><xref rid="F1" ref-type="fig">Figs1 </xref><xref rid="F2" ref-type="fig"> 2</xref> were made with Biorender.com with permission.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> This work was supported by the Academy of Medical Sciences Springboard Award (SBF006/1023) and EPSRC (EP/X022935/1) to M.L.</p></fn></fn-group><notes><def-list><title>Abbreviations</title><def-item><term>AD</term><def><p>atopic dermatitis</p></def></def-item><def-item><term>AMP</term><def><p>antimicrobial peptide</p></def></def-item><def-item><term>CC</term><def><p>clonal complex</p></def></def-item><def-item><term>COX</term><def><p>cyclooxygenase</p></def></def-item><def-item><term>DSF</term><def><p>diffusible signal factor</p></def></def-item><def-item><term>7,10-EODA</term><def><p>7,10-epoxyoctadeca-7,9-dienoic acid</p></def></def-item><def-item><term>EPS</term><def><p>extracellular polymeric substance</p></def></def-item><def-item><term>ETC</term><def><p>electron transport chain</p></def></def-item><def-item><term>exoFA</term><def><p>exogenous FA</p></def></def-item><def-item><term>FA</term><def><p>fatty acid</p></def></def-item><def-item><term>FAK</term><def><p>FA kinase</p></def></def-item><def-item><term>FAME</term><def><p>FA-modifying enzyme</p></def></def-item><def-item><term>GML</term><def><p>glycerol monolaurate</p></def></def-item><def-item><term>2-HDA</term><def><p>2-hexadecenoic acid</p></def></def-item><def-item><term>HFD-P</term><def><p>polyunsaturated high-fat diet</p></def></def-item><def-item><term>HFD-S</term><def><p>saturated high-fat diet</p></def></def-item><def-item><term>IsdA</term><def><p>iron-regulated surface determinant protein A</p></def></def-item><def-item><term>LAM</term><def><p>lauric acid monoester</p></def></def-item><def-item><term>LCFAs</term><def><p>long-chain FAs</p></def></def-item><def-item><term>LCP</term><def><p>LytR-CpsA-Psr</p></def></def-item><def-item><term>LTA</term><def><p>lipoteichoic acid</p></def></def-item><def-item><term>MDR</term><def><p>multidrug resistant</p></def></def-item><def-item><term>2M,6-ODA</term><def><p>(6<italic toggle="yes">Z</italic>)-(&#x000b1;)-2-methoxy-6-octadecenoic acid</p></def></def-item><def-item><term>MRSA</term><def><p>methicillin-resistant <italic toggle="yes">S. aureus</italic></p></def></def-item><def-item><term>MspA</term><def><p>membrane-stabilizing protein A</p></def></def-item><def-item><term>MSSA</term><def><p>methicillin-susceptible <italic toggle="yes">S. aureus</italic></p></def></def-item><def-item><term>MVs</term><def><p>membrane vesicles</p></def></def-item><def-item><term>OhyA</term><def><p>oleate hydratase</p></def></def-item><def-item><term>PG</term><def><p>phosphatidylglycerol</p></def></def-item><def-item><term>PGN</term><def><p>peptidoglycan</p></def></def-item><def-item><term>PMF</term><def><p>proton motive force</p></def></def-item><def-item><term>PUFA</term><def><p>polyunsaturated FA</p></def></def-item><def-item><term>RL</term><def><p>rhamnolipid</p></def></def-item><def-item><term>ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term>SCFA</term><def><p>short-chain FA</p></def></def-item><def-item><term>sFAs</term><def><p>saturated FAs</p></def></def-item><def-item><term>STX</term><def><p>staphyloxanthin</p></def></def-item><def-item><term>TPP+</term><def><p>tetraphenylphosphonium ion</p></def></def-item><def-item><term>T7SS</term><def><p>type 7 secretion system</p></def></def-item><def-item><term>uFAs</term><def><p>unsaturated FAs</p></def></def-item><def-item><term>WTA</term><def><p>wall teichoic acid</p></def></def-item></def-list></notes><ref-list><title>References</title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoon</surname><given-names>BK</given-names></name>
<name><surname>Jackman</surname><given-names>JA</given-names></name>
<name><surname>Valle-Gonz&#x000e1;lez</surname><given-names>ER</given-names></name>
<name><surname>Cho</surname><given-names>N-J</given-names></name>
</person-group><article-title>Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications</article-title><source>Int J Mol Sci</source><year>2018</year><volume>19</volume><fpage>4</fpage><pub-id pub-id-type="doi">10.3390/ijms19041114</pub-id><pub-id pub-id-type="pmid">29642500</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Desbois</surname><given-names>AP</given-names></name>
</person-group><article-title>Potential applications of antimicrobial fatty acids in medicine, agriculture and other industries</article-title><source>Recent Pat Antiinfect Drug Discov</source><year>2012</year><volume>7</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.2174/157489112801619728</pub-id><pub-id pub-id-type="pmid">22630821</pub-id>
</element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pearce</surname><given-names>J</given-names></name>
</person-group><article-title>Fatty acid synthesis in liver and adipose tissue</article-title><source>Proc Nutr Soc</source><year>1983</year><volume>42</volume><issue>2</issue><fpage>263</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">6351084</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wille</surname><given-names>JJ</given-names></name>
<name><surname>Kydonieus</surname><given-names>A</given-names></name>
</person-group><article-title>Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria</article-title><source>Skin Pharmacol Appl Skin Physiol</source><year>2003</year><volume>16</volume><issue>3</issue><fpage>176</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">12677098</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takigawa</surname><given-names>H</given-names></name>
<name><surname>Nakagawa</surname><given-names>H</given-names></name>
<name><surname>Kuzukawa</surname><given-names>M</given-names></name>
<name><surname>Mori</surname><given-names>H</given-names></name>
<name><surname>Imokawa</surname><given-names>G</given-names></name>
</person-group><article-title>Deficient production of hexadecenoic acid in the skin is associated in part with the vulnerability of atopic dermatitis patients to colonization by <italic toggle="yes">Staphylococcus aureus</italic></article-title><italic toggle="yes">.</italic><source>Dermatology</source><year>2005</year><volume>211</volume><issue>3</issue><fpage>240</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16205069</pub-id>
</element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Georgel</surname><given-names>P</given-names></name>
<name><surname>Crozat</surname><given-names>K</given-names></name>
<name><surname>Lauth</surname><given-names>X</given-names></name>
<name><surname>Makrantonaki</surname><given-names>E</given-names></name>
<name><surname>Seltmann</surname><given-names>H</given-names></name>
<name><surname>Sovath</surname><given-names>S</given-names></name>
<etal>et al</etal>
</person-group><article-title>A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria</article-title><source>Infect Immun</source><year>2005</year><volume>73</volume><issue>8</issue><fpage>4512</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">16040962</pub-id>
</element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>S</given-names></name>
<name><surname>Villarreal</surname><given-names>M</given-names></name>
<name><surname>Stewart</surname><given-names>S</given-names></name>
<name><surname>Choi</surname><given-names>J</given-names></name>
<name><surname>Ganguli-Indra</surname><given-names>G</given-names></name>
<name><surname>Babineau</surname><given-names>DC</given-names></name>
<etal>et al</etal>
</person-group><article-title>Altered composition of epidermal lipids correlates with <italic toggle="yes">Staphylococcus aureus</italic> colonization status in atopic dermatitis</article-title><source>Br J Dermatol</source><year>2017</year><volume>177</volume><issue>4</issue><fpage>e125</fpage><lpage>e7</lpage><pub-id pub-id-type="pmid">28244066</pub-id>
</element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tong</surname><given-names>SYC</given-names></name>
<name><surname>Davis</surname><given-names>JS</given-names></name>
<name><surname>Eichenberger</surname><given-names>E</given-names></name>
<name><surname>Holland</surname><given-names>TL</given-names></name>
<name><surname>Fowler</surname><given-names>VG</given-names><suffix>Jr</suffix></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> infections: epidemiology, pathophysiology, clinical manifestations, and management</article-title><source>Clin Microbiol Rev</source><year>2015</year><volume>28</volume><fpage>603</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1128/CMR.00134-14</pub-id><pub-id pub-id-type="pmid">26016486</pub-id>
</element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Douglas</surname><given-names>EJA</given-names></name>
<name><surname>Laabei</surname><given-names>M</given-names></name>
</person-group><article-title>Staph wars: the antibiotic pipeline strikes back</article-title><source>Microbiology</source><year>2023</year><volume>169</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1099/mic.0.001387</pub-id><pub-id pub-id-type="pmid">37656158</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Antimicrobial Resistance</surname><given-names>C</given-names></name>
</person-group><article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title><source>Lancet</source><italic toggle="yes">.</italic><year>2022</year><volume>399</volume><issue>10325</issue><fpage>629</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">35065702</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>Collaborators GBDAR</collab>
</person-group><article-title>Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050</article-title><source>Lancet</source><year>2024</year><volume>404</volume><fpage>1199</fpage><lpage>1226</lpage><pub-id pub-id-type="pmid">39299261</pub-id>
</element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="other"><person-group person-group-type="author">
<collab>WHO</collab>
</person-group><article-title>WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance</article-title><year>2024</year></element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Naghavi</surname><given-names>M</given-names></name>
<name><surname>Murray</surname><given-names>CJL</given-names></name>
<name><surname>Ikuta</surname><given-names>KS</given-names></name>
<name><surname>Mestrovic</surname><given-names>T</given-names></name>
<name><surname>Swetschinski</surname><given-names>L</given-names></name>
<name><surname>Sartorius</surname><given-names>B</given-names></name>
</person-group><article-title>Global burden of antimicrobial resistance: essential pieces of a global puzzle - Authors' reply</article-title><source>Lancet</source><italic toggle="yes">.</italic><year>2022</year><volume>399</volume><issue>10344</issue><fpage>2349</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">35753339</pub-id>
</element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakr</surname><given-names>A</given-names></name>
<name><surname>Br&#x000e9;geon</surname><given-names>F</given-names></name>
<name><surname>M&#x000e8;ge</surname><given-names>J-L</given-names></name>
<name><surname>Rolain</surname><given-names>J-M</given-names></name>
<name><surname>Blin</surname><given-names>O</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> nasal colonization: an update on mechanisms, epidemiology, risk factors, and subsequent infections</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><elocation-id>2419</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.02419</pub-id><pub-id pub-id-type="pmid">30349525</pub-id>
</element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clarridge</surname><given-names>JE</given-names><suffix>3rd</suffix></name>
<name><surname>Harrington</surname><given-names>AT</given-names></name>
<name><surname>Roberts</surname><given-names>MC</given-names></name>
<name><surname>Soge</surname><given-names>OO</given-names></name>
<name><surname>Maquelin</surname><given-names>K</given-names></name>
</person-group><article-title>Impact of strain typing methods on assessment of relationship between paired nares and wound isolates of methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Clin Microbiol</source><year>2013</year><volume>51</volume><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1128/JCM.02423-12</pub-id><pub-id pub-id-type="pmid">23135945</pub-id>
</element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>von Eiff</surname><given-names>C</given-names></name>
<name><surname>Becker</surname><given-names>K</given-names></name>
<name><surname>Machka</surname><given-names>K</given-names></name>
<name><surname>Stammer</surname><given-names>H</given-names></name>
<name><surname>Peters</surname><given-names>G</given-names></name>
</person-group><article-title>Nasal carriage as a source of <italic toggle="yes">Staphylococcus aureus</italic> bacteremia. study group</article-title><source>N Engl J Med</source><year>2001</year><volume>344</volume><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1056/NEJM200101043440102</pub-id><pub-id pub-id-type="pmid">11136954</pub-id>
</element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>SJ</given-names></name>
<name><surname>Aly</surname><given-names>R</given-names></name>
<name><surname>Shinefeld</surname><given-names>HR</given-names></name>
<name><surname>Elias</surname><given-names>PM</given-names></name>
</person-group><article-title>In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids</article-title><source>Arch Dermatol</source><year>1988</year><volume>124</volume><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1001/archderm.1988.01670020027012</pub-id><pub-id pub-id-type="pmid">3341800</pub-id>
</element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Harris-Tryon</surname><given-names>TA</given-names></name>
<name><surname>Grice</surname><given-names>EA</given-names></name>
</person-group><article-title>Microbiota and maintenance of skin barrier function</article-title><source>Science</source><year>2022</year><volume>376</volume><fpage>940</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1126/science.abo0693</pub-id><pub-id pub-id-type="pmid">35617415</pub-id>
</element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costello</surname><given-names>EK</given-names></name>
<name><surname>Lauber</surname><given-names>CL</given-names></name>
<name><surname>Hamady</surname><given-names>M</given-names></name>
<name><surname>Fierer</surname><given-names>N</given-names></name>
<name><surname>Gordon</surname><given-names>JI</given-names></name>
<etal>et al</etal>
</person-group><article-title>Bacterial community variation in human body habitats across space and time</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>1694</fpage><lpage>1697</lpage><pub-id pub-id-type="doi">10.1126/science.1177486</pub-id><pub-id pub-id-type="pmid">19892944</pub-id>
</element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lampe</surname><given-names>MA</given-names></name>
<name><surname>Burlingame</surname><given-names>AL</given-names></name>
<name><surname>Whitney</surname><given-names>J</given-names></name>
<name><surname>Williams</surname><given-names>ML</given-names></name>
<name><surname>Brown</surname><given-names>BE</given-names></name>
<etal>et al</etal>
</person-group><article-title>Human stratum corneum lipids: characterization and regional variations</article-title><source>J Liq res</source><year>1983</year><volume>24</volume><fpage>120</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/S0022-2275(20)38005-6</pub-id></element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cartron</surname><given-names>ML</given-names></name>
<name><surname>England</surname><given-names>SR</given-names></name>
<name><surname>Chiriac</surname><given-names>AI</given-names></name>
<name><surname>Josten</surname><given-names>M</given-names></name>
<name><surname>Turner</surname><given-names>R</given-names></name>
<name><surname>Rauter</surname><given-names>Y</given-names></name>
<etal>et al</etal>
</person-group><article-title>Bactericidal activity of the human skin fatty acid cis-6-hexadecanoic acid on <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><issue>7</issue><fpage>3599</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">24709265</pub-id>
</element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>SR</given-names></name>
<name><surname>Mohamed</surname><given-names>R</given-names></name>
<name><surname>Bian</surname><given-names>L</given-names></name>
<name><surname>Routh</surname><given-names>AF</given-names></name>
<name><surname>Kokai-Kun</surname><given-names>JF</given-names></name>
<name><surname>Mond</surname><given-names>JJ</given-names></name>
<etal>et al</etal>
</person-group><article-title>The <italic toggle="yes">Staphylococcus aureus</italic> surface protein IsdA mediates resistance to innate defenses of human skin</article-title><source>Cell Host Microbe</source><year>2007</year><volume>1</volume><issue>3</issue><fpage>199</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">18005699</pub-id>
</element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>Y-C</given-names></name>
<name><surname>Schlievert</surname><given-names>PM</given-names></name>
<name><surname>Anderson</surname><given-names>MJ</given-names></name>
<name><surname>Fair</surname><given-names>CL</given-names></name>
<name><surname>Schaefers</surname><given-names>MM</given-names></name>
<etal>et al</etal>
</person-group><article-title>Glycerol monolaurate and dodecylglycerol effects on <italic toggle="yes">Staphylococcus aureus</italic> and toxic shock syndrome toxin-1 in vitro and in vivo</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><elocation-id>e7499</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0007499</pub-id><pub-id pub-id-type="pmid">19838303</pub-id>
</element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>MT</given-names></name>
<name><surname>Hanzelmann</surname><given-names>D</given-names></name>
<name><surname>H&#x000e4;rtner</surname><given-names>T</given-names></name>
<name><surname>Peschel</surname><given-names>A</given-names></name>
<name><surname>G&#x000f6;tz</surname><given-names>F</given-names></name>
</person-group><article-title>Skin-specific unsaturated fatty acids boost the <italic toggle="yes">Staphylococcus aureus</italic> innate immune response</article-title><source>Infect Immun</source><year>2016</year><volume>84</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1128/IAI.00822-15</pub-id><pub-id pub-id-type="pmid">26502910</pub-id>
</element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakatsuji</surname><given-names>T</given-names></name>
<name><surname>Kao</surname><given-names>MC</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Zouboulis</surname><given-names>CC</given-names></name>
<etal>et al</etal>
</person-group><article-title>Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression</article-title><source>J Invest Dermatol</source><year>2010</year><volume>130(4)</volume><fpage>985</fpage><pub-id pub-id-type="pmid">20032992</pub-id>
</element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Del Giudice</surname><given-names>P</given-names></name>
</person-group><article-title>Skin infections caused by <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Acta Derm Venereol</source><year>2020</year><volume>100</volume></element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thiboutot</surname><given-names>D</given-names></name>
</person-group><article-title>Regulation of human sebaceous glands</article-title><source>J Invest Dermatol</source><year>2004</year><volume>123</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/j.1523-1747.2004.t01-2-.x</pub-id><pub-id pub-id-type="pmid">15191536</pub-id>
</element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cruz</surname><given-names>AR</given-names></name>
<name><surname>van Strijp</surname><given-names>JAG</given-names></name>
<name><surname>Bagnoli</surname><given-names>F</given-names></name>
<name><surname>Manetti</surname><given-names>AGO</given-names></name>
</person-group><article-title>Virulence gene expression of <italic toggle="yes">Staphylococcus aureus</italic> in human skin</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><elocation-id>692023</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.692023</pub-id><pub-id pub-id-type="pmid">34177874</pub-id>
</element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakamura</surname><given-names>K</given-names></name>
<name><surname>Williams</surname><given-names>MR</given-names></name>
<name><surname>Kwiecinski</surname><given-names>JM</given-names></name>
<name><surname>Horswill</surname><given-names>AR</given-names></name>
<name><surname>Gallo</surname><given-names>RL</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> enters hair follicles using triacylglycerol lipases preserved through the genus <italic toggle="yes">Staphylococcus</italic></article-title><source>J Invest Dermatol</source><year>2021</year><volume>141</volume><fpage>2094</fpage><lpage>2097</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2021.02.009</pub-id><pub-id pub-id-type="pmid">33705795</pub-id>
</element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Hal</surname><given-names>SJ</given-names></name>
<name><surname>Jensen</surname><given-names>SO</given-names></name>
<name><surname>Vaska</surname><given-names>VL</given-names></name>
<name><surname>Espedido</surname><given-names>BA</given-names></name>
<name><surname>Paterson</surname><given-names>DL</given-names></name>
<etal>et al</etal>
</person-group><article-title>Predictors of mortality in <italic toggle="yes">Staphylococcus aureus</italic> bacteremia</article-title><source>Clin Microbiol Rev</source><year>2012</year><volume>25</volume><fpage>362</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1128/CMR.05022-11</pub-id><pub-id pub-id-type="pmid">22491776</pub-id>
</element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="other"><person-group person-group-type="author">
<name><surname>Nsonwu</surname><given-names>O</given-names></name>
<name><surname>Rooney</surname><given-names>G</given-names></name>
<name><surname>Chudasama</surname><given-names>D</given-names></name>
<name><surname>Thelwall</surname><given-names>S</given-names></name>
<name><surname>Hope</surname><given-names>R</given-names></name>
</person-group><article-title>Thirty-day all-cause mortality following MRSA, MSSA and gram-negative bacteraemia and C. difficile infections</article-title><year>2019</year></element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>S-P</given-names></name>
<name><surname>Chen</surname><given-names>Y-H</given-names></name>
<name><surname>Li</surname><given-names>H</given-names></name>
</person-group><article-title>Association between the levels of polyunsaturated fatty acids and blood lipids in healthy individuals</article-title><source>Exp Ther Med</source><year>2012</year><volume>4</volume><fpage>1107</fpage><lpage>1111</lpage><pub-id pub-id-type="doi">10.3892/etm.2012.724</pub-id><pub-id pub-id-type="pmid">23226783</pub-id>
</element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yanagisawa</surname><given-names>N</given-names></name>
<name><surname>Shimada</surname><given-names>K</given-names></name>
<name><surname>Miyazaki</surname><given-names>T</given-names></name>
<name><surname>Kume</surname><given-names>A</given-names></name>
<name><surname>Kitamura</surname><given-names>Y</given-names></name>
<etal>et al</etal>
</person-group><article-title>Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an Urban area</article-title><source>JAT</source><year>2010</year><volume>17</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.5551/jat.2618</pub-id></element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rouzer</surname><given-names>CA</given-names></name>
<name><surname>Ivanova</surname><given-names>PT</given-names></name>
<name><surname>Byrne</surname><given-names>MO</given-names></name>
<name><surname>Milne</surname><given-names>SB</given-names></name>
<name><surname>Marnett</surname><given-names>LJ</given-names></name>
<etal>et al</etal>
</person-group><article-title>Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: structural and functional implications</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>14795</fpage><lpage>14808</lpage><pub-id pub-id-type="doi">10.1021/bi061723j</pub-id><pub-id pub-id-type="pmid">17144673</pub-id>
</element-citation></ref><ref id="R35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dennis</surname><given-names>EA</given-names></name>
<name><surname>Norris</surname><given-names>PC</given-names></name>
</person-group><article-title>Eicosanoid storm in infection and inflammation</article-title><source>Nat Rev Immunol</source><year>2015</year><volume>15</volume><fpage>511</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/nri3859</pub-id><pub-id pub-id-type="pmid">26139350</pub-id>
</element-citation></ref><ref id="R36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Das</surname><given-names>UN</given-names></name>
</person-group><article-title>Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: a review</article-title><source>J Adv Res</source><year>2018</year><volume>11</volume><fpage>57</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.jare.2018.01.001</pub-id><pub-id pub-id-type="pmid">30034876</pub-id>
</element-citation></ref><ref id="R37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ahmad</surname><given-names>NS</given-names></name>
<name><surname>Tan</surname><given-names>TL</given-names></name>
<name><surname>Arifin</surname><given-names>KT</given-names></name>
<name><surname>Ngah</surname><given-names>WZW</given-names></name>
<name><surname>Yusof</surname><given-names>YAM</given-names></name>
</person-group><article-title>High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome</article-title><source>PLoS One</source><year>2020</year><volume>15</volume><elocation-id>e0230285</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0230285</pub-id><pub-id pub-id-type="pmid">32160261</pub-id>
</element-citation></ref><ref id="R38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amunugama</surname><given-names>K</given-names></name>
<name><surname>Pike</surname><given-names>DP</given-names></name>
<name><surname>Ford</surname><given-names>DA</given-names></name>
</person-group><article-title>The lipid biology of sepsis</article-title><source>J Lipid Res</source><year>2021</year><volume>62</volume><elocation-id>100090</elocation-id><pub-id pub-id-type="doi">10.1016/j.jlr.2021.100090</pub-id><pub-id pub-id-type="pmid">34087197</pub-id>
</element-citation></ref><ref id="R39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yamaguchi</surname><given-names>J</given-names></name>
<name><surname>Kinoshita</surname><given-names>K</given-names></name>
<name><surname>Ihara</surname><given-names>S</given-names></name>
<name><surname>Furukawa</surname><given-names>M</given-names></name>
<name><surname>Sakurai</surname><given-names>A</given-names></name>
</person-group><article-title>The clinical significance of low serum arachidonic acid in sepsis patients with hypoalbuminemia</article-title><source>Intern Med</source><year>2018</year><volume>57</volume><fpage>1833</fpage><lpage>1840</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.9124-17</pub-id><pub-id pub-id-type="pmid">29491308</pub-id>
</element-citation></ref><ref id="R40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Svahn</surname><given-names>SL</given-names></name>
<name><surname>Grahnemo</surname><given-names>L</given-names></name>
<name><surname>P&#x000e1;lsd&#x000f3;ttir</surname><given-names>V</given-names></name>
<name><surname>Nookaew</surname><given-names>I</given-names></name>
<name><surname>Wendt</surname><given-names>K</given-names></name>
<etal>et al</etal>
</person-group><article-title>Dietary polyunsaturated fatty acids increase survival and decrease bacterial load during septic <italic toggle="yes">Staphylococcus aureus</italic> infection and improve neutrophil function in mice</article-title><source>Infect Immun</source><year>2015</year><volume>83</volume><fpage>514</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1128/IAI.02349-14</pub-id><pub-id pub-id-type="pmid">25404025</pub-id>
</element-citation></ref><ref id="R41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Svahn</surname><given-names>SL</given-names></name>
<name><surname>Ulleryd</surname><given-names>MA</given-names></name>
<name><surname>Grahnemo</surname><given-names>L</given-names></name>
<name><surname>St&#x000e5;hlman</surname><given-names>M</given-names></name>
<name><surname>Bor&#x000e9;n</surname><given-names>J</given-names></name>
<etal>et al</etal>
</person-group><article-title>Dietary Omega-3 fatty acids increase survival and decrease bacterial load in mice subjected to <italic toggle="yes">Staphylococcus aureus-</italic> induced sepsis</article-title><source>Infect Immun</source><year>2016</year><volume>84</volume><fpage>1205</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1128/IAI.01391-15</pub-id><pub-id pub-id-type="pmid">26857576</pub-id>
</element-citation></ref><ref id="R42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strobel</surname><given-names>M</given-names></name>
<name><surname>Pf&#x000f6;rtner</surname><given-names>H</given-names></name>
<name><surname>Tuchscherr</surname><given-names>L</given-names></name>
<name><surname>V&#x000f6;lker</surname><given-names>U</given-names></name>
<name><surname>Schmidt</surname><given-names>F</given-names></name>
<etal>et al</etal>
</person-group><article-title>Post-invasion events after infection with <italic toggle="yes">Staphylococcus aureus</italic> are strongly dependent on both the host cell type and the infecting <italic toggle="yes">S. aureus</italic> strain</article-title><source>Clinc Microbiol Infect</source><year>2016</year><volume>22</volume><fpage>799</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2016.06.020</pub-id></element-citation></ref><ref id="R43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garzoni</surname><given-names>C</given-names></name>
<name><surname>Kelley</surname><given-names>WL</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic>: new evidence for intracellular persistence</article-title><source>Trends Microbiol</source><year>2009</year><volume>17</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2008.11.005</pub-id><pub-id pub-id-type="pmid">19208480</pub-id>
</element-citation></ref><ref id="R44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kubica</surname><given-names>M</given-names></name>
<name><surname>Guzik</surname><given-names>K</given-names></name>
<name><surname>Koziel</surname><given-names>J</given-names></name>
<name><surname>Zarebski</surname><given-names>M</given-names></name>
<name><surname>Richter</surname><given-names>W</given-names></name>
<etal>et al</etal>
</person-group><article-title>A potential new pathway for <italic toggle="yes">Staphylococcus aureus</italic> dissemination: the silent survival of <italic toggle="yes">S. aureus</italic> phagocytosed by human monocyte-derived macrophages</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><elocation-id>e1409</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0001409</pub-id><pub-id pub-id-type="pmid">18183290</pub-id>
</element-citation></ref><ref id="R45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gresham</surname><given-names>HD</given-names></name>
<name><surname>Lowrance</surname><given-names>JH</given-names></name>
<name><surname>Caver</surname><given-names>TE</given-names></name>
<name><surname>Wilson</surname><given-names>BS</given-names></name>
<name><surname>Cheung</surname><given-names>AL</given-names></name>
<etal>et al</etal>
</person-group><article-title>Survival of <italic toggle="yes">Staphylococcus aureus</italic> inside neutrophils contributes to infection</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>3713</fpage><lpage>3722</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.164.7.3713</pub-id><pub-id pub-id-type="pmid">10725730</pub-id>
</element-citation></ref><ref id="R46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Horn</surname><given-names>J</given-names></name>
<name><surname>Stelzner</surname><given-names>K</given-names></name>
<name><surname>Rudel</surname><given-names>T</given-names></name>
<name><surname>Fraunholz</surname><given-names>M</given-names></name>
</person-group><article-title>Inside job: <italic toggle="yes">Staphylococcus aureus</italic> host-pathogen interactions</article-title><source>Int J Med Microbiol</source><year>2018</year><volume>308</volume><fpage>607</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2017.11.009</pub-id><pub-id pub-id-type="pmid">29217333</pub-id>
</element-citation></ref><ref id="R47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flannagan</surname><given-names>RS</given-names></name>
<name><surname>Heit</surname><given-names>B</given-names></name>
<name><surname>Heinrichs</surname><given-names>DE</given-names></name>
</person-group><article-title>Intracellular replication of <italic toggle="yes">Staphylococcus aureus</italic> in mature phagolysosomes in macrophages precedes host cell death, and bacterial escape and dissemination</article-title><source>Cell Microbiol</source><year>2016</year><volume>18</volume><fpage>514</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1111/cmi.12527</pub-id><pub-id pub-id-type="pmid">26408990</pub-id>
</element-citation></ref><ref id="R48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Surewaard</surname><given-names>BGJ</given-names></name>
<name><surname>Deniset</surname><given-names>JF</given-names></name>
<name><surname>Zemp</surname><given-names>FJ</given-names></name>
<name><surname>Amrein</surname><given-names>M</given-names></name>
<name><surname>Otto</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>Identification and treatment of the <italic toggle="yes">Staphylococcus aureus</italic> reservoir in vivo</article-title><source>J Exp Med</source><year>2016</year><volume>213</volume><fpage>1141</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1084/jem.20160334</pub-id><pub-id pub-id-type="pmid">27325887</pub-id>
</element-citation></ref><ref id="R49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jorch</surname><given-names>SK</given-names></name>
<name><surname>Surewaard</surname><given-names>BG</given-names></name>
<name><surname>Hossain</surname><given-names>M</given-names></name>
<name><surname>Peiseler</surname><given-names>M</given-names></name>
<name><surname>Deppermann</surname><given-names>C</given-names></name>
<etal>et al</etal>
</person-group><article-title>Peritoneal GATA6+ macrophages function as a portal for <italic toggle="yes">Staphylococcus aureus</italic> dissemination</article-title><source>J Clin Invest</source><year>2019</year><volume>129</volume><fpage>4643</fpage><lpage>4656</lpage><pub-id pub-id-type="doi">10.1172/JCI127286</pub-id><pub-id pub-id-type="pmid">31545300</pub-id>
</element-citation></ref><ref id="R50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pollitt</surname><given-names>EJG</given-names></name>
<name><surname>Szkuta</surname><given-names>PT</given-names></name>
<name><surname>Burns</surname><given-names>N</given-names></name>
<name><surname>Foster</surname><given-names>SJ</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> infection dynamics</article-title><source>PLoS Pathog</source><year>2018</year><volume>14</volume><elocation-id>e1007112</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007112</pub-id><pub-id pub-id-type="pmid">29902272</pub-id>
</element-citation></ref><ref id="R51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>B</given-names></name>
<name><surname>Fung</surname><given-names>K</given-names></name>
<name><surname>Ye</surname><given-names>S</given-names></name>
<name><surname>Lai</surname><given-names>P-M</given-names></name>
<name><surname>Wei</surname><given-names>YX</given-names></name>
<etal>et al</etal>
</person-group><article-title>Linoleic acid metabolism activation in macrophages promotes the clearing of intracellular <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Chem Sci</source><year>2022</year><volume>13</volume><fpage>12445</fpage><lpage>12460</lpage><pub-id pub-id-type="doi">10.1039/D2SC04307F</pub-id><pub-id pub-id-type="pmid">36382278</pub-id>
</element-citation></ref><ref id="R52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karygianni</surname><given-names>L</given-names></name>
<name><surname>Ren</surname><given-names>Z</given-names></name>
<name><surname>Koo</surname><given-names>H</given-names></name>
<name><surname>Thurnheer</surname><given-names>T</given-names></name>
</person-group><article-title>Biofilm matrixome: extracellular components in structured microbial communities</article-title><source>Trends Microbiol</source><year>2020</year><volume>28</volume><fpage>668</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2020.03.016</pub-id><pub-id pub-id-type="pmid">32663461</pub-id>
</element-citation></ref><ref id="R53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>H</given-names></name>
<name><surname>Tong</surname><given-names>Y</given-names></name>
<name><surname>Cheng</surname><given-names>J</given-names></name>
<name><surname>Abbas</surname><given-names>Z</given-names></name>
<name><surname>Li</surname><given-names>Z</given-names></name>
<etal>et al</etal>
</person-group><article-title>Biofilm and small colony variants-an update on <italic toggle="yes">Staphylococcus aureus</italic> strategies toward drug resistance</article-title><source>Int J Mol Sci</source><year>2022</year><volume>23</volume><elocation-id>1241</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23031241</pub-id><pub-id pub-id-type="pmid">35163165</pub-id>
</element-citation></ref><ref id="R54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stenz</surname><given-names>L</given-names></name>
<name><surname>Fran&#x000e7;ois</surname><given-names>P</given-names></name>
<name><surname>Fischer</surname><given-names>A</given-names></name>
<name><surname>Huyghe</surname><given-names>A</given-names></name>
<name><surname>Tangomo</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>Impact of oleic acid (cis-9-octadecenoic acid) on bacterial viability and biofilm production in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>FEMS Microbiol Lett</source><year>2008</year><volume>287</volume><fpage>149</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2008.01316.x</pub-id><pub-id pub-id-type="pmid">18754790</pub-id>
</element-citation></ref><ref id="R55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>Y-G</given-names></name>
<name><surname>Lee</surname><given-names>J-H</given-names></name>
<name><surname>Raorane</surname><given-names>CJ</given-names></name>
<name><surname>Oh</surname><given-names>ST</given-names></name>
<name><surname>Park</surname><given-names>JG</given-names></name>
<etal>et al</etal>
</person-group><article-title>Herring oil and omega fatty acids inhibit <italic toggle="yes">Staphylococcus aureus</italic> biofilm formation and virulence</article-title><source>Front Microbiol</source><year>2018</year><volume>9</volume><elocation-id>1241</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.01241</pub-id><pub-id pub-id-type="pmid">29963020</pub-id>
</element-citation></ref><ref id="R56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>JH</given-names></name>
<name><surname>Kim</surname><given-names>YG</given-names></name>
</person-group><article-title>Lee J. inhibition of <italic toggle="yes">Staphylococcus aureus</italic> biofilm formation and virulence factor production by petroselinic acid and other unsaturated C18 fatty acids</article-title><source>Microbiol Spectr</source><year>2022</year><volume>10</volume><issue>3</issue><elocation-id>e0133022</elocation-id><pub-id pub-id-type="pmid">35647620</pub-id>
</element-citation></ref><ref id="R57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>L</given-names></name>
<name><surname>Zhang</surname><given-names>L-H</given-names></name>
<name><surname>C&#x000e1;mara</surname><given-names>M</given-names></name>
<name><surname>He</surname><given-names>Y-W</given-names></name>
</person-group><article-title>The DSF family of quorum sensing signals: diversity, biosynthesis, and turnover</article-title><source>Trends Microbiol</source><year>2017</year><volume>25</volume><fpage>293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2016.11.013</pub-id><pub-id pub-id-type="pmid">27979499</pub-id>
</element-citation></ref><ref id="R58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>RP</given-names></name>
<name><surname>An</surname><given-names>S</given-names></name>
<name><surname>Allan</surname><given-names>JH</given-names></name>
<name><surname>McCarthy</surname><given-names>Y</given-names></name>
<name><surname>Dow</surname><given-names>JM</given-names></name>
</person-group><article-title>The DSF family of cell-cell signals: an expanding class of bacterial virulence regulators</article-title><source>PLoS Pathog</source><year>2015</year><volume>11</volume><elocation-id>e1004986</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004986</pub-id><pub-id pub-id-type="pmid">26181439</pub-id>
</element-citation></ref><ref id="R59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jennings</surname><given-names>JA</given-names></name>
<name><surname>Courtney</surname><given-names>HS</given-names></name>
<name><surname>Haggard</surname><given-names>WO</given-names></name>
</person-group><article-title>Cis-2-decenoic acid inhibits <italic toggle="yes">S. aureus</italic> growth and biofilm in vitro: a pilot study</article-title><source>Clin Orthop Relat Res</source><year>2012</year><volume>470</volume><fpage>2663</fpage><lpage>2670</lpage><pub-id pub-id-type="doi">10.1007/s11999-012-2388-2</pub-id><pub-id pub-id-type="pmid">22585351</pub-id>
</element-citation></ref><ref id="R60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Greenway</surname><given-names>DL</given-names></name>
<name><surname>Dyke</surname><given-names>KG</given-names></name>
</person-group><article-title>Mechanism of the inhibitory action of linoleic acid on the growth of <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Gen Microbiol</source><year>1979</year><volume>115</volume><issue>1</issue><fpage>233</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">93615</pub-id>
</element-citation></ref><ref id="R61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Knapp</surname><given-names>HR</given-names></name>
<name><surname>Melly</surname><given-names>MA</given-names></name>
</person-group><article-title>Bactericidal effects of polyunsaturated fatty acids</article-title><source>J Infect Dis</source><year>1986</year><volume>154</volume><issue>1</issue><fpage>84</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">3086465</pub-id>
</element-citation></ref><ref id="R62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Desbois</surname><given-names>AP</given-names></name>
<name><surname>Smith</surname><given-names>VJ</given-names></name>
</person-group><article-title>Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential</article-title><source>Appl Microbiol Biotechnol</source><year>2010</year><volume>85</volume><fpage>1629</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1007/s00253-009-2355-3</pub-id><pub-id pub-id-type="pmid">19956944</pub-id>
</element-citation></ref><ref id="R63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>H&#x00105;c-Wydro</surname><given-names>K</given-names></name>
<name><surname>Wydro</surname><given-names>P</given-names></name>
</person-group><article-title>The influence of fatty acids on model cholesterol/phospholipid membranes</article-title><source>Chemistry and Physics of Lipids</source><year>2007</year><volume>150</volume><fpage>66</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.chemphyslip.2007.06.213</pub-id><pub-id pub-id-type="pmid">17651712</pub-id>
</element-citation></ref><ref id="R64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bayer</surname><given-names>AS</given-names></name>
<name><surname>Prasad</surname><given-names>R</given-names></name>
<name><surname>Chandra</surname><given-names>J</given-names></name>
<name><surname>Koul</surname><given-names>A</given-names></name>
<name><surname>Smriti</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>In Vitro Resistance of <italic toggle="yes">Staphylococcus aureus</italic> to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity</article-title><source>Infect Immun</source><year>2000</year><volume>68</volume><fpage>3548</fpage><lpage>3553</lpage><pub-id pub-id-type="doi">10.1128/IAI.68.6.3548-3553.2000</pub-id><pub-id pub-id-type="pmid">10816510</pub-id>
</element-citation></ref><ref id="R65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parsons</surname><given-names>JB</given-names></name>
<name><surname>Yao</surname><given-names>J</given-names></name>
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>Jackson</surname><given-names>P</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title>Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><issue>19</issue><fpage>5294</fpage><lpage>304</lpage><pub-id pub-id-type="pmid">22843840</pub-id>
</element-citation></ref><ref id="R66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kenny</surname><given-names>JG</given-names></name>
<name><surname>Ward</surname><given-names>D</given-names></name>
<name><surname>Josefsson</surname><given-names>E</given-names></name>
<name><surname>Jonsson</surname><given-names>I-M</given-names></name>
<name><surname>Hinds</surname><given-names>J</given-names></name>
<etal>et al</etal>
</person-group><article-title>The <italic toggle="yes">Staphylococcus aureus</italic> response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><elocation-id>e4344</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0004344</pub-id><pub-id pub-id-type="pmid">19183815</pub-id>
</element-citation></ref><ref id="R67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chamberlain</surname><given-names>NR</given-names></name>
<name><surname>Mehrtens</surname><given-names>BG</given-names></name>
<name><surname>Xiong</surname><given-names>Z</given-names></name>
<name><surname>Kapral</surname><given-names>FA</given-names></name>
<name><surname>Boardman</surname><given-names>JL</given-names></name>
<name><surname>Rearick</surname><given-names>JI</given-names></name>
</person-group><article-title>Correlation of carotenoid production, decreased membrane fluidity, and resistance to oleic acid killing in <italic toggle="yes">Staphylococcus aureus</italic> 18Z</article-title><source>Infect Immun</source><year>1991</year><volume>59</volume><issue>12</issue><fpage>4332</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1937793</pub-id>
</element-citation></ref><ref id="R68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xiong</surname><given-names>Z</given-names></name>
<name><surname>Kapral</surname><given-names>FA</given-names></name>
</person-group><article-title>Carotenoid pigment levels in <italic toggle="yes">Staphylococcus aureus</italic> and sensitivity to oleic acid</article-title><source>J Med Microbiol</source><year>1992</year><volume>37</volume><fpage>192</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1099/00222615-37-3-192</pub-id><pub-id pub-id-type="pmid">1518034</pub-id>
</element-citation></ref><ref id="R69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopez</surname><given-names>MS</given-names></name>
<name><surname>Tan</surname><given-names>IS</given-names></name>
<name><surname>Yan</surname><given-names>D</given-names></name>
<name><surname>Kang</surname><given-names>J</given-names></name>
<name><surname>McCreary</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>Host-derived fatty acids activate type VII secretion in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2017</year><volume>114</volume><fpage>11223</fpage><lpage>11228</lpage><pub-id pub-id-type="doi">10.1073/pnas.1700627114</pub-id><pub-id pub-id-type="pmid">28973946</pub-id>
</element-citation></ref><ref id="R70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>DeMars</surname><given-names>Z</given-names></name>
<name><surname>Singh</surname><given-names>VK</given-names></name>
<name><surname>Bose</surname><given-names>JL</given-names></name>
</person-group><article-title>Exogenous fatty acids remodel <italic toggle="yes">Staphylococcus aureus</italic> lipid composition through fatty acid kinase</article-title><source>J Bacteriol</source><year>2020</year><volume>202</volume><elocation-id>e00128-20</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00128-20</pub-id><pub-id pub-id-type="pmid">32366591</pub-id>
</element-citation></ref><ref id="R71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arouri</surname><given-names>A</given-names></name>
<name><surname>Mouritsen</surname><given-names>OG</given-names></name>
</person-group><article-title>Membrane-perturbing effect of fatty acids and lysolipids</article-title><source>Prog Lipid Res</source><year>2013</year><volume>52</volume><fpage>130</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2012.09.002</pub-id><pub-id pub-id-type="pmid">23117036</pub-id>
</element-citation></ref><ref id="R72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arouri</surname><given-names>A</given-names></name>
<name><surname>Lauritsen</surname><given-names>KE</given-names></name>
<name><surname>Nielsen</surname><given-names>HL</given-names></name>
<name><surname>Mouritsen</surname><given-names>OG</given-names></name>
</person-group><article-title>Effect of fatty acids on the permeability barrier of model and biological membranes</article-title><source>Chem Phys Lipids</source><year>2016</year><volume>200</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.chemphyslip.2016.10.001</pub-id><pub-id pub-id-type="pmid">27725161</pub-id>
</element-citation></ref><ref id="R73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walker</surname><given-names>JE</given-names></name>
</person-group><article-title>The ATP synthase: the understood, the uncertain and the unknown</article-title><source>Biochem Soc Trans</source><year>2013</year><volume>41</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1042/BST20110773</pub-id><pub-id pub-id-type="pmid">23356252</pub-id>
</element-citation></ref><ref id="R74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boyer</surname><given-names>PD</given-names></name>
</person-group><article-title>The ATP synthase--a splendid molecular machine</article-title><source>Annu Rev Biochem</source><year>1997</year><volume>66</volume><fpage>717</fpage><lpage>749</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.66.1.717</pub-id><pub-id pub-id-type="pmid">9242922</pub-id>
</element-citation></ref><ref id="R75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Skulachev</surname><given-names>VP</given-names></name>
</person-group><article-title>Anion carriers in fatty acid-mediated physiological uncoupling</article-title><source>J Bioenerg Biomembr</source><year>1999</year><volume>31</volume><fpage>431</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">10653472</pub-id>
</element-citation></ref><ref id="R76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Skulachev</surname><given-names>VP</given-names></name>
</person-group><article-title>Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation</article-title><source>FEBS Letters</source><year>1991</year><volume>294</volume><fpage>158</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/0014-5793(91)80658-P</pub-id><pub-id pub-id-type="pmid">1756853</pub-id>
</element-citation></ref><ref id="R77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ruhr</surname><given-names>E</given-names></name>
<name><surname>Sahl</surname><given-names>HG</given-names></name>
</person-group><article-title>Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles</article-title><source>Antimicrob Agents Chemother</source><year>1985</year><volume>27</volume><fpage>841</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1128/AAC.27.5.841</pub-id><pub-id pub-id-type="pmid">4015074</pub-id>
</element-citation></ref><ref id="R78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raafat</surname><given-names>D</given-names></name>
<name><surname>von Bargen</surname><given-names>K</given-names></name>
<name><surname>Haas</surname><given-names>A</given-names></name>
</person-group><article-title>Insights into the mode of action of chitosan as an antibacterial compound</article-title><source>Appl Environ Microbiol</source><year>2008</year><volume>74(12)</volume><fpage>3764</fpage><lpage>3773</lpage><pub-id pub-id-type="pmid">18456858</pub-id>
</element-citation></ref><ref id="R79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>Y-M</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title>Membrane lipid homeostasis in bacteria</article-title><source>Nat Rev Microbiol</source><year>2008</year><volume>6</volume><fpage>222</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1839</pub-id><pub-id pub-id-type="pmid">18264115</pub-id>
</element-citation></ref><ref id="R80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wright</surname><given-names>HT</given-names></name>
<name><surname>Reynolds</surname><given-names>KA</given-names></name>
</person-group><article-title>Antibacterial targets in fatty acid biosynthesis</article-title><source>Curr Opin Microbiol</source><year>2007</year><volume>10</volume><fpage>447</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2007.07.001</pub-id><pub-id pub-id-type="pmid">17707686</pub-id>
</element-citation></ref><ref id="R81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balemans</surname><given-names>W</given-names></name>
<name><surname>Lounis</surname><given-names>N</given-names></name>
<name><surname>Gilissen</surname><given-names>R</given-names></name>
<name><surname>Guillemont</surname><given-names>J</given-names></name>
<name><surname>Simmen</surname><given-names>K</given-names></name>
<etal>et al</etal>
</person-group><article-title>Essentiality of FASII pathway for <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Nature</source><year>2010</year><volume>463</volume><fpage>E3</fpage><lpage>E4</lpage><pub-id pub-id-type="doi">10.1038/nature08667</pub-id><pub-id pub-id-type="pmid">20090698</pub-id>
</element-citation></ref><ref id="R82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Douglas</surname><given-names>EJA</given-names></name>
<name><surname>Wulandari</surname><given-names>SW</given-names></name>
<name><surname>Lovell</surname><given-names>SD</given-names></name>
<name><surname>Laabei</surname><given-names>M</given-names></name>
</person-group><article-title>Novel antimicrobial strategies to treat multi-drug resistant <italic toggle="yes">Staphylococcus aureus</italic> infections</article-title><source>Microb Biotechnol</source><year>2023</year><volume>16</volume><fpage>1456</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.14268</pub-id><pub-id pub-id-type="pmid">37178319</pub-id>
</element-citation></ref><ref id="R83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>CJ</given-names></name>
<name><surname>Yoo</surname><given-names>J-S</given-names></name>
<name><surname>Lee</surname><given-names>T-G</given-names></name>
<name><surname>Cho</surname><given-names>H-Y</given-names></name>
<name><surname>Kim</surname><given-names>Y-H</given-names></name>
<etal>et al</etal>
</person-group><article-title>Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids</article-title><source>FEBS Lett</source><year>2005</year><volume>579</volume><fpage>5157</fpage><lpage>5162</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2005.08.028</pub-id><pub-id pub-id-type="pmid">16146629</pub-id>
</element-citation></ref><ref id="R84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fan</surname><given-names>F</given-names></name>
<name><surname>Yan</surname><given-names>K</given-names></name>
<name><surname>Wallis</surname><given-names>NG</given-names></name>
<name><surname>Reed</surname><given-names>S</given-names></name>
<name><surname>Moore</surname><given-names>TD</given-names></name>
<etal>et al</etal>
</person-group><article-title>Defining and combating the mechanisms of triclosan resistance in clinical isolates of <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>2002</year><volume>46</volume><fpage>3343</fpage><lpage>3347</lpage><pub-id pub-id-type="doi">10.1128/AAC.46.11.3343-3347.2002</pub-id><pub-id pub-id-type="pmid">12384334</pub-id>
</element-citation></ref><ref id="R85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>J</given-names></name>
<name><surname>Maxwell</surname><given-names>JB</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title>Resistance to AFN-1252 arises from missense mutations in <italic toggle="yes">Staphylococcus aureus</italic> enoyl-acyl carrier protein reductase (FabI)</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>36261</fpage><lpage>36271</lpage><pub-id pub-id-type="doi">10.1074/jbc.M113.512905</pub-id><pub-id pub-id-type="pmid">24189061</pub-id>
</element-citation></ref><ref id="R86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grandgirard</surname><given-names>D</given-names></name>
<name><surname>Furi</surname><given-names>L</given-names></name>
<name><surname>Ciusa</surname><given-names>ML</given-names></name>
<name><surname>Baldassarri</surname><given-names>L</given-names></name>
<name><surname>Knight</surname><given-names>DR</given-names></name>
<etal>et al</etal>
</person-group><article-title>Mutations upstream of fabI in triclosan resistant <italic toggle="yes">Staphylococcus aureus</italic> strains are associated with elevated fabI gene expression</article-title><source>BMC Genomics</source><year>2015</year><volume>16</volume><elocation-id>345</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-015-1544-y</pub-id><pub-id pub-id-type="pmid">25924916</pub-id>
</element-citation></ref><ref id="R87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parsons</surname><given-names>JB</given-names></name>
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>Subramanian</surname><given-names>C</given-names></name>
<name><surname>Saenkham</surname><given-names>P</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title>Metabolic basis for the differential susceptibility of gram-positive pathogens to fatty acid synthesis inhibitors</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>15378</fpage><lpage>15383</lpage><pub-id pub-id-type="doi">10.1073/pnas.1109208108</pub-id><pub-id pub-id-type="pmid">21876172</pub-id>
</element-citation></ref><ref id="R88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parsons</surname><given-names>JB</given-names></name>
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>Rosch</surname><given-names>JW</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> fatty acid auxotrophs do not proliferate in mice</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><fpage>5729</fpage><lpage>5732</lpage><pub-id pub-id-type="doi">10.1128/AAC.01038-13</pub-id><pub-id pub-id-type="pmid">23979734</pub-id>
</element-citation></ref><ref id="R89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Altwiley</surname><given-names>D</given-names></name>
<name><surname>Brignoli</surname><given-names>T</given-names></name>
<name><surname>Duggan</surname><given-names>S</given-names></name>
<name><surname>Massey</surname><given-names>RC</given-names></name>
</person-group><article-title>Triclosan-resistant small-colony variants of <italic toggle="yes">Staphylococcus aureus</italic> produce less capsule, less phenol-soluble modulins, and are attenuated in a <italic toggle="yes">Galleria mellonella</italic> model of infection</article-title><source>Microbiology</source><year>2023</year><volume>169</volume><elocation-id>001277</elocation-id><pub-id pub-id-type="doi">10.1099/mic.0.001277</pub-id><pub-id pub-id-type="pmid">36748621</pub-id>
</element-citation></ref><ref id="R90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morvan</surname><given-names>C</given-names></name>
<name><surname>Halpern</surname><given-names>D</given-names></name>
<name><surname>K&#x000e9;nanian</surname><given-names>G</given-names></name>
<name><surname>Hays</surname><given-names>C</given-names></name>
<name><surname>Anba-Mondoloni</surname><given-names>J</given-names></name>
<etal>et al</etal>
</person-group><article-title>Environmental fatty acids enable emergence of infectious <italic toggle="yes">Staphylococcus aureus</italic> resistant to FASII-targeted antimicrobials</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><elocation-id>12944</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12944</pub-id><pub-id pub-id-type="pmid">27703138</pub-id>
</element-citation></ref><ref id="R91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>K&#x000e9;nanian</surname><given-names>G</given-names></name>
<name><surname>Morvan</surname><given-names>C</given-names></name>
<name><surname>Weckel</surname><given-names>A</given-names></name>
<name><surname>Pathania</surname><given-names>A</given-names></name>
<name><surname>Anba-Mondoloni</surname><given-names>J</given-names></name>
<etal>et al</etal>
</person-group><article-title>Permissive fatty acid incorporation promotes staphylococcal adaptation to FASII antibiotics in host environments</article-title><source>Cell Rep</source><year>2019</year><volume>29</volume><fpage>3974</fpage><lpage>3982</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.11.071</pub-id><pub-id pub-id-type="pmid">31851927</pub-id>
</element-citation></ref><ref id="R92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ayala</surname><given-names>A</given-names></name>
<name><surname>Mu&#x000f1;oz</surname><given-names>MF</given-names></name>
<name><surname>Arg&#x000fc;elles</surname><given-names>S</given-names></name>
</person-group><article-title>Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal</article-title><source>Oxid Med Cell Longev</source><year>2014</year><volume>2014</volume><elocation-id>360438</elocation-id><pub-id pub-id-type="doi">10.1155/2014/360438</pub-id><pub-id pub-id-type="pmid">24999379</pub-id>
</element-citation></ref><ref id="R93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gutteridge</surname><given-names>JMC</given-names></name>
<name><surname>Lamport</surname><given-names>P</given-names></name>
<name><surname>Dormandy</surname><given-names>TL</given-names></name>
</person-group><article-title>Autoxidation as a cause of antibacterial activity in unsaturated fatty acids</article-title><source>J Med Microbiol</source><year>1974</year><volume>7</volume><fpage>387</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1099/00222615-7-3-387</pub-id><pub-id pub-id-type="pmid">4371778</pub-id>
</element-citation></ref><ref id="R94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yin</surname><given-names>H</given-names></name>
<name><surname>Xu</surname><given-names>L</given-names></name>
<name><surname>Porter</surname><given-names>NA</given-names></name>
</person-group><article-title>Free radical lipid peroxidation: mechanisms and analysis</article-title><source>Chem rev</source><year>2011</year><volume>111</volume><fpage>5944</fpage><lpage>5972</lpage><pub-id pub-id-type="doi">10.1021/cr200084z</pub-id><pub-id pub-id-type="pmid">21861450</pub-id>
</element-citation></ref><ref id="R95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beavers</surname><given-names>WN</given-names></name>
<name><surname>Monteith</surname><given-names>AJ</given-names></name>
<name><surname>Amarnath</surname><given-names>V</given-names></name>
<name><surname>Mernaugh</surname><given-names>RL</given-names></name>
<name><surname>Roberts</surname><given-names>LJ</given-names><suffix>2nd</suffix></name>
<etal>et al</etal>
</person-group><article-title>Arachidonic acid kills <italic toggle="yes">Staphylococcus aureus</italic> through a lipid peroxidation mechanism</article-title><source>mBio</source><year>2019</year><volume>10</volume><elocation-id>e01333-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01333-19</pub-id><pub-id pub-id-type="pmid">31575763</pub-id>
</element-citation></ref><ref id="R96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Neumann</surname><given-names>Y</given-names></name>
<name><surname>Ohlsen</surname><given-names>K</given-names></name>
<name><surname>Donat</surname><given-names>S</given-names></name>
<name><surname>Engelmann</surname><given-names>S</given-names></name>
<name><surname>Kusch</surname><given-names>H</given-names></name>
<etal>et al</etal>
</person-group><article-title>The effect of skin fatty acids on <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Arch Microbiol</source><year>2015</year><volume>197</volume><fpage>245</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1007/s00203-014-1048-1</pub-id><pub-id pub-id-type="pmid">25325933</pub-id>
</element-citation></ref><ref id="R97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Douglas</surname><given-names>EJ</given-names></name>
<name><surname>Palk</surname><given-names>N</given-names></name>
<name><surname>Brignoli</surname><given-names>T</given-names></name>
<name><surname>Altwiley</surname><given-names>D</given-names></name>
<name><surname>Boura</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>Extensive remodelling of the cell wall during the development of <italic toggle="yes">Staphylococcus aureus</italic> bacteraemia</article-title><source>Elife</source><year>2023</year><volume>12</volume><pub-id pub-id-type="doi">10.7554/eLife.87026.3</pub-id></element-citation></ref><ref id="R98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qoronfleh</surname><given-names>MW</given-names></name>
<name><surname>Gustafson</surname><given-names>JE</given-names></name>
<name><surname>Wilkinson</surname><given-names>BJ</given-names></name>
</person-group><article-title>Conditions that induce <italic toggle="yes">Staphylococcus aureus</italic> heat shock proteins also inhibit autolysis</article-title><source>FEMS Microbiology Letters</source><year>1988</year><fpage>103</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.1998.tb13189.x</pub-id></element-citation></ref><ref id="R99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Biswas</surname><given-names>R</given-names></name>
<name><surname>Voggu</surname><given-names>L</given-names></name>
<name><surname>Simon</surname><given-names>UK</given-names></name>
<name><surname>Hentschel</surname><given-names>P</given-names></name>
<name><surname>Thumm</surname><given-names>G</given-names></name>
<etal>et al</etal>
</person-group><article-title>Activity of the major staphylococcal autolysin Atl</article-title><source>FEMS Microbiol Lett</source><year>2006</year><volume>259</volume><fpage>260</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2006.00281.x</pub-id><pub-id pub-id-type="pmid">16734789</pub-id>
</element-citation></ref><ref id="R100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanabria-R&#x000ed;os</surname><given-names>DJ</given-names></name>
<name><surname>Rivera-Torres</surname><given-names>Y</given-names></name>
<name><surname>Rosario</surname><given-names>J</given-names></name>
<name><surname>Gutierrez</surname><given-names>R</given-names></name>
<name><surname>Torres-Garc&#x000ed;a</surname><given-names>Y</given-names></name>
<etal>et al</etal>
</person-group><article-title>Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria</article-title><source>Bioorg Med Chem Lett</source><year>2015</year><volume>25</volume><fpage>5067</fpage><lpage>5071</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2015.10.022</pub-id><pub-id pub-id-type="pmid">26483137</pub-id>
</element-citation></ref><ref id="R101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Visansirikul</surname><given-names>S</given-names></name>
<name><surname>Kolodziej</surname><given-names>SA</given-names></name>
<name><surname>Demchenko</surname><given-names>AV</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> capsular polysaccharides: a structural and synthetic perspective</article-title><source>Org Biomol Chem</source><year>2020</year><volume>18</volume><fpage>783</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1039/c9ob02546d</pub-id><pub-id pub-id-type="pmid">31922180</pub-id>
</element-citation></ref><ref id="R102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mortensen</surname><given-names>JE</given-names></name>
<name><surname>Kapral</surname><given-names>FA</given-names></name>
</person-group><article-title>Effect of capsulation on the resistance of <italic toggle="yes">Staphylococcus aureus</italic> to the bactericidal lipids produced in abscesses</article-title><source>J Med Microbiol</source><year>1992</year><volume>36</volume><fpage>337</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1099/00222615-36-5-337</pub-id><pub-id pub-id-type="pmid">1588584</pub-id>
</element-citation></ref><ref id="R103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Key</surname><given-names>FM</given-names></name>
<name><surname>Khadka</surname><given-names>VD</given-names></name>
<name><surname>Romo-Gonz&#x000e1;lez</surname><given-names>C</given-names></name>
<name><surname>Blake</surname><given-names>KJ</given-names></name>
<name><surname>Deng</surname><given-names>L</given-names></name>
<etal>et al</etal>
</person-group><article-title>On-person adaptive evolution of <italic toggle="yes">Staphylococcus aureus</italic> during treatment for atopic dermatitis</article-title><source>Cell Host Microbe</source><year>2023</year><volume>31</volume><fpage>593</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2023.03.009</pub-id><pub-id pub-id-type="pmid">37054679</pub-id>
</element-citation></ref><ref id="R104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Neuhaus</surname><given-names>FC</given-names></name>
<name><surname>Baddiley</surname><given-names>J</given-names></name>
</person-group><article-title>A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria</article-title><source>Microbiol Mol Biol Rev</source><year>2003</year><volume>67</volume><fpage>686</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1128/MMBR.67.4.686-723.2003</pub-id><pub-id pub-id-type="pmid">14665680</pub-id>
</element-citation></ref><ref id="R105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Dalen</surname><given-names>R</given-names></name>
<name><surname>Peschel</surname><given-names>A</given-names></name>
<name><surname>van Sorge</surname><given-names>NM</given-names></name>
</person-group><article-title>Wall teichoic acid in <italic toggle="yes">Staphylococcus aureus</italic> host interaction</article-title><source>Trends Microbiol</source><year>2020</year><volume>28</volume><fpage>985</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2020.05.017</pub-id><pub-id pub-id-type="pmid">32540314</pub-id>
</element-citation></ref><ref id="R106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weidenmaier</surname><given-names>C</given-names></name>
<name><surname>Kokai-Kun</surname><given-names>JF</given-names></name>
<name><surname>Kristian</surname><given-names>SA</given-names></name>
<name><surname>Chanturiya</surname><given-names>T</given-names></name>
<name><surname>Kalbacher</surname><given-names>H</given-names></name>
<etal>et al</etal>
</person-group><article-title>Role of teichoic acids in <italic toggle="yes">Staphylococcus aureus</italic> nasal colonization, a major risk factor in nosocomial infections</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>243</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1038/nm991</pub-id><pub-id pub-id-type="pmid">14758355</pub-id>
</element-citation></ref><ref id="R107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kohler</surname><given-names>T</given-names></name>
<name><surname>Weidenmaier</surname><given-names>C</given-names></name>
<name><surname>Peschel</surname><given-names>A</given-names></name>
</person-group><article-title>Wall teichoic acid protects <italic toggle="yes">Staphylococcus aureus</italic> against antimicrobial fatty acids from human skin</article-title><source>J Bacteriol</source><year>2009</year><volume>191</volume><fpage>4482</fpage><lpage>4484</lpage><pub-id pub-id-type="doi">10.1128/JB.00221-09</pub-id><pub-id pub-id-type="pmid">19429623</pub-id>
</element-citation></ref><ref id="R108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schaefer</surname><given-names>K</given-names></name>
<name><surname>Matano</surname><given-names>LM</given-names></name>
<name><surname>Qiao</surname><given-names>Y</given-names></name>
<name><surname>Kahne</surname><given-names>D</given-names></name>
<name><surname>Walker</surname><given-names>S</given-names></name>
</person-group><article-title>In vitro reconstitution demonstrates the cell wall ligase activity of LCP proteins</article-title><source>Nat Chem Biol</source><year>2017</year><volume>13</volume><fpage>396</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2302</pub-id><pub-id pub-id-type="pmid">28166208</pub-id>
</element-citation></ref><ref id="R109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schaefer</surname><given-names>K</given-names></name>
<name><surname>Owens</surname><given-names>TW</given-names></name>
<name><surname>Kahne</surname><given-names>D</given-names></name>
<name><surname>Walker</surname><given-names>S</given-names></name>
</person-group><article-title>Substrate preferences establish the order of cell wall assembly in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Am Chem Soc</source><year>2018</year><volume>140</volume><fpage>2442</fpage><lpage>2445</lpage><pub-id pub-id-type="doi">10.1021/jacs.7b13551</pub-id><pub-id pub-id-type="pmid">29402087</pub-id>
</element-citation></ref><ref id="R110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chan</surname><given-names>YGY</given-names></name>
<name><surname>Frankel</surname><given-names>MB</given-names></name>
<name><surname>Dengler</surname><given-names>V</given-names></name>
<name><surname>Schneewind</surname><given-names>O</given-names></name>
<name><surname>Missiakas</surname><given-names>D</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> mutants lacking the LytR-CpsA-Psr family of enzymes release cell wall teichoic acids into the extracellular medium</article-title><source>J Bacteriol</source><year>2013</year><volume>195</volume><fpage>4650</fpage><lpage>4659</lpage><pub-id pub-id-type="doi">10.1128/JB.00544-13</pub-id><pub-id pub-id-type="pmid">23935043</pub-id>
</element-citation></ref><ref id="R111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>SR</given-names></name>
<name><surname>Wiltshire</surname><given-names>MD</given-names></name>
<name><surname>Foster</surname><given-names>SJ</given-names></name>
</person-group><article-title>IsdA of <italic toggle="yes">Staphylococcus aureus</italic> is a broad spectrum, iron&#x02010;regulated adhesin</article-title><source>Mol Microbiol</source><year>2004</year><volume>51</volume><fpage>1509</fpage><lpage>1519</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2003.03938.x</pub-id><pub-id pub-id-type="pmid">14982642</pub-id>
</element-citation></ref><ref id="R112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>SR</given-names></name>
<name><surname>Brummell</surname><given-names>KJ</given-names></name>
<name><surname>Horsburgh</surname><given-names>MJ</given-names></name>
<name><surname>McDowell</surname><given-names>PW</given-names></name>
<name><surname>Mohamad</surname><given-names>SAS</given-names></name>
<etal>et al</etal>
</person-group><article-title>Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage</article-title><source>J Infect Dis</source><year>2006</year><volume>193</volume><fpage>1098</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1086/501471</pub-id><pub-id pub-id-type="pmid">16544250</pub-id>
</element-citation></ref><ref id="R113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clarke</surname><given-names>SR</given-names></name>
<name><surname>Andre</surname><given-names>G</given-names></name>
<name><surname>Walsh</surname><given-names>EJ</given-names></name>
<name><surname>Dufr&#x000ea;ne</surname><given-names>YF</given-names></name>
<name><surname>Foster</surname><given-names>TJ</given-names></name>
<etal>et al</etal>
</person-group><article-title>Iron-regulated surface determinant protein a mediates adhesion of <italic toggle="yes">Staphylococcus aureus</italic> to human corneocyte envelope proteins</article-title><source>Infect Immun</source><year>2009</year><volume>77</volume><fpage>2408</fpage><lpage>2416</lpage><pub-id pub-id-type="doi">10.1128/IAI.01304-08</pub-id><pub-id pub-id-type="pmid">19307218</pub-id>
</element-citation></ref><ref id="R114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>M</given-names></name>
<name><surname>Tanaka</surname><given-names>WN</given-names></name>
<name><surname>Zhu</surname><given-names>H</given-names></name>
<name><surname>Xie</surname><given-names>G</given-names></name>
<name><surname>Dooley</surname><given-names>DM</given-names></name>
<etal>et al</etal>
</person-group><article-title>Direct hemin transfer from IsdA to IsdC in the iron-regulated surface determinant (Isd) heme acquisition system of <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>6668</fpage><lpage>6676</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708372200</pub-id><pub-id pub-id-type="pmid">18184657</pub-id>
</element-citation></ref><ref id="R115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwiecinski</surname><given-names>J</given-names></name>
<name><surname>Jin</surname><given-names>T</given-names></name>
<name><surname>Josefsson</surname><given-names>E</given-names></name>
</person-group><article-title>Surface proteins of <italic toggle="yes">Staphylococcus aureus</italic> play an important role in experimental skin infection</article-title><source>APMIS</source><year>2014</year><volume>122</volume><fpage>1240</fpage><lpage>1250</lpage><pub-id pub-id-type="pmid">25051890</pub-id>
</element-citation></ref><ref id="R116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>King</surname><given-names>NP</given-names></name>
<name><surname>Sakin&#x000e7;</surname><given-names>T</given-names></name>
<name><surname>Ben Zakour</surname><given-names>NL</given-names></name>
<name><surname>Totsika</surname><given-names>M</given-names></name>
<name><surname>Heras</surname><given-names>B</given-names></name>
<etal>et al</etal>
</person-group><article-title>Characterisation of a cell wall-anchored protein of <italic toggle="yes">Staphylococcus saprophyticus</italic> associated with linoleic acid resistance</article-title><source>BMC Microbiol</source><year>2012</year><volume>12</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-12-8</pub-id><pub-id pub-id-type="pmid">22243671</pub-id>
</element-citation></ref><ref id="R117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alnaseri</surname><given-names>H</given-names></name>
<name><surname>Arsic</surname><given-names>B</given-names></name>
<name><surname>Schneider</surname><given-names>JET</given-names></name>
<name><surname>Kaiser</surname><given-names>JC</given-names></name>
<name><surname>Scinocca</surname><given-names>ZC</given-names></name>
<etal>et al</etal>
</person-group><article-title>Inducible expression of a resistance-nodulation-division-type efflux pump in <italic toggle="yes">Staphylococcus aureus</italic> provides resistance to linoleic and arachidonic acids</article-title><source>J Bacteriol</source><year>2015</year><volume>197</volume><fpage>1893</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1128/JB.02607-14</pub-id><pub-id pub-id-type="pmid">25802299</pub-id>
</element-citation></ref><ref id="R118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kengmo Tchoupa</surname><given-names>A</given-names></name>
<name><surname>Peschel</surname><given-names>A</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> releases proinflammatory membrane vesicles to resist</article-title><source>mSphere</source><year>2020</year><volume>5</volume></element-citation></ref><ref id="R119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dye</surname><given-names>ES</given-names></name>
<name><surname>Kapral</surname><given-names>FA</given-names></name>
</person-group><article-title>Partial characterization of a bactericidal system in staphylococcal abscesses</article-title><source>Infect Immun</source><year>1980</year><volume>30</volume><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1128/iai.30.1.198-203.1980</pub-id><pub-id pub-id-type="pmid">6254879</pub-id>
</element-citation></ref><ref id="R120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mortensen</surname><given-names>JE</given-names></name>
<name><surname>Shryock</surname><given-names>TR</given-names></name>
<name><surname>Kapral</surname><given-names>FA</given-names></name>
</person-group><article-title>modification of bactericidal fatty acids by an enzyme of <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J med microbiol</source><year>1992</year><volume>36</volume><fpage>293</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1099/00222615-36-4-293</pub-id><pub-id pub-id-type="pmid">1560452</pub-id>
</element-citation></ref><ref id="R121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kengmo Tchoupa</surname><given-names>A</given-names></name>
<name><surname>Elsherbini</surname><given-names>AMA</given-names></name>
<name><surname>Camus</surname><given-names>J</given-names></name>
<name><surname>Fu</surname><given-names>X</given-names></name>
<name><surname>Hu</surname><given-names>X</given-names></name>
<name><surname>Ghaneme</surname><given-names>O</given-names></name>
<etal>et al</etal>
</person-group><article-title>Lipase-mediated detoxification of host-derived antimicrobial fatty acids by <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Commun Biol</source><year>2024</year><volume>7</volume><issue>1</issue><fpage>572</fpage><pub-id pub-id-type="pmid">38750133</pub-id>
</element-citation></ref><ref id="R122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mortimer</surname><given-names>CE</given-names></name>
<name><surname>Niehaus</surname><given-names>WG</given-names></name>
</person-group><article-title>Enzymatic interconversion of oleic acid, 10-hydroxyoctadecanoic acid, and trans-delta 10-octadecenoic acid. reaction pathway and stereospecificity</article-title><source>J Biol Chem</source><year>1974</year><volume>249</volume><fpage>2833</fpage><lpage>2842</lpage><pub-id pub-id-type="pmid">4828323</pub-id>
</element-citation></ref><ref id="R123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Subramanian</surname><given-names>C</given-names></name>
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>Batte</surname><given-names>JL</given-names></name>
<name><surname>Whaley</surname><given-names>SG</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title>Oleate hydratase from <italic toggle="yes">Staphylococcus aureus</italic> protects against palmitoleic acid, the major antimicrobial fatty acid produced by mammalian skin</article-title><source>J Biol Chem</source><year>2019</year><volume>294</volume><fpage>9285</fpage><lpage>9294</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.008439</pub-id><pub-id pub-id-type="pmid">31018965</pub-id>
</element-citation></ref><ref id="R124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Unnikrishnan</surname><given-names>M</given-names></name>
<name><surname>Constantinidou</surname><given-names>C</given-names></name>
<name><surname>Palmer</surname><given-names>T</given-names></name>
<name><surname>Pallen</surname><given-names>MJ</given-names></name>
</person-group><article-title>The enigmatic Esx proteins: looking beyond mycobacteria</article-title><source>Trends Microbiol</source><year>2017</year><volume>25</volume><fpage>192</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2016.11.004</pub-id><pub-id pub-id-type="pmid">27894646</pub-id>
</element-citation></ref><ref id="R125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burts</surname><given-names>ML</given-names></name>
<name><surname>DeDent</surname><given-names>AC</given-names></name>
<name><surname>Missiakas</surname><given-names>DM</given-names></name>
</person-group><article-title>EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Mol Microbiol</source><year>2008</year><volume>69</volume><fpage>736</fpage><lpage>746</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06324.x</pub-id><pub-id pub-id-type="pmid">18554323</pub-id>
</element-citation></ref><ref id="R126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ishii</surname><given-names>K</given-names></name>
<name><surname>Adachi</surname><given-names>T</given-names></name>
<name><surname>Yasukawa</surname><given-names>J</given-names></name>
<name><surname>Suzuki</surname><given-names>Y</given-names></name>
<name><surname>Hamamoto</surname><given-names>H</given-names></name>
<etal>et al</etal>
</person-group><article-title>Induction of virulence gene expression in <italic toggle="yes">Staphylococcus aureus</italic> by pulmonary surfactant</article-title><source>Infect Immun</source><year>2014</year><volume>82</volume><fpage>1500</fpage><lpage>1510</lpage><pub-id pub-id-type="doi">10.1128/IAI.01635-13</pub-id><pub-id pub-id-type="pmid">24452679</pub-id>
</element-citation></ref><ref id="R127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kengmo Tchoupa</surname><given-names>A</given-names></name>
<name><surname>Watkins</surname><given-names>KE</given-names></name>
<name><surname>Jones</surname><given-names>RA</given-names></name>
<name><surname>Kuroki</surname><given-names>A</given-names></name>
<name><surname>Alam</surname><given-names>MT</given-names></name>
<etal>et al</etal>
</person-group><article-title>The type VII secretion system protects <italic toggle="yes">Staphylococcus aureus</italic> against antimicrobial host fatty acids</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><elocation-id>14838</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-71653-z</pub-id><pub-id pub-id-type="pmid">32908165</pub-id>
</element-citation></ref><ref id="R128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pelz</surname><given-names>A</given-names></name>
<name><surname>Wieland</surname><given-names>K-P</given-names></name>
<name><surname>Putzbach</surname><given-names>K</given-names></name>
<name><surname>Hentschel</surname><given-names>P</given-names></name>
<name><surname>Albert</surname><given-names>K</given-names></name>
<etal>et al</etal>
</person-group><article-title>Structure and biosynthesis of staphyloxanthin from <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>32493</fpage><lpage>32498</lpage><pub-id pub-id-type="doi">10.1074/jbc.M505070200</pub-id><pub-id pub-id-type="pmid">16020541</pub-id>
</element-citation></ref><ref id="R129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>GY</given-names></name>
<name><surname>Essex</surname><given-names>A</given-names></name>
<name><surname>Buchanan</surname><given-names>JT</given-names></name>
<name><surname>Datta</surname><given-names>V</given-names></name>
<name><surname>Hoffman</surname><given-names>HM</given-names></name>
<etal>et al</etal>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity</article-title><source>J Exp Med</source><year>2005</year><volume>202</volume><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1084/jem.20050846</pub-id><pub-id pub-id-type="pmid">16009720</pub-id>
</element-citation></ref><ref id="R130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tiwari</surname><given-names>KB</given-names></name>
<name><surname>Gatto</surname><given-names>C</given-names></name>
<name><surname>Wilkinson</surname><given-names>BJ</given-names></name>
</person-group><article-title>Interrelationships between fatty acid composition, staphyloxanthin content, fluidity, and carbon flow in the <italic toggle="yes">Staphylococcus aureus</italic> membrane</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>1201</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23051201</pub-id><pub-id pub-id-type="pmid">29772798</pub-id>
</element-citation></ref><ref id="R131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>F</given-names></name>
<name><surname>Di</surname><given-names>H</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Cao</surname><given-names>Q</given-names></name>
<name><surname>Xu</surname><given-names>B</given-names></name>
<etal>et al</etal>
</person-group><article-title>Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</article-title><source>Nat Chem Biol</source><year>2016</year><volume>12</volume><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2003</pub-id><pub-id pub-id-type="pmid">26780405</pub-id>
</element-citation></ref><ref id="R132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Askoura</surname><given-names>M</given-names></name>
<name><surname>Yousef</surname><given-names>N</given-names></name>
<name><surname>Mansour</surname><given-names>B</given-names></name>
<name><surname>Yehia</surname><given-names>FA-ZA</given-names></name>
</person-group><article-title>Antibiofilm and staphyloxanthin inhibitory potential of terbinafine against <italic toggle="yes">Staphylococcus aureus</italic>: in vitro and in vivo studies</article-title><source>Ann Clin Microbiol Antimicrob</source><year>2022</year><volume>21</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1186/s12941-022-00513-7</pub-id><pub-id pub-id-type="pmid">35637481</pub-id>
</element-citation></ref><ref id="R133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Laabei</surname><given-names>M</given-names></name>
<name><surname>Recker</surname><given-names>M</given-names></name>
<name><surname>Rudkin</surname><given-names>JK</given-names></name>
<name><surname>Aldeljawi</surname><given-names>M</given-names></name>
<name><surname>Gulay</surname><given-names>Z</given-names></name>
<etal>et al</etal>
</person-group><article-title>Predicting the virulence of MRSA from its genome sequence</article-title><source>Genome Res</source><year>2014</year><volume>24</volume><fpage>839</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1101/gr.165415.113</pub-id><pub-id pub-id-type="pmid">24717264</pub-id>
</element-citation></ref><ref id="R134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duggan</surname><given-names>S</given-names></name>
<name><surname>Laabei</surname><given-names>M</given-names></name>
<name><surname>Alnahari</surname><given-names>AA</given-names></name>
<name><surname>O&#x02019;Brien</surname><given-names>EC</given-names></name>
<name><surname>Lacey</surname><given-names>KA</given-names></name>
<etal>et al</etal>
</person-group><article-title>A small membrane stabilizing protein critical to the pathogenicity of <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Infect Immun</source><year>2020</year><volume>88</volume><elocation-id>e00162-20</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00162-20</pub-id><pub-id pub-id-type="pmid">32571989</pub-id>
</element-citation></ref><ref id="R135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonini</surname><given-names>D</given-names></name>
<name><surname>Duggan</surname><given-names>S</given-names></name>
<name><surname>Alnahari</surname><given-names>A</given-names></name>
<name><surname>Brignoli</surname><given-names>T</given-names></name>
<name><surname>Strahl</surname><given-names>H</given-names></name>
<etal>et al</etal>
</person-group><article-title>Lipoteichoic acid biosynthesis by <italic toggle="yes">Staphylococcus aureus</italic> is controlled by the MspA protein</article-title><source>mBio</source><year>2024</year><volume>15</volume><elocation-id>e0151224</elocation-id><pub-id pub-id-type="doi">10.1128/mbio.01512-24</pub-id><pub-id pub-id-type="pmid">39037275</pub-id>
</element-citation></ref><ref id="R136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Casillas-Vargas</surname><given-names>G</given-names></name>
<name><surname>Ocasio-Malav&#x000e9;</surname><given-names>C</given-names></name>
<name><surname>Medina</surname><given-names>S</given-names></name>
<name><surname>Morales-Guzm&#x000e1;n</surname><given-names>C</given-names></name>
<name><surname>Del Valle</surname><given-names>RG</given-names></name>
<etal>et al</etal>
</person-group><article-title>Antibacterial fatty acids: an update of possible mechanisms of action and implications in the development of the next-generation of antibacterial agents</article-title><source>Prog Lipid Res</source><year>2021</year><volume>82</volume><fpage>101093</fpage><pub-id pub-id-type="doi">10.1016/j.plipres.2021.101093</pub-id><pub-id pub-id-type="pmid">33577909</pub-id>
</element-citation></ref><ref id="R137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Truong-Bolduc</surname><given-names>QC</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Hooper</surname><given-names>DC</given-names></name>
</person-group><article-title>Tet38 efflux pump contributes to fosfomycin resistance in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>2018</year><volume>62</volume><elocation-id>e00927-18</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00927-18</pub-id><pub-id pub-id-type="pmid">29891612</pub-id>
</element-citation></ref><ref id="R138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Truong-Bolduc</surname><given-names>QC</given-names></name>
<name><surname>Dunman</surname><given-names>PM</given-names></name>
<name><surname>Strahilevitz</surname><given-names>J</given-names></name>
<name><surname>Projan</surname><given-names>SJ</given-names></name>
<name><surname>Hooper</surname><given-names>DC</given-names></name>
</person-group><article-title>MgrA is a multiple regulator of two new efflux pumps in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2005</year><volume>187</volume><fpage>2395</fpage><lpage>2405</lpage><pub-id pub-id-type="doi">10.1128/JB.187.7.2395-2405.2005</pub-id><pub-id pub-id-type="pmid">15774883</pub-id>
</element-citation></ref><ref id="R139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Truong-Bolduc</surname><given-names>QC</given-names></name>
<name><surname>Khan</surname><given-names>NS</given-names></name>
<name><surname>Vyas</surname><given-names>JM</given-names></name>
<name><surname>Hooper</surname><given-names>DC</given-names></name>
</person-group><article-title>Tet38 efflux pump affects <italic toggle="yes">Staphylococcus aureus i</italic>nternalization by epithelial cells through interaction with CD36 and contributes to bacterial escape from acidic and nonacidic phagolysosomes</article-title><source>Infect Immun</source><year>2017</year><volume>85</volume><elocation-id>e00862-16</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00862-16</pub-id><pub-id pub-id-type="pmid">27956597</pub-id>
</element-citation></ref><ref id="R140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>C</given-names></name>
<name><surname>Hooper</surname><given-names>DC</given-names></name>
</person-group><article-title>Effect of <italic toggle="yes">Staphylococcus aureus</italic> Tet38 native efflux pump on in vivo response to tetracycline in a murine subcutaneous abscess model</article-title><source>J Antimicrob Chemother</source><year>2018</year><volume>73</volume><fpage>720</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1093/jac/dkx432</pub-id><pub-id pub-id-type="pmid">29216347</pub-id>
</element-citation></ref><ref id="R141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ding</surname><given-names>Y</given-names></name>
<name><surname>Onodera</surname><given-names>Y</given-names></name>
<name><surname>Lee</surname><given-names>JC</given-names></name>
<name><surname>Hooper</surname><given-names>DC</given-names></name>
</person-group><article-title>NorB, an efflux pump in <italic toggle="yes">Staphylococcus aureus</italic> strain MW2, contributes to bacterial fitness in abscesses</article-title><source>J Bacteriol</source><year>2008</year><volume>190</volume><fpage>7123</fpage><lpage>7129</lpage><pub-id pub-id-type="doi">10.1128/JB.00655-08</pub-id><pub-id pub-id-type="pmid">18723624</pub-id>
</element-citation></ref><ref id="R142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ding</surname><given-names>Y</given-names></name>
<name><surname>Fu</surname><given-names>Y</given-names></name>
<name><surname>Lee</surname><given-names>JC</given-names></name>
<name><surname>Hooper</surname><given-names>DC</given-names></name>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivo</article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><fpage>6586</fpage><lpage>6593</lpage><pub-id pub-id-type="doi">10.1128/JB.01414-12</pub-id><pub-id pub-id-type="pmid">23042988</pub-id>
</element-citation></ref><ref id="R143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Truong-Bolduc</surname><given-names>QC</given-names></name>
<name><surname>Villet</surname><given-names>RA</given-names></name>
<name><surname>Estabrooks</surname><given-names>ZA</given-names></name>
<name><surname>Hooper</surname><given-names>DC</given-names></name>
</person-group><article-title>Native efflux pumps contribute resistance to antimicrobials of skin and the ability of <italic toggle="yes">Staphylococcus aureus</italic> to colonize skin</article-title><source>J Infect Dis</source><year>2014</year><volume>209</volume><fpage>1485</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1093/infdis/jit660</pub-id><pub-id pub-id-type="pmid">24280365</pub-id>
</element-citation></ref><ref id="R144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alnaseri</surname><given-names>H</given-names></name>
<name><surname>Kuiack</surname><given-names>RC</given-names></name>
<name><surname>Ferguson</surname><given-names>KA</given-names></name>
<name><surname>Schneider</surname><given-names>JET</given-names></name>
<name><surname>Heinrichs</surname><given-names>DE</given-names></name>
<etal>et al</etal>
</person-group><article-title>DNA Binding and sensor specificity of FarR, a novel TetR family regulator required for induction of the fatty acid efflux pump FarE in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2019</year><volume>201</volume><elocation-id>e00602-18</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00602-18</pub-id><pub-id pub-id-type="pmid">30455282</pub-id>
</element-citation></ref><ref id="R145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moran</surname><given-names>JC</given-names></name>
<name><surname>Alorabi</surname><given-names>JA</given-names></name>
<name><surname>Horsburgh</surname><given-names>MJ</given-names></name>
</person-group><article-title>Comparative transcriptomics reveals discrete survival responses of <italic toggle="yes">S. aureus</italic> and <italic toggle="yes">S. epidermidis</italic> to sapienic acid</article-title><source>Front Microbiol</source><year>2017</year><volume>8</volume><fpage>33</fpage><pub-id pub-id-type="pmid">28179897</pub-id>
</element-citation></ref><ref id="R146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vaish</surname><given-names>M</given-names></name>
<name><surname>Price-Whelan</surname><given-names>A</given-names></name>
<name><surname>Reyes-Robles</surname><given-names>T</given-names></name>
<name><surname>Liu</surname><given-names>J</given-names></name>
<name><surname>Jereen</surname><given-names>A</given-names></name>
<etal>et al</etal>
</person-group><article-title>Roles of <italic toggle="yes">Staphylococcus aureus</italic> Mnh1 and Mnh2 antiporters in salt tolerance, alkali tolerance, and pathogenesis</article-title><source>J Bacteriol</source><year>2018</year><volume>200</volume><elocation-id>e00611-17</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00611-17</pub-id><pub-id pub-id-type="pmid">29263099</pub-id>
</element-citation></ref><ref id="R147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bayer</surname><given-names>AS</given-names></name>
<name><surname>McNamara</surname><given-names>P</given-names></name>
<name><surname>Yeaman</surname><given-names>MR</given-names></name>
<name><surname>Lucindo</surname><given-names>N</given-names></name>
<name><surname>Jones</surname><given-names>T</given-names></name>
<etal>et al</etal>
</person-group><article-title>Transposon disruption of the complex I NADH oxidoreductase gene (snoD) in <italic toggle="yes">Staphylococcus aureus</italic> is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1</article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><fpage>211</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1128/JB.188.1.211-222.2006</pub-id><pub-id pub-id-type="pmid">16352837</pub-id>
</element-citation></ref><ref id="R148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sannasiddappa</surname><given-names>TH</given-names></name>
<name><surname>Hood</surname><given-names>GA</given-names></name>
<name><surname>Hanson</surname><given-names>KJ</given-names></name>
<name><surname>Costabile</surname><given-names>A</given-names></name>
<name><surname>Gibson</surname><given-names>GR</given-names></name>
<etal>et al</etal>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> MnhF mediates cholate efflux and facilitates survival under human colonic conditions</article-title><source>Infect Immun</source><year>2015</year><volume>83</volume><fpage>2350</fpage><lpage>2357</lpage><pub-id pub-id-type="doi">10.1128/IAI.00238-15</pub-id><pub-id pub-id-type="pmid">25824834</pub-id>
</element-citation></ref><ref id="R149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Swartz</surname><given-names>TH</given-names></name>
<name><surname>Ito</surname><given-names>M</given-names></name>
<name><surname>Ohira</surname><given-names>T</given-names></name>
<name><surname>Natsui</surname><given-names>S</given-names></name>
<name><surname>Hicks</surname><given-names>DB</given-names></name>
<etal>et al</etal>
</person-group><article-title>Catalytic properties of <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Bacillus</italic> members of the secondary cation/proton antiporter-3 (Mrp) family are revealed by an optimized assay in an <italic toggle="yes">Escherichia coli</italic> host</article-title><source>J Bacteriol</source><year>2007</year><volume>189</volume><fpage>3081</fpage><lpage>3090</lpage><pub-id pub-id-type="doi">10.1128/JB.00021-07</pub-id><pub-id pub-id-type="pmid">17293423</pub-id>
</element-citation></ref><ref id="R150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garc&#x000ed;a-Fern&#x000e1;ndez</surname><given-names>E</given-names></name>
<name><surname>Koch</surname><given-names>G</given-names></name>
<name><surname>Wagner</surname><given-names>RM</given-names></name>
<name><surname>Fekete</surname><given-names>A</given-names></name>
<name><surname>Stengel</surname><given-names>ST</given-names></name>
<etal>et al</etal>
</person-group><article-title>Membrane microdomain disassembly inhibits MRSA antibiotic resistance</article-title><source>Cell</source><year>2017</year><volume>171</volume><fpage>1354</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.10.012</pub-id><pub-id pub-id-type="pmid">29103614</pub-id>
</element-citation></ref><ref id="R151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yun</surname><given-names>M-K</given-names></name>
<name><surname>Hoagland</surname><given-names>D</given-names></name>
<name><surname>Kumar</surname><given-names>G</given-names></name>
<name><surname>Waddell</surname><given-names>MB</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
<etal>et al</etal>
</person-group><article-title>The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase</article-title><source>Bioorg Med Chem</source><year>2014</year><volume>22</volume><fpage>2157</fpage><lpage>2165</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2014.02.022</pub-id><pub-id pub-id-type="pmid">24613625</pub-id>
</element-citation></ref><ref id="R152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parsons</surname><given-names>JB</given-names></name>
<name><surname>Broussard</surname><given-names>TC</given-names></name>
<name><surname>Bose</surname><given-names>JL</given-names></name>
<name><surname>Rosch</surname><given-names>JW</given-names></name>
<name><surname>Jackson</surname><given-names>P</given-names></name>
<etal>et al</etal>
</person-group><article-title>Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>10532</fpage><lpage>10537</lpage><pub-id pub-id-type="doi">10.1073/pnas.1408797111</pub-id><pub-id pub-id-type="pmid">25002480</pub-id>
</element-citation></ref><ref id="R153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cuypers</surname><given-names>MG</given-names></name>
<name><surname>Subramanian</surname><given-names>C</given-names></name>
<name><surname>Gullett</surname><given-names>JM</given-names></name>
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>White</surname><given-names>SW</given-names></name>
<etal>et al</etal>
</person-group><article-title>Acyl-chain selectivity and physiological roles of <italic toggle="yes">Staphylococcus aureus</italic> fatty acid-binding proteins</article-title><source>J Biol Chem</source><year>2019</year><volume>294</volume><fpage>38</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA118.006160</pub-id><pub-id pub-id-type="pmid">30429218</pub-id>
</element-citation></ref><ref id="R154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krute</surname><given-names>CN</given-names></name>
<name><surname>Ridder</surname><given-names>MJ</given-names></name>
<name><surname>Seawell</surname><given-names>NA</given-names></name>
<name><surname>Bose</surname><given-names>JL</given-names></name>
</person-group><article-title>Inactivation of the exogenous fatty acid utilization pathway leads to increased resistance to unsaturated fatty acids in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Microbiology</source><year>2019</year><volume>165</volume><fpage>197</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000757</pub-id><pub-id pub-id-type="pmid">30566075</pub-id>
</element-citation></ref><ref id="R155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ericson</surname><given-names>ME</given-names></name>
<name><surname>Subramanian</surname><given-names>C</given-names></name>
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title>Role of fatty acid kinase in cellular lipid homeostasis and SaeRS-dependent virulence factor expression in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>mBio</source><year>2017</year><volume>8</volume><elocation-id>e00988-17</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00988-17</pub-id><pub-id pub-id-type="pmid">28765222</pub-id>
</element-citation></ref><ref id="R156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>Yao</surname><given-names>J</given-names></name>
<name><surname>Batte</surname><given-names>JL</given-names></name>
<name><surname>Gullett</surname><given-names>JM</given-names></name>
<name><surname>Subramanian</surname><given-names>C</given-names></name>
<etal>et al</etal>
</person-group><article-title>Host fatty acid utilization by <italic toggle="yes">Staphylococcus aureus</italic> at the infection site</article-title><source>mBio</source><year>2020</year><volume>11</volume><elocation-id>e00920-20</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00920-20</pub-id><pub-id pub-id-type="pmid">32430471</pub-id>
</element-citation></ref><ref id="R157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>K&#x000e9;nanian</surname><given-names>G</given-names></name>
<name><surname>Morvan</surname><given-names>C</given-names></name>
<name><surname>Weckel</surname><given-names>A</given-names></name>
<name><surname>Pathania</surname><given-names>A</given-names></name>
<name><surname>Anba-Mondoloni</surname><given-names>J</given-names></name>
<etal>et al</etal>
</person-group><article-title>Permissive fatty acid incorporation promotes staphylococcal adaptation to FASII antibiotics in host environments</article-title><source>Cell Reports</source><year>2019</year><volume>29</volume><fpage>3974</fpage><lpage>3982</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.11.071</pub-id><pub-id pub-id-type="pmid">31851927</pub-id>
</element-citation></ref><ref id="R158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ridder</surname><given-names>MJ</given-names></name>
<name><surname>Daly</surname><given-names>SM</given-names></name>
<name><surname>Triplett</surname><given-names>KD</given-names></name>
<name><surname>Seawell</surname><given-names>NA</given-names></name>
<name><surname>Hall</surname><given-names>PR</given-names></name>
<etal>et al</etal>
</person-group><article-title><italic toggle="yes">Staphylococcus aureus</italic> fatty acid kinase fakA modulates pathogenesis during skin infection via proteases</article-title><source>Infect Immun</source><year>2020</year><volume>88</volume><elocation-id>e00163-20</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00163-20</pub-id><pub-id pub-id-type="pmid">32513856</pub-id>
</element-citation></ref><ref id="R159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clark</surname><given-names>DP</given-names></name>
<name><surname>Cronan</surname><given-names>JE</given-names></name>
</person-group><article-title>Two-carbon compounds and fatty acids as carbon sources</article-title><source>EcoSal Plus</source><year>2005</year><volume>1</volume><pub-id pub-id-type="doi">10.1128/ecosalplus.3.4.4</pub-id></element-citation></ref><ref id="R160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kuiack</surname><given-names>RC</given-names></name>
<name><surname>Tuffs</surname><given-names>SW</given-names></name>
<name><surname>Dufresne</surname><given-names>K</given-names></name>
<name><surname>Flick</surname><given-names>R</given-names></name>
<name><surname>McCormick</surname><given-names>JK</given-names></name>
<etal>et al</etal>
</person-group><article-title>The fadXDEBA locus of <italic toggle="yes">Staphylococcus aureus</italic> is required for metabolism of exogenous palmitic acid and in vivo growth</article-title><source>Mol Microbiol</source><year>2023</year><volume>120</volume><fpage>425</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1111/mmi.15131</pub-id><pub-id pub-id-type="pmid">37501506</pub-id>
</element-citation></ref><ref id="R161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parsons</surname><given-names>JB</given-names></name>
<name><surname>Yao</surname><given-names>J</given-names></name>
<name><surname>Frank</surname><given-names>MW</given-names></name>
<name><surname>Jackson</surname><given-names>P</given-names></name>
<name><surname>Rock</surname><given-names>CO</given-names></name>
</person-group><article-title>Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><fpage>5294</fpage><lpage>5304</lpage><pub-id pub-id-type="doi">10.1128/JB.00743-12</pub-id><pub-id pub-id-type="pmid">22843840</pub-id>
</element-citation></ref><ref id="R162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mullen</surname><given-names>A</given-names></name>
<name><surname>Loscher</surname><given-names>CE</given-names></name>
<name><surname>Roche</surname><given-names>HM</given-names></name>
</person-group><article-title>Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages</article-title><source>J Nutr Biochem</source><year>2010</year><volume>21</volume><fpage>444</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2009.02.008</pub-id><pub-id pub-id-type="pmid">19427777</pub-id>
</element-citation></ref><ref id="R163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mil-Homens</surname><given-names>D</given-names></name>
<name><surname>Bernardes</surname><given-names>N</given-names></name>
<name><surname>Fialho</surname><given-names>AM</given-names></name>
</person-group><article-title>The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen <italic toggle="yes">Burkholderia cenocepacia</italic></article-title><source>FEMS Microbiol Lett</source><year>2012</year><volume>328</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2011.02476.x</pub-id><pub-id pub-id-type="pmid">22150831</pub-id>
</element-citation></ref><ref id="R164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McNeil</surname><given-names>JC</given-names></name>
<name><surname>Hulten</surname><given-names>KG</given-names></name>
<name><surname>Kaplan</surname><given-names>SL</given-names></name>
<name><surname>Mason</surname><given-names>EO</given-names></name>
</person-group><article-title>Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among <italic toggle="yes">Staphylococcus aureus</italic> isolates causing skin and soft tissue infections in otherwise healthy children</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><fpage>2878</fpage><lpage>2883</lpage><pub-id pub-id-type="doi">10.1128/AAC.02707-13</pub-id><pub-id pub-id-type="pmid">24614375</pub-id>
</element-citation></ref><ref id="R165"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hajikhani</surname><given-names>B</given-names></name>
<name><surname>Goudarzi</surname><given-names>M</given-names></name>
<name><surname>Kakavandi</surname><given-names>S</given-names></name>
<name><surname>Amini</surname><given-names>S</given-names></name>
<name><surname>Zamani</surname><given-names>S</given-names></name>
<etal>et al</etal>
</person-group><article-title>The global prevalence of fusidic acid resistance in clinical isolates of <italic toggle="yes">Staphylococcus aureus</italic>: a systematic review and meta-analysis</article-title><source>Antimicrob Resist Infect Control</source><year>2021</year><volume>10</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.1186/s13756-021-00943-6</pub-id><pub-id pub-id-type="pmid">33933162</pub-id>
</element-citation></ref><ref id="R166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lacey</surname><given-names>RW</given-names></name>
<name><surname>Lord</surname><given-names>VL</given-names></name>
</person-group><article-title>Sensitivity of staphylococci to fatty acids: novel inactivation of linolenic acid by serum</article-title><source>J Med Microbiol</source><year>1981</year><volume>14</volume><fpage>41</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1099/00222615-14-1-41</pub-id><pub-id pub-id-type="pmid">7463466</pub-id>
</element-citation></ref><ref id="R167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rouse</surname><given-names>MS</given-names></name>
<name><surname>Rotger</surname><given-names>M</given-names></name>
<name><surname>Piper</surname><given-names>KE</given-names></name>
<name><surname>Steckelberg</surname><given-names>JM</given-names></name>
<name><surname>Scholz</surname><given-names>M</given-names></name>
<etal>et al</etal>
</person-group><article-title>In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Antimicrob Agents Chemother</source><year>2005</year><volume>49</volume><fpage>3187</fpage><lpage>3191</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.8.3187-3191.2005</pub-id><pub-id pub-id-type="pmid">16048923</pub-id>
</element-citation></ref><ref id="R168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Huang</surname><given-names>CM</given-names></name>
<name><surname>Chen</surname><given-names>CH</given-names></name>
<name><surname>Pornpattananangkul</surname><given-names>D</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Chan</surname><given-names>M</given-names></name>
<name><surname>Hsieh</surname><given-names>MF</given-names></name>
<etal>et al</etal>
</person-group><article-title>Eradication of drug resistant <italic toggle="yes">Staphylococcus aureus</italic> by liposomal oleic acids</article-title><source>Biomaterials</source><year>2011</year><volume>32</volume><issue>1</issue><fpage>214</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">20880576</pub-id>
</element-citation></ref><ref id="R169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>CH</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Nakatsuji</surname><given-names>T</given-names></name>
<name><surname>Liu</surname><given-names>YT</given-names></name>
<name><surname>Zouboulis</surname><given-names>C</given-names></name>
<name><surname>Gallo</surname><given-names>R</given-names></name>
<etal>et al</etal>
</person-group><article-title>An innate bactericidal oleic acid effective against skin infection of methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>: a therapy concordant with evolutionary medicine</article-title><source>J Microbiol Biotechnol</source><year>2011</year><volume>21</volume><issue>4</issue><fpage>391</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21532323</pub-id>
</element-citation></ref><ref id="R170"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ellamar</surname><given-names>JB</given-names></name>
<name><surname>Song</surname><given-names>K-S</given-names></name>
<name><surname>Kim</surname><given-names>H-R</given-names></name>
</person-group><article-title>One-step production of a biologically active novel furan fatty acid from 7,10-dihydroxy-8(<italic toggle="yes">E</italic>)-octadecenoic acid</article-title><source>J Agric Food Chem</source><year>2011</year><volume>59</volume><fpage>8175</fpage><lpage>8179</lpage><pub-id pub-id-type="doi">10.1021/jf2015683</pub-id><pub-id pub-id-type="pmid">21711016</pub-id>
</element-citation></ref><ref id="R171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dasagrandhi</surname><given-names>C</given-names></name>
<name><surname>Ellamar</surname><given-names>JB</given-names></name>
<name><surname>Kim</surname><given-names>YS</given-names></name>
<name><surname>Kim</surname><given-names>H-R</given-names></name>
</person-group><article-title>Antimicrobial activity of a novel furan fatty acid, 7,10-epoxyoctadeca-7,9-dienoic acid against methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Food Sci Biotechnol</source><year>2016</year><volume>25</volume><fpage>1671</fpage><lpage>1675</lpage><pub-id pub-id-type="doi">10.1007/s10068-016-0257-6</pub-id><pub-id pub-id-type="pmid">30263461</pub-id>
</element-citation></ref><ref id="R172"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dasagrandhi</surname><given-names>C</given-names></name>
<name><surname>Kim</surname><given-names>Y-S</given-names></name>
<name><surname>Kim</surname><given-names>I-H</given-names></name>
<name><surname>Hou</surname><given-names>CT</given-names></name>
<name><surname>Kim</surname><given-names>H-R</given-names></name>
</person-group><article-title>7,10-epoxyoctadeca-7,9-dienoic Acid: a small molecule adjuvant that potentiates &#x003b2;-Lactam antibiotics against multidrug-resistant <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Indian J Microbiol</source><year>2017</year><volume>57</volume><fpage>461</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1007/s12088-017-0680-2</pub-id><pub-id pub-id-type="pmid">29151647</pub-id>
</element-citation></ref><ref id="R173"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sanabria-R&#x000ed;os</surname><given-names>DJ</given-names></name>
<name><surname>Rivera-Torres</surname><given-names>Y</given-names></name>
<name><surname>Maldonado-Dom&#x000ed;nguez</surname><given-names>G</given-names></name>
<name><surname>Dom&#x000ed;nguez</surname><given-names>I</given-names></name>
<name><surname>R&#x000ed;os</surname><given-names>C</given-names></name>
<etal>et al</etal>
</person-group><article-title>Antibacterial activity of 2-alkynoic fatty acids against multidrug-resistant bacteria</article-title><source>Chem Phys Lipids</source><year>2014</year><volume>178</volume><fpage>84</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.chemphyslip.2013.12.006</pub-id><pub-id pub-id-type="pmid">24365283</pub-id>
</element-citation></ref><ref id="R174"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carballeira</surname><given-names>NM</given-names></name>
</person-group><article-title>New advances in the chemistry of methoxylated lipids</article-title><source>Prog Lipid Res</source><year>2002</year><volume>41</volume><fpage>437</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/S0163-7827(02)00005-X</pub-id><pub-id pub-id-type="pmid">12169299</pub-id>
</element-citation></ref><ref id="R175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Carballeira</surname><given-names>NM</given-names></name>
<name><surname>Montano</surname><given-names>N</given-names></name>
<name><surname>Morales</surname><given-names>C</given-names></name>
<name><surname>Mooney</surname><given-names>J</given-names></name>
<name><surname>Torres</surname><given-names>X</given-names></name>
<etal>et al</etal>
</person-group><article-title>2-methoxylated FA display unusual antibacterial activity towards clinical isolates of methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> (CIMRSA) and <italic toggle="yes">Escherichia coli</italic></article-title><source>Lipids</source><year>2017</year><volume>52</volume><fpage>535</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1007/s11745-017-4262-1</pub-id><pub-id pub-id-type="pmid">28523480</pub-id>
</element-citation></ref><ref id="R176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hancock</surname><given-names>REW</given-names></name>
<name><surname>Sahl</surname><given-names>H-G</given-names></name>
</person-group><article-title>Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies</article-title><source>Nat Biotechnol</source><year>2006</year><volume>24</volume><fpage>1551</fpage><lpage>1557</lpage><pub-id pub-id-type="doi">10.1038/nbt1267</pub-id><pub-id pub-id-type="pmid">17160061</pub-id>
</element-citation></ref><ref id="R177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zasloff</surname><given-names>M</given-names></name>
</person-group><article-title>Antimicrobial peptides of multicellular organisms</article-title><source>Nature</source><year>2002</year><volume>415</volume><fpage>389</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1038/415389a</pub-id><pub-id pub-id-type="pmid">11807545</pub-id>
</element-citation></ref><ref id="R178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reinhardt</surname><given-names>A</given-names></name>
<name><surname>Neundorf</surname><given-names>I</given-names></name>
</person-group><article-title>Design and application of antimicrobial peptide conjugates</article-title><source>Int J Mol Sci</source><year>2016</year><volume>17</volume><elocation-id>701</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17050701</pub-id><pub-id pub-id-type="pmid">27187357</pub-id>
</element-citation></ref><ref id="R179"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mak</surname><given-names>P</given-names></name>
<name><surname>Pohl</surname><given-names>J</given-names></name>
<name><surname>Dubin</surname><given-names>A</given-names></name>
<name><surname>Reed</surname><given-names>MS</given-names></name>
<name><surname>Bowers</surname><given-names>SE</given-names></name>
<etal>et al</etal>
</person-group><article-title>The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes</article-title><source>Int J Antimicrob Agents</source><year>2003</year><volume>21</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/S0924-8579(02)00245-5</pub-id><pub-id pub-id-type="pmid">12507833</pub-id>
</element-citation></ref><ref id="R180"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chu-Kung</surname><given-names>AF</given-names></name>
<name><surname>Bozzelli</surname><given-names>KN</given-names></name>
<name><surname>Lockwood</surname><given-names>NA</given-names></name>
<name><surname>Haseman</surname><given-names>JR</given-names></name>
<name><surname>Mayo</surname><given-names>KH</given-names></name>
<etal>et al</etal>
</person-group><article-title>Promotion of peptide antimicrobial activity by fatty acid conjugation</article-title><source>Bioconjug Chem</source><year>2004</year><volume>15</volume><fpage>530</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1021/bc0341573</pub-id><pub-id pub-id-type="pmid">15149180</pub-id>
</element-citation></ref><ref id="R181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chu-Kung</surname><given-names>AF</given-names></name>
<name><surname>Nguyen</surname><given-names>R</given-names></name>
<name><surname>Bozzelli</surname><given-names>KN</given-names></name>
<name><surname>Tirrell</surname><given-names>M</given-names></name>
</person-group><article-title>Chain length dependence of antimicrobial peptide&#x02013;fatty acid conjugate activity</article-title><source>J Colloid Interface Sci</source><year>2010</year><volume>345</volume><fpage>160</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.jcis.2009.11.057</pub-id><pub-id pub-id-type="pmid">20185142</pub-id>
</element-citation></ref><ref id="R182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grimsey</surname><given-names>E</given-names></name>
<name><surname>Collis</surname><given-names>DWP</given-names></name>
<name><surname>Mikut</surname><given-names>R</given-names></name>
<name><surname>Hilpert</surname><given-names>K</given-names></name>
</person-group><article-title>The effect of lipidation and glycosylation on short cationic antimicrobial peptides</article-title><source>Biochim Biophys Acta Biomembr</source><year>2020</year><volume>1862</volume><fpage>183195</fpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2020.183195</pub-id><pub-id pub-id-type="pmid">32130974</pub-id>
</element-citation></ref><ref id="R183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhong</surname><given-names>C</given-names></name>
<name><surname>Liu</surname><given-names>T</given-names></name>
<name><surname>Gou</surname><given-names>S</given-names></name>
<name><surname>He</surname><given-names>Y</given-names></name>
<name><surname>Zhu</surname><given-names>N</given-names></name>
<etal>et al</etal>
</person-group><article-title>Design and synthesis of new N-terminal fatty acid modified-antimicrobial peptide analogues with potent in vitro biological activity</article-title><source>Eur J Med Chem</source><year>2019</year><volume>182</volume><elocation-id>111636</elocation-id><pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111636</pub-id><pub-id pub-id-type="pmid">31466017</pub-id>
</element-citation></ref><ref id="R184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krishnakumari</surname><given-names>V</given-names></name>
<name><surname>Nagaraj</surname><given-names>R</given-names></name>
</person-group><article-title>N-Terminal fatty acylation of peptides spanning the cationic C-terminal segment of bovine &#x003b2;-defensin-2 results in salt-resistant antibacterial activity</article-title><source>Biophys Chem</source><year>2015</year><volume>199</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.bpc.2015.02.005</pub-id><pub-id pub-id-type="pmid">25791057</pub-id>
</element-citation></ref><ref id="R185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Bambeke</surname><given-names>F</given-names></name>
<name><surname>Van Laethem</surname><given-names>Y</given-names></name>
<name><surname>Courvalin</surname><given-names>P</given-names></name>
<name><surname>Tulkens</surname><given-names>PM</given-names></name>
</person-group><article-title>Glycopeptide antibiotics: from conventional molecules to new derivatives</article-title><source>Drugs</source><year>2004</year><volume>64</volume><fpage>913</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.2165/00003495-200464090-00001</pub-id><pub-id pub-id-type="pmid">15101783</pub-id>
</element-citation></ref><ref id="R186"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sidders</surname><given-names>AE</given-names></name>
<name><surname>Kedziora</surname><given-names>KM</given-names></name>
<name><surname>Arts</surname><given-names>M</given-names></name>
<name><surname>Daniel</surname><given-names>J-M</given-names></name>
<name><surname>de Benedetti</surname><given-names>S</given-names></name>
<etal>et al</etal>
</person-group><article-title>Antibiotic-induced accumulation of lipid II synergizes with antimicrobial fatty acids to eradicate bacterial populations</article-title><source>Elife</source><year>2023</year><volume>12</volume><elocation-id>e80246</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.80246</pub-id><pub-id pub-id-type="pmid">36876902</pub-id>
</element-citation></ref><ref id="R187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>P</given-names></name>
<name><surname>Wu</surname><given-names>J</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<name><surname>Zhang</surname><given-names>H</given-names></name>
<name><surname>Xia</surname><given-names>Y</given-names></name>
<etal>et al</etal>
</person-group><article-title>The synergistic therapeutic efficacy of vancomycin and omega-3 fatty acids alleviates <italic toggle="yes">Staphylococcus aureus</italic>-induced osteomyelitis in rats</article-title><source>Biomed Pharmacother</source><year>2019</year><volume>111</volume><fpage>1228</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2018.12.125</pub-id><pub-id pub-id-type="pmid">30841436</pub-id>
</element-citation></ref><ref id="R188"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Taber</surname><given-names>HW</given-names></name>
<name><surname>Mueller</surname><given-names>JP</given-names></name>
<name><surname>Miller</surname><given-names>PF</given-names></name>
<name><surname>Arrow</surname><given-names>AS</given-names></name>
</person-group><article-title>Bacterial uptake of aminoglycoside antibiotics</article-title><source>Microbiol Rev</source><year>1987</year><volume>51</volume><fpage>439</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1128/mr.51.4.439-457.1987</pub-id><pub-id pub-id-type="pmid">3325794</pub-id>
</element-citation></ref><ref id="R189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Radlinski</surname><given-names>LC</given-names></name>
<name><surname>Rowe</surname><given-names>SE</given-names></name>
<name><surname>Brzozowski</surname><given-names>R</given-names></name>
<name><surname>Wilkinson</surname><given-names>AD</given-names></name>
<name><surname>Huang</surname><given-names>R</given-names></name>
<etal>et al</etal>
</person-group><article-title>Chemical induction of aminoglycoside uptake overcomes antibiotic tolerance and resistance in <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Cell Chem Biol</source><year>2019</year><volume>26</volume><fpage>1355</fpage><lpage>1364</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2019.07.009</pub-id><pub-id pub-id-type="pmid">31402316</pub-id>
</element-citation></ref><ref id="R190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zalis</surname><given-names>EA</given-names></name>
<name><surname>Nuxoll</surname><given-names>AS</given-names></name>
<name><surname>Manuse</surname><given-names>S</given-names></name>
<name><surname>Clair</surname><given-names>G</given-names></name>
<name><surname>Radlinski</surname><given-names>LC</given-names></name>
<etal>et al</etal>
</person-group><article-title>Stochastic variation in expression of the tricarboxylic acid cycle produces persister cells</article-title><source>mBio</source><year>2019</year><volume>10</volume><elocation-id>e01930-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01930-19</pub-id><pub-id pub-id-type="pmid">31530676</pub-id>
</element-citation></ref><ref id="R191"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prayle</surname><given-names>A</given-names></name>
<name><surname>Watson</surname><given-names>A</given-names></name>
<name><surname>Fortnum</surname><given-names>H</given-names></name>
<name><surname>Smyth</surname><given-names>A</given-names></name>
</person-group><article-title>Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis</article-title><source>Thorax</source><year>2010</year><volume>65</volume><fpage>654</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1136/thx.2009.131532</pub-id><pub-id pub-id-type="pmid">20627927</pub-id>
</element-citation></ref><ref id="R192"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beavers</surname><given-names>WN</given-names></name>
<name><surname>Munneke</surname><given-names>MJ</given-names></name>
<name><surname>Stackhouse</surname><given-names>AR</given-names></name>
<name><surname>Freiberg</surname><given-names>JA</given-names></name>
<name><surname>Skaar</surname><given-names>EP</given-names></name>
</person-group><article-title>Host polyunsaturated fatty acids potentiate aminoglycoside killing of <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Microbiol Spectr</source><year>2022</year><volume>10</volume><elocation-id>e0276721</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.02767-21</pub-id><pub-id pub-id-type="pmid">35377191</pub-id>
</element-citation></ref><ref id="R193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>S</given-names></name>
<name><surname>Lee</surname><given-names>J-H</given-names></name>
<name><surname>Kim</surname><given-names>Y-G</given-names></name>
<name><surname>Hu</surname><given-names>L</given-names></name>
<name><surname>Lee</surname><given-names>J</given-names></name>
</person-group><article-title>Fatty acids as aminoglycoside antibiotic adjuvants against <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Front Microbiol</source><year>2022</year><volume>13</volume><elocation-id>876932</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2022.876932</pub-id><pub-id pub-id-type="pmid">35633672</pub-id>
</element-citation></ref><ref id="R194"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dijksteel</surname><given-names>GS</given-names></name>
<name><surname>Ulrich</surname><given-names>MMW</given-names></name>
<name><surname>Middelkoop</surname><given-names>E</given-names></name>
<name><surname>Boekema</surname><given-names>BKHL</given-names></name>
</person-group><article-title>Review: lessons learned from clinical trials using antimicrobial peptides (AMPs)</article-title><source>Front Microbiol</source><year>2021</year><volume>12</volume><fpage>616979</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2021.616979</pub-id><pub-id pub-id-type="pmid">33692766</pub-id>
</element-citation></ref><ref id="R195"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>WC</given-names></name>
<name><surname>Hsu</surname><given-names>KC</given-names></name>
<name><surname>You</surname><given-names>MF</given-names></name>
<name><surname>Lee</surname><given-names>KH</given-names></name>
<name><surname>Chi</surname><given-names>CH</given-names></name>
<name><surname>Chen</surname><given-names>JY</given-names></name>
</person-group><article-title>Octanoic acid promotes clearance of antibiotic-tolerant cells and eradicates biofilms of <italic toggle="yes">Staphylococcus aureus</italic> isolated from recurrent bovine mastitis</article-title><source>Biofilm</source><year>2023</year><volume>6</volume><fpage>100149</fpage><pub-id pub-id-type="pmid">37635811</pub-id>
</element-citation></ref><ref id="R196"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>T</given-names></name>
<name><surname>Yamamoto</surname><given-names>Y</given-names></name>
<name><surname>Miura</surname><given-names>M</given-names></name>
<name><surname>Konno</surname><given-names>H</given-names></name>
<name><surname>Yano</surname><given-names>S</given-names></name>
<name><surname>Nonomura</surname><given-names>Y</given-names></name>
</person-group><article-title>Systematic analysis of selective bactericidal activity of fatty acids against <italic toggle="yes">Staphylococcus aureus</italic> with minimum inhibitory concentration and minimum bactericidal concentration</article-title><source>J Oleo Sci</source><year>2019</year><volume>68</volume><issue>3</issue><fpage>291</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">30760667</pub-id>
</element-citation></ref><ref id="R197"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kabara</surname><given-names>JJ</given-names></name>
<name><surname>Swieczkowski</surname><given-names>DM</given-names></name>
<name><surname>Conley</surname><given-names>AJ</given-names></name>
<name><surname>Truant</surname><given-names>JP</given-names></name>
</person-group><article-title>Fatty acids and derivatives as antimicrobial agents</article-title><source>Antimicrob Agents Chemother</source><year>1972</year><volume>2</volume><issue>1</issue><fpage>23</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">4670656</pub-id>
</element-citation></ref><ref id="R198"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dole&#x0017e;alov&#x000e1;</surname><given-names>M</given-names></name>
<name><surname>Jani&#x00161;</surname><given-names>R</given-names></name>
<name><surname>Svobodov&#x000e1;</surname><given-names>H</given-names></name>
<name><surname>Ka&#x00161;p&#x000e1;rkov&#x000e1;</surname><given-names>V</given-names></name>
<name><surname>Humpol&#x000ed;&#x0010d;ek</surname><given-names>P</given-names></name>
<etal>et al</etal>
</person-group><article-title>Antimicrobial properties of 1-monoacylglycerols prepared from undecanoic (C11:0) and undecenoic (C11:1) acid</article-title><source>Euro J Lipid Sci &#x00026; Tech</source><year>2010</year><volume>112</volume><fpage>1106</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1002/ejlt.200900295</pub-id></element-citation></ref><ref id="R199"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>YG</given-names></name>
<name><surname>Lee</surname><given-names>JH</given-names></name>
<name><surname>Park</surname><given-names>S</given-names></name>
<name><surname>Kim</surname><given-names>S</given-names></name>
<name><surname>Lee</surname><given-names>J</given-names></name>
</person-group><article-title>Inhibition of polymicrobial biofilm formation by saw palmetto oil, lauric acid and myristic acid</article-title><source>Microb Biotechnol</source><year>2022</year><volume>15</volume><fpage>590</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.13864</pub-id><pub-id pub-id-type="pmid">34156757</pub-id>
</element-citation></ref><ref id="R200"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>YG</given-names></name>
<name><surname>Lee</surname><given-names>JH</given-names></name>
</person-group><article-title>Lee J. Antibiofilm activities of fatty acids including myristoleic acid against <italic toggle="yes">Cutibacterium</italic> acnes via reduced cell hydrophobicity</article-title><source>Phytomedicine</source><year>2021</year><volume>91</volume><fpage>153710</fpage><pub-id pub-id-type="pmid">34461422</pub-id>
</element-citation></ref><ref id="R201"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ohta</surname><given-names>S</given-names></name>
<name><surname>Chang</surname><given-names>T</given-names></name>
<name><surname>Kawashima</surname><given-names>A</given-names></name>
<name><surname>Aozasa</surname><given-names>O</given-names></name>
<name><surname>Mase</surname><given-names>Y</given-names></name>
<etal>et al</etal>
</person-group><article-title>Antibiotic-activity of unsaturated fatty-acids on methicillin-resistant <italic toggle="yes">Staphylococcus-Aureus</italic></article-title><source>Bioscience, Biotechnology, and Biochemistry</source><year>1993</year><volume>57</volume><fpage>2194</fpage><lpage>2195</lpage><pub-id pub-id-type="doi">10.1271/bbb.57.2194</pub-id></element-citation></ref><ref id="R202"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Butcher</surname><given-names>GW</given-names></name>
<name><surname>King</surname><given-names>G</given-names></name>
<name><surname>Dyke</surname><given-names>KG</given-names></name>
</person-group><article-title>Sensitivity of <italic toggle="yes">Staphylococcus aureus</italic> to unsaturated fatty acids</article-title><source>J Gen Microbiol</source><italic toggle="yes">.</italic><year>1976</year><volume>94</volume><issue>2</issue><fpage>290</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">950553</pub-id>
</element-citation></ref><ref id="R203"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cora&#x000e7;a-Huber</surname><given-names>DC</given-names></name>
<name><surname>Steixner</surname><given-names>S</given-names></name>
<name><surname>Wurm</surname><given-names>A</given-names></name>
<name><surname>Nogler</surname><given-names>M</given-names></name>
</person-group><article-title>Antibacterial and anti-biofilm activity of mmega-3 polyunsaturated fatty acids against periprosthetic joint infections-isolated multi-drug resistant strains</article-title><source>Biomedicines</source><year>2021</year><volume>9</volume><elocation-id>334</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines9040334</pub-id><pub-id pub-id-type="pmid">33810261</pub-id>
</element-citation></ref><ref id="R204"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le</surname><given-names>PNT</given-names></name>
<name><surname>Desbois</surname><given-names>AP</given-names></name>
</person-group><article-title>Antibacterial effect of eicosapentaenoic acid against <italic toggle="yes">Bacillus cereus</italic> and <italic toggle="yes">Staphylococcus aureus</italic>: killing kinetics, selection for resistance, and potential cellular target</article-title><source>Mar Drugs</source><year>2017</year><volume>15</volume><elocation-id>334</elocation-id><pub-id pub-id-type="doi">10.3390/md15110334</pub-id><pub-id pub-id-type="pmid">29104213</pub-id>
</element-citation></ref></ref-list></back></article>